Screening bacterial symbionts of marine invertebrates for ribosomally synthesized natural products by Hanekom, Thea
  
Screening Bacterial Symbionts of Marine 
Invertebrates for Ribosomally Synthesized 
Natural Products 
 
Thea Hanekom 
 
A thesis submitted in partial fulfilment of the requirements for the degree of Magister 
Scientiae in the Department of Biotechnology, University of the Western Cape. 
 
July 2016 
Supervisor: Professor Marla Trindade 
 
 
 
 
 
 
ii 
 
Abstract 
Pharmaceutical research and development strategies rely on the constant discovery of 
novel natural products as potential drugs. Recent studies have shown that the 
microorganisms associated with sponges are the true producers of some previously 
isolated compounds. This study created a large collection of bacterial symbionts 
associated with the South African marine sponge, Hamacantha esperioides. The 
bioactivity assays performed, showed that 44 isolates produced compounds with 
antimicrobial or anti-inflammatory activity. The successful identification of novel 
species that produce potential natural products highlights the importance of cultivation-
dependent methods. To further screen for natural products, a cultivation-independent 
approach was used. A sequenced-based method, based on the biosynthetic genes of 
polytheonamide, was developed to screen for proteusins in sponge metagenomic DNA 
and the genomes of bacterial symbionts. The degenerate primers could amplify the 
targeted genes from DNA known to contain homologues. Evaluation of the primers’ 
specificity showed non-specific amplification of genes, some containing similar 
conserved domains as the target genes. This study demonstrated that the use and 
development of cultivation-dependent and -independent screens are important for the 
discovery of novel natural products from the symbiotic bacteria of South African 
sponges. 
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53 °C (Lanes 9-13). Template DNA added: S. meliloti (Lanes 1, 4, 6, 10 and 12) and 
poyB-plasmid (Lanes 2, 5, 7, 9 and 11). The DNA ladders are as follows: M1) 1 kb; 
M2) λ PstI and 100 bp. 
Figure 36 Different attempts of extracting mDNA with the modified urea lysis method. 
Lanes 1-4) the extracted mDNA. Lanes 5-6) the mDNA, from lanes 3 and 4, after 
purification with PVPP. The DNA markers are M1) λ DNA, about 48.5 kb; M2) λ Hind 
III and M3) λ PstI. 
Figure 37 The validation PCR of the extracted mDNA with the universal 16S rRNA 
primers. Lanes 1, 3, 5 and 7) mDNA at concentrations: undiluted, 10 times diluted, 50 
times diluted and 100 times diluted. Lanes 2, 4, 6 and 8) spiked-mDNA (mDNA with 
gDNA of D. maris). The spiked-mDNA was diluted the same as the mDNA. Lane 9) 
control reaction with gDNA of D. maris as template and lane 10) no template DNA. 
DNA marker λ PstI (M1). 
Figure 38 Size selection of the DNA purified with formamaide. The fragments greater 
than 23 kb in size was cleaned (A) as well as fragments between approximately 9 to 
23 kb (B). 
Figure 39 Phusion PCR with 16S rRNA primers: E9F with U1510R (lanes 1 and 4), 
Ento271F with Ento1290R (lanes 3 and 6) and Ento735F with Ento1290R (lanes 2, 5 
and 7). Sample PE05-A was added as template to the reactions in lanes 1, 3 and 7. 
Lane 2) A nested PCR was performed with the products of a PCR reaction mixture that 
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1. The need for natural product discovery and drug development 
Humankind has for centuries exploited the medicinal properties of natural products by 
using them as traditional medicines. Plant extracts were used as the basis for many of 
these remedies. Classical natural product discovery relied on the analysis of these 
traditional medicines to identify the active components (Harvey, 2000). In addition to 
the analysis of traditional medicines, natural product discovery also depended on 
serendipitous findings. 
Biotechnology is essentially the exploitation of organisms, or the biochemical 
compounds or proteins that they produce, to the benefit of various industries. The 
biochemical compounds are referred to as natural products. This review will focus on 
the discovery and development of pharmaceutically relevant natural products of 
microbial origin. 
Natural products are produced by organisms across all three domains of life, namely 
eukaryotes, bacteria and archaea. So far the main source of natural products is terrestrial 
organisms, especially plants, fungi and soil bacteria. Fungi are well known producers of 
natural products such as the non-ribosomal peptides, penicillin and cephalosporin 
(Walsh & Fischbach, 2010). The golden era for drug discovery from microorganisms, 
especially for antibiotics, began after the discovery of penicillin (Li & Vederas, 2009; 
Silver, 2011). This era reached its peak in the 1960s and then followed a rapid decline. 
By the 1980s novel compounds were rarely discovered (Light, 2009; Silver, 2011).  
The majority of the drugs available today are synthetic analogues or derivatives of 
natural products (Li & Vederas, 2009). This can be attributed to the limited supply of 
some natural products for research and clinical trials, as well as to the difficulty in 
obtaining natural products with acceptable pharmacological properties (Schmidt et al., 
2005). When the structures of natural products are known, the knowledge can be used as 
the foundation for combinatorial chemistry (Newman & Cragg, 2007) or combinatorial  
biosynthesis (Floss, 2006) to produce alternative products. 
The number of effective antimicrobials is decreasing as more strains of common 
diseases exhibit resistance to even the antimicrobials that are considered to be a last 
resort. This necessitates the need to discover and develop new antimicrobial 
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compounds. Natural products are not only important for the development of 
antimicrobials, but they are also important for the development of other pharmaceuticals 
such as anti-inflammatory, neuro-active (Kokel et al., 2010), antiviral (Férir et al., 
2013) and antimalarial drugs (Ang et al., 2000). The discovery of novel natural products 
is also vital since no new chemical classes of drugs have been approved as 
pharmaceuticals since the 1980s (Silver, 2011). As a consequence, researchers have 
started to focus on the marine environment, which is an enormous source of 
biodiversity, but has not yet been exhaustively exploited as a source of natural products 
for the development of pharmaceuticals. 
2. Classification of natural products 
Prominent classes of natural products include alkaloids, terpenoids, non-ribosomal 
peptides, polyketides, as well as ribosomally synthesized and post-translationally 
modified peptides (RiPPs). Research efforts in the field of natural products has focussed 
primarily on polyketides and non-ribosomal peptides since they represent a substantial 
number of important pharmaceuticals (Cane, 1997).  
2.1. Polyketides and non-ribosomal peptides 
Polyketides and non-ribosomal peptides have a similar system of biosynthesis that is 
based on chain elongation. The core synthesis of the molecule is catalysed by 
transferring the molecule along consecutive multi-modular enzymes, referred to as 
polyketide synthases (PKSs) or non-ribosomal peptide synthetases (NRPSs). A PKS or 
NRPS module is a single polypeptide that consists of at least two individually folded 
protein domains, where each domain functions as an independent enzyme (Figure 1). 
Various auxiliary tailoring enzymes can modify the functional group of the new chain 
before it is passed onto the next module, or they modify the assembled chain into the 
mature compound. The auxiliary enzymes are encoded together with the multi-modular 
enzymes within the biosynthesis cluster of the natural product (Walsh, 2004; Finking & 
Marahiel, 2004).   
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Figure 1 The core genes in a polyketide or non-ribosomal peptide biosynthetic pathway 
encode modules, called non-ribosomal peptide synthetases or polyketide synthases. 
These modules consist of different combinations of domains with specific enzymatic 
functions for the biosynthesis of a non-ribosomal peptide or polyketide. This figure was 
adapted from Finking and Marahiel (2004). 
Due to the similarity in the structures of PKSs and NRPSs, there are molecules 
produced by hybrids of these enzymes, for example, melithiazol (Figure 2), which is 
passed between PKS and NRPS domains and hybrids thereof, during biosynthesis 
(Silakowski et al., 1999). 
 
Figure 2 The gene cluster (top) of melithiazol (bottom) includes PKSs, NRPSs and 
hybrid modules (Silakowski et al., 1999). 
Polyketides are isoprenoids with biosynthetic pathways similar to fatty acids. Fatty 
acids and polyketides are synthesized from an acetyl coenzyme A molecule, but unlike 
fatty acids, polyketides can be synthesized from derivatives thereof (Ridley & Khosla, 
2009). The PKSs catalyse the synthesis of the polyketides through a condensation 
reaction of the acyl thioester precursors that result in the formation of ketides. 
Polyketide synthesis can be classified into three groups, PKS I to III, based on the 
organisation of the gene cluster, as well as the structure and the function of the 
synthesising enzymes (Ridley & Khosla, 2009). It is important to note that type II PKSs, 
which synthesise aromatic polyketides, differs from the other two types. Type II PKSs 
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use the enzymatic modules repeatedly (Cane, 1997; Cane & Walsh, 1999), while a 
molecule synthesized by type I and III PKSs is passed in one direction along the 
modules. PKSs commonly function in conjunction with other enzymes such as fatty 
acid synthases, terpene synthases or, as mentioned before, NRPSs.  
Non-ribosomal peptides are synthesized through the condensation of activated amino 
acids (Finking & Marahiel, 2004; Li et al., 2009). There are five important domains for 
the elongation of the peptide. The condensation domain, the adenylation-domain,  
peptidyl carrier protein,   thioesterase-domain and the  Cy-domain (Finking & Marahiel, 
2004). As in polyketide synthesis, non-ribosomal peptide synthesis relies on tailoring 
enzymes that modify the peptide into its mature structure. 
2.2. Ribosomally synthesized and post-translationally modified peptides 
(RiPPs) 
The scope of this review includes only classes of RiPPs produced by bacteria, as the 
research focus of this thesis will be to screen for RiPPs produced by sponge-associated 
bacteria. Information for the non-bacterial classes (toxoglossan venom peptides, 
amotoxins, phallotoxins, cyclotides, orbitides, pyrroloquinoline (PQQ), pantocin and the 
thyroid hormones T3 and T4) can be found in the review by Arnison et al. (2013). 
Natural products that are synthesized through ribosomes and undergo post-translational 
modifications are collectively called RiPPs. There is also a restriction of only including 
peptides that are not larger than 10 kDa (Arnison et al., 2013). It is important to note 
that due to a lack of consensus in the description and classification of RiPPs (McIntosh 
et al., 2009; Arnison et al., 2013), there are many terms within this class of natural 
products that describe the same concept. An example thereof is the core peptide of 
RiPPs that eventually becomes the mature and active peptide. It is sometimes referred to 
as the structural peptide, propeptide or prepeptide (Oman & van der Donk, 2010). 
Another example is the use of bacteriocins. Defining bacteriocins is not a new notion as 
Jack et al. (Jack et al., 1995) already in 1995 explained: “bacteriocins comprise a 
rather ill-defined potpourri of proteinaceous molecules”. Bacteriocins are a collective 
name for antimicrobial peptides originally thought to be only produced by Gram 
negative bacteria, such as the Enterobacteriaceae family, but they are found to be also 
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produced by Gram positive lactic acid bacteria. Bacteriocins include, for example, 
members of the RiPP classes such as lanthipeptides (Zhang et al., 2012), glycosins 
(Wang & van der Donk, 2011), sactipeptides and thiopeptides (Kelly et al., 2009). 
Along with the confusion caused by terminology, there is also the matter of peptides 
being classified into more than one of the RiPP classes. Examples are microcins B17 
and J25. These compounds are classified as microcins (Section 2.2.5.) as well as linear 
azole-containing peptides (LAPs, in the case of micorcin B17; Section 2.2.7.1.) or as 
lasso peptides (in the case of micorcin J25; Section 2.2.6.). 
The interest in researching RiPPs as pharmaceutical drugs has increased over the last 15 
years, mainly due to the availability of sequencing techniques (Arnison et al., 2013). 
Another driving factor for the increase in research is the structural diversity that RiPPs 
display, with more than 17 classes identified thus far (Arnison et al., 2013). Some of the 
diversity is brought about by post-translational modifications that are so different to 
traditional ribosomal peptide synthesis that the active product is sometimes not 
recognised as being a product of ribosomal synthesis (Kersten et al., 2011).  
2.2.1. General structure and synthesis of RiPPs 
The biosynthetic genes of RiPPs, arranged within an operon, are involved in the 
synthesis, modification, export and regulation of RiPPs. They include precursor gene(s) 
of the peptide, maturation enzymes and auxiliary genes. Examples of maturation 
enzymes are cyclohydratases, dehydrogenases, radical S-adenosylmethionine dependent 
methyltransferase (rSAMs), thiazole-oxazole modification enzymes and lanthionine 
synthetases. Auxiliary genes include those that encode a docking scaffold, ATP-binding 
cassette (ABC) transporters and anti-toxin genes with an immunity function for the 
producing organism. With the sequencing of RiPP biosynthetic pathways it was noticed 
that the auxiliary enzymes are shared between different classes (Wieland Brown et al., 
2009; Freeman et al., 2012). It should be noted that there are instances where not all of 
the biosynthetic genes are encoded within the operon (Haft et al., 2010; Kelly et al., 
2009). 
Precursor peptides are about 20 to 60 amino acid residues in length (Kawulka et al., 
2003). For most of the RiPP classes the precursor can be divided into the leader and 
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core peptide. The core peptide will be modified by the post-translational enzymes into 
the active natural product. This is flanked by a leader peptide at the N-terminus. 
However, there are exceptions to this rule, for example, the leader peptide of 
bottromycins (Arnison et al., 2013) seems to have been shifted to the C-terminus of the 
core peptide. The sequence of leader peptides is usually highly conserved for all 
members of the same class of RiPP. Although the functions of many leader peptides are 
still elusive, they are known to assist  the post-translational process (Figure 3) by 
activating the maturation enzyme and orientating the core peptide (Patton et al., 2008; 
Yang & van der Donk, 2013; Dunbar & Mitchell, 2013; Knerr & van der Donk, 2012). 
 
Figure 3 Activation of the post-translational modification enzymes can be catalysed 
when the leader peptide (red coil) is recognized by the enzymes. The leader peptide also 
helps to orientate the core peptide (blue) to ensure that post-translational modifications 
occur at the correct positions (adapted from Yang & van der Donk, 2013). 
Various maturation enzymes will modify the structure of the peptide either at the 
molecular level, by modification of a functional group, or at the macromolecular level, 
by forming for example rings (cyaobactins, thiopeptides, etc.) or even knots 
(lassopeptides). The peptide is activated after post-translational modifications, for 
example, when homologues of ABC transport proteins activate the core peptide by 
cleaving the leader peptide from the core peptide as it is exported from the cell 
(McIntosh et al., 2009). 
One of the main differences between peptides synthesized by the ribosome and NRPSs 
lies with the monomers that are utilised. For ribosomal peptides the organisation of the 
monomers, the proteinogenic amino acids, are genetically encoded and transcribed. 
RiPPs could contain non-proteinogenic amino acids, but they are not incorporated 
Precursor 
peptide 
activation 
Orientation 
of core 
peptide 
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directly during transcription. The presence of non-proteinogenic amino acids are rather 
due to post-translational modifications of proteinogenic amino acids. For non-ribosomal 
peptides it is only the modules (NRPSs) that are genetically encoded. The organisation 
of the monomers is then inferred from the modules and the monomers incorporated are 
not restricted to only the proteinogenic amino acids (Caboche et al., 2010).  
A short introduction on the main characteristics of the bacterial RiPP classes will now 
be presented. 
2.2.2. Lanthipeptides 
Lanthipeptides have been researched for more than 50 years and are the archetypes of 
RiPPs. They were formerly known as lanthionine-containing antibiotics or lantibiotics, 
but are now referred to as lanthipeptides because they have shown bioactivities other 
than antimicrobial activities. These peptides are recognized by their lanthionine or 
methyllanthionine thioether (Lan or MeLan) bonds (Figure 4) between Cys and 
dehydrated Thr or Ser residues (Flühe & Marahiel, 2013). There are four classes within 
this group and peptides are classified according to the enzymes involved in the catalysis 
of the thioether crosslink formation. 
 
Figure 4 Examples of lanthipeptides with a conserved methyllanthionine ring (red; 
Patton et al., 2008). 
2.2.3. Linaridins 
The rare peptides of this class was previously considered to be lanthipeptides since they 
have the same thioether crosslink moiety, but with the recent discovery of the 
biosynthetic gene cluster of cypemycin (Claesen & Bibb, 2010), it was shown that the 
moiety is not formed by the same enzymes as those of the lanthipeptides. Only two 
members are known in this class (Figure 5), cypemycin  and grisemycin and their 
haloduracin 
α 
plantaricin 
C 
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biosynthesis has been elucidated by Claesen and Bibb (Claesen & Bibb, 2010; Claesen 
& Bibb, 2011). 
 
Figure 5 Cypemycin and grisemysen are the only members, so far, of linaridins and 
have a similar structure to lanthipeptides as they contain a thioether cross link moiety 
(red; Claesen & Bibb, 2011). 
2.2.4. Microviridins 
Microviridins are a family of tricyclic depsipeptides. They are distinguished by having 
two conserved ω-ester bonds between the residues Thr-Asp and Ser-Glu (Figure 6), as 
well as an ω-amide bond between the residues Lys-Glu (McIntosh et al., 2009). They 
also have an unique cage-like structure which lends it high stability against proteases 
(Ziemert et al., 2008). 
 
Figure 6 Microviridin A (1), B (2) and C (3) are tricyclic depsipeptides with ω-ester 
(red) and ω-amide bonds (blue). This figure was adapted from (Murakami et al., 1997). 
2.2.5. Microcins 
These peptides are mainly produced by Escherichia coli. Peptides are classified within 
this class when they have a molecular mass of less than 10 kDa, which is small in 
1 2 
3 
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contrast to the size of other antimicrobial peptides produced by Gram-negative bacteria. 
There are only fourteen members in this class (Arnison et al., 2013), of which the two 
peptides, J25 (Figure 7) and microcin B17 (Figure 9), are prominent as they are 
structurally related to other larger RiPP families, namely, lasso peptides (Section 2.2.6.) 
and LAPs (Section 2.2.7.1.). 
 
Figure 7 Microcin J25 is also classified as a lasso peptide (Section 2.2.6.; Oman & van 
der Donk, 2009).  
2.2.6. Lasso Peptides 
Lasso peptides are classified according to their exceptional knot-like structure. They 
consist of 16 to 21 residues. A ring-structure is created through an isopeptide bond 
between the N-terminal Gly and residue 8 or 9, which is either an Asp or Glu (Figure 8). 
The C-terminal residues are threaded through and entrapped within the ring which 
contributes to the stable structure of these peptides (Knappe et al., 2008), known as the 
lasso fold.  
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Figure 8 The general topology of lasso peptides consists of a ring that is formed with an 
isopeptide bond between the eighth or ninth residue (arrows) and the N-terminal residue 
of the peptide. The C-terminal of the peptide is threaded through the ring. The structure 
of lasso peptides is stable as the tail is trapped within the ring. Figures acquired from 
Knappe et al. (2008) and Maksimov et al. (2012).  
2.2.7. Thiazole/oxazole-modified microcins (TOMMs) 
These RiPPs are divided into three classes: linear azole-containing peptides (LAPs), 
thiopeptides and cyanobactins (Melby et al., 2011). They are related by having thiazole 
and (methyl)oxazole heterocycles which are formed when cyclodehydratase and/or 
dehydrogenase catalyse the cyclisation of Cys, Ser and Thr residues within the core 
peptide.  
2.2.7.1. Linear Azole-containing Peptides (LAPs) 
The post-translational modifications by cyclodehydratase and/or dehydrogenase of the 
Cys, Ser and Thr residues within the core peptide of LAPs results in the characteristic 
thiazole and (methyl)oxazole heterocycles (Figure 9; Oman & van der Donk, 2009). 
Peptides within this class are also classified within other classes, as mentioned before. 
They are distinguished from other azol(in)e RiPPs as they are linear and do not form 
macrocyclised structures. 
 
Figure 9 Molecular structure of the LAP, microcin B17 (Oman & van der Donk, 2010). 
These peptides (and other TOMMs) are distinguished by their thiazole (blue) and 
oxazole (red) heterocycles. 
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2.2.7.2. Thiopeptides 
Thiopeptides  have only recently been classified as RiPPs when four independent 
research groups published the biosynthetic gene clusters of a few thiopeptides (Wieland 
Brown et al., 2009; Morris et al., 2009; Liao et al., 2009; Kelly et al., 2009). These 
peptides are distinguished from other thio-containing RiPPs as they are highly modified 
with many non-proteinogenic residues that are the result of post-translational 
modification of proteinogenic residues. They have one or more macro-cycles with a 
nitrogenous heterocyclic core, namely pyridine, hydroperidine or dehydropiperidine 
(Figure 10).  
 
Figure 10 The thiopeptides  thiostrepton A (A), nosihepeptide (B) and GE2270A (C), 
with  pyridine, hydroperidine or dehydropiperidine  at the cores (red) of the peptides 
(Kelly et al., 2009). 
2.2.7.3. Cyanobactins 
The diverse group of cyanobactins are produced by members of the photosynthetic 
bacterial phylum, Cyanobacteria. They are distinguished as small N- to C-terminal 
(head-to-tail) cyclised peptides. These peptides are usually of a low molecular weight, 
with six to eight residues, although some have been reported to consist of up to 20 
residues (Donia & Schmidt, 2011). Some of the post-translational modifications of this 
class include the formation of thiazole and oxazole heterocyclic moieties (Leikoski et 
al., 2010), as mentioned before. Although hundreds of cyanobactins have been 
discovered through chemical extraction and cultivation-dependent methods, genome 
mining is becoming an effective tool for the discovery of novel cyanobactins (Donia & 
Schmidt, 2011; Donia et al., 2008).  The first biosynthetic pathway for this group was 
A B C 
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elucidated in 2005 by Schmidt et al. (Schmidt et al., 2005) for the production of  
patellamide A and C (Figure 11).  
 
 
Figure 11 The cyanobactins, patellamide A and B, was the first members of their class 
to have their biosynthetic pathway characterised (Schmidt et al., 2005). These peptides, 
like other TOMMs, are distinguished by their thiazole (blue) and oxazole (red) 
heterocycles. 
2.2.8. Sactipeptides 
Sactipeptides are macrocyclic peptides with unique bonds between the sulphur of Cys 
residues and the α-carbon of another (non-conserved) residue. Although this type of 
bond is not found in any other RiPP classes, it is a familiar chemical feature of non-
ribosomal peptides. 
 
Figure 12 The primary (A) and three dimensional structure of subtilosin A (B). The 
peptides in this class are distinguished by their head-to-tail cyclisation (N-C linkage, 
absent in B) and sulphur-alpha-carbon linkages (red lines) between Cys and other 
residues (Kawulka et al., 2003). 
patellamide A patellamide C 
A 
B 
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2.2.9. Bacterial head-to-tail cyclized peptides 
Bacterial head-to-tail cyclised peptides form rigid structures that are able to withstand 
degradation. They are separated from other N- to C-terminal cyclised peptides as they 
have a large core peptide, with 35-70 amino acid residues, and different enzymes for 
macrocyclisation that catalyse the formation of a peptide bond (Figure 12). Their 
biosynthetic enzymes are divided into three groups according to their chemical 
properties. Another contrast to other RiPP classes are that the leader peptides are not as 
conserved and vary in length (van Belkum et al., 2011). 
2.2.10. Glycocins 
The two members of the glycocins class, sublancin and glycocin F, are glycosylated at 
Cys residues. The glycosylation of these peptides are characterised by the bond between 
the sulphide of Cys and the sugar. These peptides show antimicrobial activity, however, 
their mechanism of action still needs to be elucidated (Arnison et al., 2013). Even 
though these peptides are glycosylated, this chemical feature is not important for the 
antimicrobial activity of sublancin (Wang & van der Donk, 2011). It was found that the 
glycosylation of the peptide rather plays a role in the immunity of the producing 
organism.  
 
Figure 13 The glycosin, sublancin, is glycosylated with a S-link to the free Cys residue 
of the peptide (red; Wang & van der Donk, 2011).  
2.2.11. Bottromycins 
Bottromycins have unique modifications and structural characteristics. They have rare 
non-proteinogenic residues, such as tert-Leu and D-amino acids, which are also found 
within the proteusin class. The full structure of the first member of this family, 
bottromycin A2 (Figure 14), has been elucidated by Shimamura et al. (2009). This is 
 
 
 
 
32 
 
more than 50 years after it was originally isolated in 1957 (Waisvisz et al.). Another 
distinctive characteristic of bottromycins are that they lack a leader peptide at the N-
terminus of the core peptide, but rather have a follower peptide, of which the full 
function is unclear. 
 
Figure 14 The structure of bottromycin A2 (A) and bottromycin D (B) with a difference 
in residue 13 (red). This figure was adapted from Shimamura et al. (2009) and Hou et 
al. (2012). These peptides are also modified to contain non-proteinogenic residues, such 
as tert-Leu (tLeu; blue). 
2.2.12. Proteusins 
The proteusins play a central role in the research presented in this thesis and will be 
discussed in more detail. The only proteusins that have been isolated thus far are the 
polytheonamides (A, B and C; Hamada et al., 2005). Polytheonamide A and B can 
change spontaneously into one another due to oxidation (Hamada et al., 2005; Freeman 
et al., 2012), since the only difference between them is the stereochemistry of the 44th 
residue (Figure 15). They were extracted from the lithistid sponge, Theonella swinhoei, 
and showed strong anti-tumour activity (Hamada et al., 1994). It was the bioactive 
properties and the novel structure  of polytheonamides (Hamada et al., 2005) that 
captured the interest of researchers. Initially it was believed that polytheonamides were 
produced by a NRPS system. It was also thought that a symbiotic bacterium of the host 
sponge might be the true producing organisms, since other non-ribosomal peptides were 
produced by the symbionts of lithistid sponges (Hamada et al., 2005). 
Polytheonamide B consists of 48 residues. It is this great size and the high amount of 
post-translational modifications (Inoue et al., 2010) observed, that led researchers to 
A 
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think that it is the largest non-ribosomal peptide isolated. However, the ribosomal origin 
of the proteins were discovered recently (Freeman et al., 2012). The extensive 
post-translational modifications (Figure 15) include the hydroxylations (4 residues) and 
C-methylation (21 residues). The peptide contains 18 D-amino acid residues and the 
non-proteinogenic residues include β-methylisoleucine, β-methylglutamine, 
β-hydroxyvaline, γ-N-methylasparagine, tert-leucine, γ-N-methyl-β-hydroxyasparagine 
and β,β-dimethylmethionine sulfoxide (residue 44; Hamada et al., 2005; Mori et al., 
2007; Freeman et al., 2012). The N-terminal residue is di-methylated, which is an 
uncommon moiety for ribosomal peptides, but it has been observed in the RiPP 
cypemycin (Freeman et al., 2012; McIntosh et al., 2009; Martin-Visscher et al., 2008; 
Claesen & Bibb, 2010). A unique feature of polytheonamides is the numerous D-amino 
acids that alternate with the L-amino acids throughout the peptide (Figure 15). 
Polytheonamides have a β-sheet as a secondary structure (Figure 16) that forms a barrel. 
This barrel ultimately acts as an ion channel across membranes which weakens the 
resting membrane potential that contributes to the cytotoxicity of polytheonamides 
(Iwamoto et al., 2010). This bioactivity allows them to be used as very potent anti-
tumour therapeutics.  
 
Figure 15 Primary structure of polytheonamide A and B. There is a stereochemical 
difference between the two peptides at the 44th residue, a β,β dimethylmethionine 
sulfoxide (red). Adapted from Hamada et al. (2005). 
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Polytheonamides are often compared to the non-ribosomal peptide gramicidin A as they 
have similar structural and functional characteristics. Both peptides are linear with 
alternating D- and L- amino acids. They form right-handed β-helixes (Figure 16) within 
environments that are similar to membranes (Mori et al., 2007) and consequently 
functions as ion channels with selectivity for monovalent cations (Iwamoto et al., 2010). 
   
Figure 16 (A) The structure of the homo-dimer, gramicidin A (Ketchem et al., 1993). 
(B) A three dimensional representation of the right-handed helix of polytheonamide B. 
(C) The top (C-terminus) view of the channel that is formed by the helical structure. 
(The graphics of B and C was created with the protein database (PDB), accession 
number: 2RQO, and the Swiss PDB-Viewer tool (Guex & Peitsch, 1997)). 
3. The marine environment as a source for natural products  
3.1. Marine natural product research 
Marine natural products were first discovered in the 1950s (Matsunaga et al., 1985; Leal 
et al., 2012), but only started to gain popularity in the 1980s, which led to an increase in 
the number of discoveries (Davies-Coleman, 2005). The discoveries were primarily 
made by marine natural product chemists who examined the extracts of 
macroorganisms. Marine natural products are screened with a wide variety of bioassays 
to determine what biological activities they have.  
The progress made with the discovery of marine natural products, and the subsequent 
development of drugs, was primarily dependent on time and technology. Even though 
A B C 
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many marine natural products were discovered between the 1960s and the 1980s, there 
was a period from 1980 to 2000 when most pharmaceutical companies abandoned their 
bioprospecting projects. The discoveries made during this period were mainly due to 
academic research. Over the last 10 years there was a renewed interest in bioprospecting 
the marine environment. The new interest in bioprospecting for marine natural products 
is partly due to improved analytical technologies and to the development of high-
throughput methods (Leal et al., 2012). The improvements included advances in 
techniques used for the isolation, purification, structure determination and high-
throughput bioactivity analysis of natural products.  The refinements enabled the use of 
a smaller sample size for analysis, as the new equipment and techniques are more 
sensitive. Some of the improved techniques include chromatography, mass spectrometry 
and nuclear magnetic resonance (Harvey, 2008; Walsh & Fischbach, 2010). The 
progress made with the discovery of marine natural products also becomes evident in 
the type of compounds isolated. Early discoveries were of simpler non-polar 
compounds and this progressed to smaller and more complex compounds (Ianora et al., 
2012). Along with the improvements in laboratory techniques, the methods of sampling 
also improved from relying on hand-picking and trawling to SCUBA diving and 
advanced depth collection with submersibles. One of the major influences that fuelled 
marine natural products research is advances in sequencing techniques that made the 
discovery of the biosynthetic pathway of the natural products more readily available. 
3.1.1. Examples of marine natural products 
In 2013 eight marine natural products were available on the market (Martins et al., 
2014). These include trabectedin (Yondelis®) and cytarabine (Cytosar-U®) that is used 
for the treatment of cancer as well as the anit-viral drug iota-carrageenan 
(Carragelose®). The latter is a sulphated polysaccharide that was extracted from red 
algae, specifically Chondrus crispus and Gigartina stellata (Pietra, 1990). The 
nucleoside cytarabine, or Ara-C, was isolated from the marine sponge Cryptotethia 
crypta (Sipkema et al., 2005), while trabectedin, an alkaloid, was isolated from the 
tunicate Ecteinascidia turbinata (Wright et al., 1990). 
Three other marine natural products will be used as examples to illustrate some of the 
achievements and limitations encountered with marine drug discovery. The examples 
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are bryostatins (a polyketide), the conopeptide MVIIA (a RiPP) and discodermin A 
(suggested to be a non-ribosomal peptide). The conopeptide is already available on the 
market while the others are still being evaluated in clinical trials. 
The bryostatins, a family of polyketides, was studied as early as 1968 when bioassays 
were performed with the chemical extracts of Bugula neritina (phylum Bryozoa). 
Bryostatin 1 was only isolated in 1981 by fractionation of the extracts that showed 
bioactivity against cancerous cell lines (Pettit et al., 2002). One of the major limitations 
of marine drug discovery, a shortage in the supply of the compound, hindered 
preclinical and clinical trials. B. neritina have been studied since 1758 (Mendola, 2003). 
The knowledge of this organism acquired over the centuries, was used to develop 
aquaculture strategies and protocols in the 1990s to provide large-scale supplies of 
bryostatin 1. Since the cost of aquacultures is significant, alternative methods of 
production were also investigated such as total- and semi-chemical synthesis (Evans et 
al., 1999; Wender et al., 1998). The latter process produced bryostatins which retained 
the activity of the natural product (Faulkner, 2000). Bryostatin 1 was the second marine 
natural compound to enter clinical trials and it is still the subject of numerous phase II 
clinical trials (Hussain et al., 2012; Ianora et al., 2012). A series of analyses by 
Haygood and Davidson on the microbial symbionts of B. neritina  led to their proposal 
that these symbionts are the producers of bryostatins (Haygood et al., 1999; Faulkner, 
2000; Davidson et al., 2001) and in 2007 a putative biosynthesis pathway was identified 
from an uncultivated microbial symbiont of B. neritina (Sudek et al., 2007). 
The first marine natural product to pass clinical trials that was licenced for marketing in 
2004 (Ianora et al., 2012; Kornprobst, 2014), is a toxin peptide produced by the cone 
snail, Conus magnus. This peptide is known as conotoxin MVIIA, ziconotide or Prailt® 
and is classified as a RiPP. Conopeptides have been discovered since the early 1980s 
within the venom of these snails, however, only after a long period of clinical trials and 
after approval of the licence (1999-2004; Svenson, 2013) was this natural product 
available for the treatment of chronic pain. The specificity of the product reduces the 
probability of adverse effects and it is this property that made it so attractive for 
development as a therapeutic (Shen et al., 2000). 
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During the early years of bioprospecting the marine environment, invertebrates were 
favourable sources of different classes of natural products. Various peptides have been 
extracted, but their bioactive properties were unknown. It was only in 1980 that the 
importance of peptides as natural products was revealed when peptides from the 
tunicate Lissoclinum patella showed some bioactivity (Matsunaga et al., 1985). In 1985 
the research group of Matsunaga et al. (1985) isolated discodermin A. It was the first 
bioactive peptide isolated from a sponge. They proposed that this antimicrobial non-
ribosomal peptide is a product of a symbiotic microorganism of the sponge, 
Discodermia kiiensis. This was due to it having a unique structure with multiple D-
amino acids and a tert-Leu residue. Until then, the latter type of residue has only been 
found in bottromycin. Bottromycin was extracted from a terrestrial Streptomyces 
bottropensis (Waisvisz et al., 1957). D-amino acids are more prevalent within bacterial 
proteins, which is another indication of the symbiotic origin of these peptides. Since 
then, other peptides containing these unusual residues have been discovered, namely 
polytheonamides and yaku’amides. It is the ribosomal origin of bottromycins and 
polytheonamides that suggest that discodermins (and yaku’amides) are produced 
through ribosomal synthesis (i.e. RiPPs; Freeman et al., 2012). 
3.2. The marine environment is suitable for the evolution/synthesis of 
novel compounds 
As the field of marine natural products expanded, scientists were intrigued by the 
biochemical diversity of marine organisms’ metabolites that were unparalleled in 
terrestrial organisms. The factors that influence the uniqueness and abundance of marine 
natural products can be ascribed to be either the taxonomical or ecological influence 
(Jensen & Fenical, 1996).  
The taxonomical influence on the novelty and diversity of marine natural products lies 
in the divergence of terrestrial and marine organisms long ago. This divergence is 
generally at species level (Jensen & Fenical, 1996). Genera with species of terrestrial 
origin which have been encountered during bioprospecting for marine natural products 
include Pseudomonas, Alteromonas, Vibrio, Bacillus, and Streptomyces. Even though 
there are biochemical differences at species level, species from the same genera share 
similarities in their metabolism and thus they have the ability to produce similar 
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compounds (Jensen & Fenical, 1996). This is why there are marine compounds with 
structural similarities to those of terrestrial origin, such as the afore-mentioned 
discodermins and bottromycins.  
The ecological difference between the marine and terrestrial environment drives the 
adaptation of micro- and macroorganisms in order to ensure their survival (Li & Qin, 
2005). These biochemical and physiological adaptions are seen through the structural 
diversity and novelty of their secondary metabolites (Jensen & Fenical, 1996; Faulkner, 
2000; Simmons et al., 2005). For example, the high salinity of the ocean creates an 
environment where halogens, especially chlorine and bromine, are more readily 
available. Various halogenated natural products have been discovered (Simmons et al., 
2005). Also, many marine macroorganisms are physically soft and their chemical 
defence mechanisms compensates for their lack of structural defence. This can be 
through the production of natural products or hosting microorganisms with the ability to 
produce advantageous natural products.  
3.3. Sponges and their symbiotic relationship with microorganisms 
The symbiosis of microorganisms with macroorganisms is complex (Taylor et al., 2007; 
Piel et al., 2004; Mohamed et al., 2008). The host macroorganism creates a unique 
microenvironment with various physical, chemical, and biological factors. These factors 
determine the selection of organisms who can survive within the specific environment 
and maintain the mutualistic relationship (Jensen & Fenical, 1996). This selection may 
be the driving force for the production of novel natural products. 
An example of this type of relationship is found within sponges. Sponges (phylum 
Porifera) are sessile invertebrates and as their name suggests, they draw in the 
surrounding water through pores and filter it (Taylor et al., 2007; Kennedy et al., 2007). 
When filtering the water, they ingest the nutrients and the microorganisms therein. 
Some microorganisms are retained and live in symbiosis with the sponge and others 
pass through the feeding chambers without being ingested. The symbiotic 
microorganisms are found to be associated with the external and internal tissue of the 
macroorganism host (Lee et al., 2001; Kennedy et al., 2008).  Up to about 40 % of the 
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sponge biomass could consist of the symbiotic microorganisms (Fusetani & Matsunaga, 
1993).  
The symbiotic relationship of sponges and microorganisms is not fully comprehended, 
but it comes across as a mutualistic relationship. In this relationship the sponge provides 
a safe, nutrient rich environment for the microorganisms compared to the open water. 
The role of the microorganisms includes the supply of nutrients (Bondarev et al., 2013), 
the removal of waste products from the sponge and the strengthening of the sponge 
structure as they constitute a high percentage of the biomass of the host. Another 
function of sponge symbionts is their production of secondary metabolites, many of 
which have widely diverse bioactive properties (Kennedy et al., 2007; Lee et al., 2001). 
For instance, antimicrobial compounds can be produced to protect the host 
macroorganism (Bondarev et al., 2013; Faulkner, 2000) as was suggested for the 
Pseudovibrio species (Bondarev et al., 2013). 
This is why, at the end of the 20
th
 century, the research focus shifted from sponges to 
their symbiotic microorganisms. Marine sponges have long been recognised as rich 
sources of natural products for drug development (Pettit et al., 2002; Mayer et al., 2010; 
Ouyang et al., 2010; Laport et al., 2009), however it has been proven that the symbiotic 
microorganisms are the true producers of many known sponge natural products 
(Muscholl-Silberhorn et al., 2008; Taylor et al., 2007). 
4. Methods for the biodiscovery of natural products 
In the previous sections a few examples of the marine natural products were discussed. 
In this section we will look at some of the methods and techniques that have been used 
to discover these compounds. The limitations and advantages of the methods are also 
discussed. 
4.1. Bioassay screens 
Bioassay screens are used with cultivation-dependent and -independent methods for the 
discovery of natural products. When a biological activity is observed, the compound (or 
crude extract) is referred to as being bioactive. Bioactive extracts are purified to 
determine the biochemical properties of the responsible compound(s).   
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Before the turn of the century, natural product research was mostly focussed on 
antimicrobial and anti-tumour bioactive compounds (Ianora et al., 2012). Since then a 
wider range of bioassay screens have been included as the applications of the 
compounds have extended to more than just the pharmaceutical industry. However, the 
focus of this study is to discover pharmaceutical-relevant natural products. Other 
pharmaceutical-relevant assays that have been developed include anti-inflammatory 
(Svenson, 2013), neuro-active (Kokel et al., 2010), antiviral (Férir et al., 2013) and 
antimalarial screens (Ang et al., 2000). With these, natural products (crude extract or 
refined compounds) are tested against different microbial strains or specific cell lines 
(Imhoff et al., 2011). Examples of screens used are those employed at The Centre for 
Marine Bioactives and Drug Discovery (MabCent-SFI), at the University of Tromsø, 
Norway (Table 1).  
Table 1 Bioassays employed by MabCent-SFI platforms.
1
 
Activity Target cell line or strain 
Toxicity MRC-5 (normal lung fibroblast) 
Anticancer 
HT-29 (colon adenocarcinoma) 
MCF-7 (breast cancer cells) 
A2058 (melanoma) 
IPC-81 (leukaemia) 
NF-κB (A549) 
Kinase inhibition 
Antibacterial 
E. coli ATCC 25922 
Staphylococcus aureus ATCC 9144 
Methicillin-resistant S. aureus (MRSA) 
Psuedomons aeruginosa ATCC 27853 
Enterococcus faecalis 
Inhibition of biofilm formation Staphylococcus epidermidis ATCC 35984 
Immunomodulation (anti-inﬂammatory) 
TNF-α 
IL-1β (THP-1) 
NF-κB (U937) 
Diabetes 
PPARc 
PTB-1B 
1 
Adapted from (Svenson, 2013) 
4.2. Traditional and cultivation-dependent screening methods 
The initial method to discover marine natural products was to screen the extracts of 
macroorganisms, such as sponges, for bioactivity. This is sometimes referred to as the 
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“grind and find” approach. This type of screening method led to the discovery of natural 
products such as bryostatins, discodermins and polytheonamides as discussed in 
Sections 3.1. and 2.2.12. Cultivation-based screens have been attempted for many of the 
macroorganisms from which bioactive compounds were discovered through the “grind 
and find” approach, but difficulties were usually encountered with the cultivation of the 
symbiotic microorganisms. 
Cultivation-dependent screening methods, typically employed for the discovery of 
marine natural products, generally consist of four stages. Initially organisms are isolated 
from an environment and fermented. The fermentation products are screened for a 
desired bioactivity (examples given in Section 4.1) and the bioactive compound is then 
isolated. Finally the biochemical characteristics of the compound are determined.  
Cultivation-dependent screening methods have been successfully applied to discover 
bioactive compounds from microbial symbionts of sponges. For example, Pseudovibrio 
species have been isolated from Irish sponges by O'Halloran et al. (2011) and 85 % of 
the isolates displayed antimicrobial activity against at least one of the indicator strain 
that were tested. Similarly Santos et al. (2010) isolated diverse bacterial species 
(Firmicutes, Alpha- and Gamma-Proteobacteria) with antimicrobial activities from 
Brazilian sponges. 
4.2.1. Limitations and significance of cultivation-dependent methods 
The limitations of cultivation-dependent methods are mainly linked to the type of 
organisms isolated, that is in turn limited by the media and conditions used for isolation.  
Generally, the organisms isolated from any environment do not represent the true 
microbial community within that environment (Ward et al., 1990). Many attempts have 
been made (for example: Schmidt et al., 2000; Bode et al., 2002; Muscholl-Silberhorn 
et al., 2008; Connon & Giovannoni, 2002) to improve the cultivation media and 
techniques employed, but it is difficult to mimic the natural environment of the 
organisms entirely. Initially, routine media (usually being rich in nutrients) was used for 
the isolation of marine microorganisms. It was soon realised that many of the species 
are adapted to have limited access to nutrients in their habitat and cannot metabolise the 
complex carbons (Connon & Giovannoni, 2002). This is why a wide array of media 
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(frequently the oligotrophic type) is continuously being developed (Connon & 
Giovannoni, 2002) to select for microorganisms based on their known physiological 
requirements. Oligotrophic media have successfully promoted the isolation of a more 
diverse collection of organisms. However, the use of nutrient rich and complex media is 
still common practice as the cultivation conditions of most microorganisms are still 
elusive (Bernan et al., 1997). It has been suggested that the cultivation of some 
organisms might not be possible until the symbiotic relationships of organisms (macro 
and micro) are understood (Bondarev et al., 2013; Querellou et al., 2010).  
Another limitation is when cultivation conditions used for screening do not activate the 
biosynthetic pathways of natural products (Jensen & Fenical, 1996; Newman & Cragg, 
2012). Consequently, many of the products remain undiscovered during the screening 
process. With the genomic age the full genome sequence of organisms became 
available. Analysis of the genomes showed that many of the natural products have not 
been discovered with the standard laboratory cultivation approaches. This concept was 
exemplified when the full genome of the model organism Streptomyces coelicolor 
A3(2) was published in 2002 (Bentley et al., 2002). Examining the genome, 18 gene 
clusters for unprecedented secondary metabolites of various classes were discovered. 
These types of gene clusters are known as “cryptic”, “silent” (Imhoff et al., 2011) or 
“orphan” pathways. Thus by changing the cultivation conditions the activation of 
cryptic pathways has been observed with the production of novel natural products (Qu 
et al., 2011). An approach to discover the products of orphan pathways is the one-strain-
many-compounds (OSMAC) approach (Bode et al., 2002) where matrices of screens are 
performed under multiple conditions.  
One of the major impediments in the development of drugs from natural products is the 
production of the compounds in large quantities for evaluation in trials and marketing 
(Proksch et al., 2002). The complexity of the compounds make the chemical synthesis, 
and thus large-scale production thereof, complicated and generally not feasible (Li & 
Qin, 2005; Kennedy et al., 2007). This creates the need for an effective, conservational 
and economically feasible supply of natural products.  One such approach is the semi-
synthesis of analogues of the natural product. An example is where cyanosafracin B, 
produced by Pseudomonas fluorescence, is used for the semi-synthesis of trabectedin 
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(Yondelis®; Cuevas & Francesch, 2009). Another example is the production of Ara-C, 
the analogue of the nucleoside cytarabine (Taylor et al., 2007; Sipkema et al., 2005; 
Dunlap et al., 2007; Laport et al., 2009).  
There are currently numerous organisms that can still be exploited for the production of 
novel natural products if they could be cultivated. The development and improvement 
of cultivation-dependent methods are thus still imperative and have the distinct 
advantage that the producing organisms are cultured under laboratory conditions and are 
available for further investigations and scaled up production. Ultimately the bioactive 
compound can be obtained in large quantities, for development and marketing purposes, 
once the large-scale fermentation of the organisms is optimised. It is important to note 
that some cultivation-independent methods are based on cultivation-dependent methods. 
An example is the functional screening of heterologously expressed libraries (refer to 
the next section). Also, when a biosynthetic pathway of a natural product has been 
identified using sequence-based cultivation-independent methods, the pathway can be 
expressed in a heterologous host to characterise the biosynthetic genes and the product. 
This underlines the importance of cultivation-dependent methods.   
4.3. Cultivation-independent screening methods 
Cultivation-independent screening methods use molecular and in silico techniques that 
do not require the isolation and cultivation of organisms for the discovery of natural 
products. Traditionally cultivation-independent methods were used to access the 
genomes of uncultured organisms through metagenomics, but the methods expanded to 
include the exploration of their transcriptomes and proteomes (Figure 17). The 
information generated from these methods is stored on open access database servers for 
comparative analysis with bioinformatics tools. It is also important to note that, 
although the focus is on uncultured organisms, cultured organisms are also investigated 
with cultivation-independent methods, since sequencing and analysis of their genomes 
could result in the identification of biosynthetic pathways for natural products that have 
not been discovered with the cultivation-dependent methods (Bentley et al., 2002; 
Udwary et al., 2007). 
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Figure 17 An overview of the cultivation-independent methods used for the screening of 
natural products. 
4.3.1. Metagenomics 
In 1998 Handelsman et al. introduced the term metagenomics (Steele & Streit, 2005), 
which is essentially the study of the genomes of a mixed community of organisms 
within an environment. Some of the first metagenomic DNA (mDNA) libraries were 
constructed from seawater (Béjà et al., 2000) and marine sponges (Schleper et al., 
1998). Since many marine natural products are biosynthesized by the (as of yet) 
uncultivable symbiotic microorganisms of invertebrates (Haygood et al., 1999; Piel et 
al., 2004; Proksch et al., 2002), researches use metagenomics (Figure 18) to circumvent 
the limitations of cultivation-dependent methods and gain access to the biosynthetic 
pathways of (known and unknown) natural products.  
Metagenomic screening methods require the construction of mDNA libraries that are 
screened either with function-based assays or with sequence-based analysis. Functional 
screening is based on the heterologous expression of the genes by the surrogate 
organism. These organisms include the workhorse of the laboratory, E. coli, but other 
hosts have also been included such as Streptomyces (Courtois et al., 2003; Li & Qin, 
2005; Ikeda et al., 2014; Wang et al., 2010); Bacillus (Eppelmann et al., 2001; Biver, 
2013) and various Proteobacteria (Charlop-Powers et al., 2013; Li & Qin, 2005). 
Functional screening can be done by observing phenotypical changes of a sought after 
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activity (Section 4.1). This has been successfully employed for the discovery of natural 
products with antimicrobial screening (Rondon et al., 2000; Courtois et al., 2003). 
Another method is where the surrogate host (or a mutant surrogate host) is dependent on 
the targeted gene for survival within specific conditions (Wang et al., 2010; Simon & 
Daniel, 2011). Many natural products have been identified with functional screens of 
metagenomes derived from soil and marine environments (Courtois et al., 2003; Brady 
et al., 2001). This method is not readily employed for the discovery of RiPPs, as 
researchers rather take advantage of the available genomic methods.  
Sequenced-based screening of a metagenome can be performed with homology-based 
techniques and sequencing. Advances in sequencing methods (next generation 
sequencing) enable the screening of mDNA without the construction of libraries 
(Suenaga, 2012; Heidelberg et al., 2010). Probes are used for homology-based 
screening methods, such as oligonucleotide primers for PCR (Więckowicz et al., 2011; 
Donia & Schmidt, 2011). This requires prior knowledge of the biosynthetic gene(s) and 
thus novel genes and natural products could go unnoticed. However, another homology-
based method, retrobiosynthetic analysis (Piel, 2011), is not dependent on prior 
knowledge of the biosynthetic gene(s), but it is based rather on the structure and 
biochemical characteristics of the compound. This knowledge can be used to deduce the 
sequence of the structural or biosynthetic genes and then degenerate primers are 
designed to target those sequences. 
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Figure 18 Metagenomics (a cultivation-independent method) is used to screen the 
genomes of uncultured organisms for natural products. 
4.3.2. Bioinformatic and in silico analyses - comparative analyses 
The interdisciplinary field of bioinformatics relies on computational techniques to 
combine the data generated by chemical analysis and molecular “omics” methods in 
databases. The omics methods include genomics, metagenomics, transcriptomics and 
proteomics. The data is analysed with specialised algorithms to correlate the genotype, 
chemotype and phenotype of a natural product. 
A major limitation of bioinformatics is the need for adequate technologies to process the 
data. For instance, with the mass inflow of sequencing data, genomes are not always 
accurately annotated (Weber, 2014) and classic gene-identification algorithms do not 
always recognise the biosynthetic genes of natural products (Haft, 2009; de Jong et al., 
2010). Various natural product databases and automated bioprospecting tools have been 
established (Fedorova et al., 2012) to circumvent this limitation. The biosynthetic genes 
of microbial natural products are usually clustered together (Robinson, 1991; Jack et al., 
1995; Walsh, 2000). This enables the use of in silico tools to perform comparative 
analysis to assist and automate the screening of natural product pathways (Brady et al., 
2001). Many of the tools focus on the discovery of non-ribosomal peptides and 
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polyketides (Weber, 2014; Caboche et al., 2007; Ichikawa et al., 2013; Weber et al., 
2009), but the tools available for the exploration of RiPPs are also gaining interest, as it 
can be seen that the RiPP-related tools were developed predominantly in the last few 
years (Table 2).  
There is also a great need for inter-disciplinary research programs. Pep2Path is such a 
software package and it can be used for the automation of peptidogenomics (Medema et 
al., 2014). Peptidogenomics is the correlation of mass spectrometry data to the 
biosynthetic gene clusters of known and putative peptides. Pep2Path is comprised of the 
two algorithms, NRP2Path and RiPP2Path, respectively for non-ribosomal peptides and 
RiPPs. The Pep2Path algorithms also make use of databases and other tools, such as 
NORINE (Caboche et al., 2007), NRPSpredictor2 (Rottig et al., 2011), Genbank,  and 
antiSMASH (Medema et al., 2011; Blin et al., 2014) to achieve the goal of 
peptidogenomics. This software is a valuable tool that makes natural product discovery 
and the characterisation thereof a high-throughput process. 
The use of bioinformatics tools is an integral part of the research and the discovery of 
novel marine natural products or biosynthetic pathways. It is also important to confirm 
the outcomes from in silico analyses with experimental procedures. This includes the 
functional characterisation of the identified putative genes as well as the production of 
the compounds encoded, determination of structural characterisation and analysis of 
bioactivities. 
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Table 2 Examples of the web-based databases and tools available for screening natural products. A short description, the class of natural 
products covered, and the year of release and updating is also indicated. Note that this is a non-exhaustive list. 
Name Short description Class covered Year Reference 
BAGEL 
BActeriocin GEnome mining 
tooL 
Web-based bacteriocin genome 
mining tool. 
RiPPs 
(bacteriocins) 
2006, 2010, 2013 (de Jong et al., 2006; 
de Jong et al., 2010; 
van Heel et al., 2013) 
BACTIBASE Web-based database and tool for 
bacteriocin characterization. 
RiPPs 
(bacteriocins) 
2007, 2010 (Hammami et al., 
2007; Hammami et 
al., 2010) 
antiSMASH 
antibiotics and Secondary 
Metabolite Analysis SHell 
The first comprehensive pipeline 
capable of identifying and annotating 
biosynthetic loci covering the whole 
range of known secondary metabolite 
compound classes in bacterial and 
fungal genome sequences. 
 
polyketides, 
non-ribosomal 
peptides, 
terpenes, RiPPs 
(lantibiotics, 
bacteriocins), 
nucleosides, 
beta-lactams, 
siderophores, 
melanins, etc. 
2011, 2014 (Medema et al., 
2011; Blin et al., 
2014) 
Pep2Path Software for automated mass 
spectrometry-guided genome mining 
of peptidic natural products.  
non-ribosomal 
peptides, RiPPs 
2014 (Medema et al., 
2014) 
RiPPquest A combinatorial tool that performs 
genome- and metabolome-mining of 
sequenced microorganisms. 
RiPPs 
(specifically 
lanthipeptides) 
2014 (Mohimani et al., 
2014) 
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4.3.3. Limitations and significance of cultivation-independent methods 
4.3.3.1. Functional screening 
Heterologous expression is one of the limitations of functional-based methods, although 
this is not limited to the field of natural product discovery. The level of heterologous 
expression is generally not sufficient for biodiscovery, for instance, quantitative 
analysis showed that only 40 % of genes are expressed in E. coli (Gabor et al., 2004). 
However, as mentioned before, this is why different approaches, including a wider 
range of surrogate hosts, are continuously developed to circumvent and improve gene 
expression. The selection of bioassays should also be carefully considered as it could 
restrain the range of compounds that will be discovered (Suenaga, 2012). Even though 
there are limitations, functional screening of DNA libraries is still one of the principal 
methods used for the discovery of natural products, especially with high-throughput 
screens that are being developed such as those at MabCent-SFI (Table 1). One of the 
major advantages is that once a novel compound is detected, it is already in a known 
expression system and thus the afore-mentioned supply problem for down-stream 
development should not be a limiting factor. 
4.3.3.2. Sequence-dependent screening 
Sequence-based screening methods are limited by the lack of extensive sequencing and 
computational technologies to assemble and annotate the (meta-)genomes (Heidelberg 
et al., 2010; Mavromatis et al., 2012), but these technologies are consistently being 
improved. Some of the solutions for this include better coverage of genomes by deep 
(second generation) and ultra-deep (third generation) sequencing (Querellou et al., 
2010). The problems of genome annotation are discussed by Poptsova and Gogarten 
(2010). Overall, annotations are based on comparative analysis and due to the 
advancements of genomic and proteomic techniques, the accumulation of experimental 
information as well as development of advanced algorithms, the annotations of 
(meta-)genomes are refined continuously. The use of sequence-based methods, 
compared to functional-based screening, has the advantage of revealing the biosynthetic 
pathways of known natural products and predicting the hypothetical pathways of novel 
natural products. Knowledge of the biosynthetic pathway is important for development 
and production of the product.  
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4.3.3.3. Cultivation-independent methods 
It should also be noted that many of the cultivation-independent methods have mainly 
been developed over the last 10 years and thus hold great potential for the discovery of 
natural products from the marine environment. These methods, especially those related 
to genomics and proteomics, are powerful tools for the discovery of novel natural 
products from uncultured organisms.  
The biosynthetic genes of a natural product can be identified using culture-independent 
molecular techniques. The compound can be produced on a large-scale, through 
heterologous expression of the biosynthetic genes, to provide enough material for the 
determination of the biochemical properties and structure of the compound, as well as to 
provide material for clinical trials and marketing. 
4.3.4. Discovery of RiPPs with combinatorial methods 
There is no standard method for the discovery of novel RiPPs. However, there are 
numerous publications available on the methods used. Early discoveries were made 
with traditional and cultivation-dependent methods. Recent methods are broadly based 
on homology analysis and it is common practice to use a combination of the methods 
discussed earlier. The methods can be considered to belong to one of three main 
methodologies, namely genome mining, reverse genomics and peptidogenomics (Table 
3). A few examples will be discussed to demonstrate these methods. 
Whether it is screening a single organism’s genome or a consortium thereof from a 
specific environment (constituting a metagenome), genome mining is probably the most 
widely used approach for the screening of RiPPs. An example of how this approach is 
implemented will be discussed with the pioneering work of Schmidt et al. (2005). With 
genome mining the biosynthesis genes of the cyanobactins, patellamide A and C, were 
determined. A library of the metagenome of the ascidian symbiont, Prochloron 
didemni, was created and initially screened with NRPS-specific PCR primers. This 
screen provided no insight into the biosynthesis of the peptides and thus the ribosomal 
origin was pursued. To design the primers the draft genome of P. didemni was manually 
examined (mined) by means of tBLASTn searches for all the possible sequences of the 
core peptide of patellamide A. Further genome mining of the flanking regions revealed 
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the whole biosynthetic cluster. The functions of the genes were confirmed by 
heterologous expression in E. coli. A similar approach was used by Kelly et al. (2009) 
to elucidate the biosynthesis of the thiopeptide, thiostrepton A, when they screened the 
genome of Streptomyces laurentii. Numerous RiPPs have been discovered with genome 
mining, for example lanthipeptides (Begley et al., 2009), linaridins (Claesen & Bibb, 
2010; Claesen & Bibb, 2011), microviridins (Weiz et al., 2011; Ziemert et al., 2010), 
microcins (Duquesne et al., 2007; Claesen & Bibb, 2010; Haft et al., 2010), lasso 
peptides (Knappe et al., 2008; Maksimov et al., 2012), cyanobactins (Schmidt & Donia, 
2009; Wang et al., 2011), sactipeptides (Murphy et al., 2011), and other TOMMs 
(Wieland Brown et al., 2009; Liao et al., 2009; Morris et al., 2009; Engelhardt et al., 
2010; Schmidt et al., 2005), as well as bacteriocins (Więckowicz et al., 2011; Haft, 
2009).  
Reverse genomics, or retrobiosynthetic analysis, combines the structural and 
biochemical characteristics of a peptide to infer the genes involved in the biosynthesis 
thereof. Degenerate primers are designed to these genes and used for the screening of 
(meta-)genomes by PCR. This approach has been successfully employed for the 
identification and characterisation of the biosynthetic pathways of RiPPs such as 
polytheonamides. As discussed before (Section 2.2.12), this peptide was thought to be 
produced by NRPSs due to the unusual incorporation of unique, non-proteinogenic 
residues. It is only 18 years after it was first isolated from the sponge T. swinhoei, that 
their ribosomal origin has been elucidated (Freeman et al., 2012). As for patellamides, 
the metagenome of T. swinhoei was first screened with NRPS-specific PCR primers, but 
the biosynthetic genes were not detected. Degenerate primers were designed to the 
amino acid sequence of the core peptide and subsequently the precursor gene was 
discovered. Using other genomic techniques the whole biosynthetic cluster was 
determine (Freeman et al., 2012).  
In the subsequent study by this group (Wilson et al., 2014; which occurred concurrent 
to the research in this thesis) the producing organism was isolated. Two new bacterial 
phylotypes of the candidate genus ‘Entotheonella’ were isolated from the sponge. This 
genus was so unique that it was suggested that these species are part of a new phylum 
‘Tectomicrobia’. ‘Entotheonella’ species are also not confined to T. swinhoei, as they 
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have been detected in a wide range of sponges of various locations (Wilson et al., 2014; 
Schmidt et al., 2000; Brück et al., 2008). Sequencing of the two species from 
T. swinhoei revealed that ‘Entotheonella’ species are rich producers of natural products 
from various classes of NRPs, PKs and RiPPs. The biosynthetic pathways of many of 
the known natural products from T. swinhoei were also identified in these genomes. The 
polytheonamide biosynthetic cluster is encoded within the genome of ‘Entotheonella 
factor TSY1’ along with other putative proteusin pathways. This shows that research of 
proteusin peptides is at its infancy and that many studies will follow this pioneering 
work.  
Another approach used for the discovery of RiPPs is a combination of genome mining 
together with data from proteomics. This is also referred to as peptidogenomics. This 
approach is not readily used for the discovery of RiPPs, but holds great potential, as 
demonstrated by the ioneering work of Kersten et al. (2011). With this approach the 
mass spectrometry data obtained with proteomics is compared to sequenced genomes of 
microorganisms (or even metagenomes) to determine the biosynthetic pathway. The 
recently developed bioinformatics tools, such as RiPPquest as well as above-mentioned 
Pep2Path and antiSMASH, are automatizing this approach (Table 2). 
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Table 3 Approaches used for the discovery of RiPPs. It is important to note that the list 
is not exhaustive. Genome mining can be centred on the precursors or the post 
translational modification (PTM) enzymes. 
Method 
Description/ 
target 
RiPP Class Reference 
Genome mining 
(genomics)  
Precursors Astexin 1  
Cypemycin 
Bottromycins 
Lasso peptide 
Linaridin 
Bottromycins 
(Maksimov 
et al., 2012; 
Claesen & 
Bibb, 2010; 
Gomez-
Escribano et 
al., 2012) 
PTM enzymes Lichenicidin, 
Putative sactipeptides 
Lanthipeptide 
Sactipeptides 
(Begley et 
al., 2009; 
Murphy et 
al., 2011) 
Retrobiosynthetic 
analysis  (reverse 
genomics) 
 Microviridin B and J 
Nocathiacin 
Polytheonamides 
Microviridins 
Thiopeptides 
Proteusins 
(Ziemert et 
al., 2008; 
Wei et al., 
2011; 
Freeman et 
al., 2012) 
Peptidogenomics  AmfS 
SGR-1832 
SSV-2083 
Lanthipeptides 
Linaridins 
Lasso peptides 
(Kersten et 
al., 2011) 
 
From the literature that was studied it can be seen that the methods used for the 
discovery of RiPPs have advanced from simple (nevertheless important) genome 
mining strategies to combinatorial methods that attempt to determine the genotype, 
chemotype and phenotype of known and unknown peptides.  
5. Aims and objectives 
Cultivation-independent methods have become paramount to the screening of marine 
natural products, especially RiPPs. However, more researchers are using a combination 
of cultivation-dependent and -independent screening methods. The combined 
techniques reduce the limitations associated with the methods when they are used 
independently. A few researchers have successfully used this approach for the screening 
of the symbiotic bacteria of invertebrates (Kennedy et al., 2008; Engelhardt et al., 2010; 
O’Halloran et al., 2011; Öztürk et al., 2013; Bondarev et al., 2013). 
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It is clear that there is no standard method for the screening of marine natural products 
and RiPPs. Numerous approaches have been presented and the most promising 
approach appears to employ a combination of methods to exploit the biotechnological 
potential of the symbiotic microorganisms of marine sponges. This can be achieved by 
combining cultivation-dependent methods, to isolate and cultivate the symbionts, and 
cultivation-independent sequencing methods, to screen for the biosynthetic genes of 
RiPPs. 
In the light of the literature study presented in the previous sections, the aims of this 
thesis will now be described. 
The aim of the cultivation-dependent section of this study was to isolate symbiotic 
bacteria from a South African marine sponge. The isolates were then screened for 
antimicrobial activities. 
The aim of the cultivation-independent section of this study was to extract metagenomic 
DNA from a South African marine sponge, create a library from the extracted DNA and 
develop a genomic screening method for RiPPs, specifically polytheonamides or 
proteusins.  
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1. Introduction 
Metagenomic diversity studies have indicated that only a small fraction of the true 
diversity of a community is represented by the cultivated organisms in any given 
environment (Ward et al., 1990). Metagenomics has also showed that many of the 
uncultivated organisms are resources for novel natural products. Therefore, there is 
clearly a need for the development and improvement of cultivation techniques to enable 
researchers to gain access to the currently uncultivated organisms. 
The rise in resistance to current antibiotics necessitates the need for the discovery of 
antimicrobial compounds. Terrestrial resources are becoming exhausted as many of the 
known antimicrobial compounds are rediscovered (Hou et al., 2012; Fischbach & 
Walsh, 2009). This is why the marine environment attracts the attention of scientists. 
Marine organisms display unique adaptions to their environments, which is mirrored in 
the structural diversity and novelty of their secondary metabolites (Jensen & Fenical, 
1996; Faulkner, 2000; Simmons et al., 2005). Examples are the incorporation of 
halogens (chlorine and bromine; Simmons et al., 2005) as well as unique peptide 
structures which are cyclic or linear with unusual or rare amino acids, such as D-amino 
acids and tert-Leu (Matsunaga et al., 1985). 
Marine sponges are recognised as rich sources of natural products (secondary 
metabolites) for drug development (Pettit et al., 2002; Mayer et al., 2010; Ouyang et al., 
2010; Laport et al., 2009). The structural characteristics of the sponge natural products 
led to the hypothesis that the symbiotic microorganisms in the sponges are the true 
producers of the compounds. Some of the compounds consist of multiple D-amino acids 
that are generally associated with microbial peptide synthesis. There are also structural 
similarities between natural products extracted from sponges and those extracted from 
terrestrial microorganisms (Fusetani & Matsunaga, 1993). For many sponge natural 
products, for example discodermins (Matsunaga et al., 1985) and polytheonamides 
(Freeman et al., 2012), it has been proven that the symbiotic microorganisms are the 
true producers (Muscholl-Silberhorn et al., 2008; Taylor et al., 2007). 
Therefore, marine bacteria are a source of novel natural products which could be 
exploited for pharmaceutical applications. More importantly, with cultivation-dependent 
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methods the producing organisms are cultured under laboratory conditions and 
consequently the supply limitation could be circumvented. There is a great need for 
effective, conservational and economically feasible supply of natural products. This 
could be achieved, for example, by discovering a cultivable microorganism for 
fermentation or implementing semi-synthesis of analogues of a natural product. Semi-
synthesis is employed to supply trabectedin (Yondelis®; Cuevas & Francesch, 2009). 
The antibiotic cyanosafracin B, produced by P.  fluorescens, is processed to obtain 
analogues of the natural products, ecteinascidins. Ecteinascidins were originally 
extracted from the tunicate E. turbinata (Cuevas & Francesch, 2009). 
This chapter describes the first study of the isolation, cultivation and antimicrobial 
screening of the microbial symbionts of the South African sponge, Hamacantha 
(Vomerula) esperioides. No other research has been done on this sponge species (to the 
knowledge of the author) other than the description of the type species by Ridley and 
Dendy (Ridley & Dendy, 1886).  
2. Materials and methods 
2.1. Sponge material (PE14) 
The H. esperioides sponge (referred to as PE14 throughout) used in this study was 
collected by Dr. Shirley Parker-Nance by SCUBA diving on 4 April 2013. The site of 
collection is at the White Sands reef in Port Elizabeth, on the eastern coast of South 
Africa (S34 ° 00.406 ’, E25 ° 43.117 ’), at a depth of 23 to 25 m. The average water 
temperature was 15 °C. The material was shipped overnight at 4 °C and processed for 
cultivation upon delivery. The material for genomic studies was stored in 10 % (v/v) 
glycerol at -20 °C.  
2.2. Media 
A wide range of media (Table 4) was used for the isolation and cultivation of symbiotic 
microorganisms of the sponge PE14. The isolation media was selected to promote the 
growth of slow growing marine organisms and to prevent bias towards the fast growing 
organisms. Details of the composition of the media are given in Appendix A. 
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Table 4 Media used for the isolation of sponge symbionts. 
Medium Abbr. pH Selectivity 
Modified 172F 172 7.5 Actinobacteria 
Actinomycete isolation medium AIM 8.1 Actinobacteria 
Activated charcoal medium ACM 7 
Pyruvate as the primary 
carbon source 
Blue-green 11 BG11 NA 
Nitrogen Free Medium; 
cyanobacteria 
Complex carbon agar CCA 7.5 General media 
Streptomyces medium (modified 
DSMZ Medium 65) 
GYM 7.2 
Actinobacteria; 
Streptomycetes 
Medium A agar MAA 
10.0
-
10.5 
Halo-tolerant and halophilic 
bacteria 
Oatmeal agar (modified ISP 
Medium 3) 
OMA NA Actinobacteria 
Planctomycetes medium PMM NA Planctomycetes bacteria 
Pringsheim’s biphasic soil-water 
medium 
PCS NA Cyanobacteria 
Reasoner’s 2A agar R2A NA 
Slow growing aquatic 
bacteria 
Seawater Agar SWA 6.5 
Low nutrients content; slow 
growing bacteria 
Shivji NA ¼ strength SNA 7.5 
Selective for firmicute 
bacteria 
Sponge extract medium SEM NA 
Nutrients required from 
sponges 
Tryptic soya broth TSA 7.5 Gram-positive bacteria 
Tryptic soya broth pH 4.5 TS4 4.5 Gram-positive acidophiles 
ZoBell agar
 
¼ strength ZBA 7.5 
Marine bacteria, primarily 
Gram-negative 
ZoBell agar ¼ strength with 
0.0001% (v/v) Crystal violet 
solution 
ZBV 7.5 Gram-negative bacteria 
NA: pH was not adjusted. 
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2.3. Microbiological techniques 
2.3.1. Cultivation of sponge symbiotic microorganisms 
Sponge material was crushed with a sterile pestle and mortar and a serial dilution of the 
liquid collected was made with filter-sterilised seawater. Dilutions (10
-1
 to 10
-6
) were 
spread-plated on the different solid media (Table 4). Cycloheximide and nalidixic acid 
were added to isolation media GYM, 172, OMA, MAA at 100 µg.ml
-1
and 50 µg.ml
-1
, 
respectively, during the preparation of the plates. Plates were incubated at 15 °C and 
checked periodically for growth over a period of 4 months.  
The liquid medium, blue-green 11 (BG11), was used for the isolation of cyanobacteria. 
After incubation of the liquid culture for 3 months, the culture was diluted and plated 
onto R2A medium for isolation of bacteria.  
When growth of a colony was observed on the isolation medium, it was transferred and 
cultured until pure. The number of media used for continuous culturing was reduced 
after isolation (Table 5). Glycerol stocks of 50 % (v/v) were prepared and stored 
at -80 °C. The selection of colonies was based on the difference in morphology and 
growth rate.  
Table 5 Colonies picked from the isolation media were further maintained on specific 
culturing medium. 
Isolation 
medium 
Continuous 
culturing 
medium  
 
Isolation 
medium 
Continuous 
culturing 
medium  
TSA 
TSA 
 ZBA 
ZBA 
TS4  ZBV 
SNA  SWA 
GYM 
 GYM 
 CCA 
172  SEM 
OMA  ACM ACM 
AIM  MAA MAA 
R2A 
R2A 
 PCS PCS 
BG11  PMM PMM 
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2.3.2. Antimicrobial Assay 
For the antimicrobial assay, the isolates were spot-inoculated on TSA, ZBA and GYM 
agar media and incubated for two weeks at 15 °C. The indicator strains, E. coli 1699 
(Cubist Pharmaceuticals), Bacillus cereus ATCC10702, S. epidermidis ATCC14990, 
Mycobacterium smegmatis LR222 and Pseudomonas putida ATCC27853, were 
cultivated overnight in Lysogeny broth (LB: 10 g.L
-1
 tryptone, 5 g.L
-1
 yeast extract, 
5 g.L
-1
 NaCl) at 37 °C. The optical density at 600 nm (OD600) was measured for each 
strain to normalise (Equation 1) the amount of cells added to 7 ml sloppy LB agar 
(0.7 % (w/v) agar). The plates that were spot-inoculated with the isolates were overlaid 
with the indicator strains and incubated overnight at 30 °C, after which zones of 
inhibition were noted. Some of the isolates showing antimicrobial activity were selected 
for further analysis. 
 
Equation 1 Normalisation of the amount of cells added to the sloppy agar (7 ml) in the 
overlay assay for E. coli (Volume A) and B. cereus, S. epidermidis, M. smegmatis or 
P. putida (Volume B).  
2.3.3. Preparation of extracts for further screening 
Extracts from liquid cultures in TSA, ZBA, GYM and ACM media were prepared for 
bioassay screening by PharmaSea partners. 
Fractionation columns (SPE columns) were prepared by first puncturing holes into the 
bottom of a 15 ml falcon tube and then covering it with glass wool. The tube was filled 
with 10 ml of SP207ss resin (Sigma-Aldrich). The SPE columns were then equilibrated 
by washing with 50 ml of acetone, followed by a wash of 50 ml methanol and a final 
wash with 100 ml MilliQ water.  
 
 
 
 
61 
 
Isolates were cultured at room temperature on an orbital shaker for 2 to 3 days. Extracts 
were prepared by acetone extraction where an equal volume of acetone was added to the 
culture and incubated on an orbital shaker for 1 hour. The acetone was evaporated in a 
fume hood before the crude extract was applied to the SPE columns. The columns were 
then washed with 50 ml MilliQ water. The organic extract was eluted with 50 ml of 
acetone. The eluate was collected and the acetone evaporated in a CentriVap centrifugal 
vacuum concentrator (Labconco). The dried extract pellet was then shipped to the 
PharmaSea partners for screening.  
Screening was performed against pathogenic and drug-resistant bacteria, yeast, and 
fungi (MEDINA, Spain). An anti-inflammatory activity screen and a cell toxicity 
(MarBio, Norway) screen was performed as part of the evaluation for preclinical safety. 
Anti-fungal screens were against the type strains Aspergillus fumigatus ATCC 46645 
(Monteiro et al., 2012) and Candida albicans MY155 (Martín et al., 2013). Anti-
inflammatory screens were against TNF-α, IL-1β and NF-κ cell lines (Svenson, 2013). 
The cell toxicity screens were against MRC-5 cell lines.  
2.4. Molecular techniques 
2.4.1. Genomic DNA extraction 
The small scale preparation method from Wilson (2001) was used to extract the 
genomic DNA of the PE14 isolates. Cultures used for extraction were grown in 5 ml of 
liquid ZBA broth at 15 °C until the stationary growth phase was reached.  
2.4.2. Amplification of 16S rRNA genes 
The 16S rRNA gene was partially amplified with the universal bacterial 16S rRNA 
primers E9F (GAGTTTGATCCTGGCTCAG; Ah Tow, 2003; Farrelly et al., 1995) and 
U1510R (GGTTACCTTGTTACGACTT; Ah Tow, 2003; Reysenbach & Pace, 1995). 
Primers E9F (forward) and U1510R (reverse) were synthesized by Inqaba Biotech 
(Pretoria, South Africa) and purified on a reverse-phase cartridge. 
Phusion High-Fidelity DNA polymerase (Fermentas, Thermo Scientific) together with 
the 5X Phusion HF Buffer was used according to the manufacturer’s instructions. All 
the PCR reaction mixtures were made to a total volume of 20 µl. The primers were 
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added to a concentration of 1 mM. DNA was added to a concentration of 50 to 100 ng 
per 20 µl reaction. The control reaction of the PCR contained no template DNA. 
The PCR reaction was performed by denaturing the DNA initially at 98 °C for 1 minute. 
This was followed by 35 cycles where the DNA was denatured at 98 °C for 10 seconds 
and the primers were annealed at 50 °C for 20 seconds after which extension was 
performed for 20 seconds at 72 °C. A final extension step of 5 minutes was performed 
at 72 °C.  
2.4.3. Qualitative and quantitative analysis of nucleic acids  
2.4.3.1. Spectrophotometric and fluorometric quantification 
The NanoDrop 1000 Spectrophotometer (Thermo Scientific) was used to determine the 
quality and quantity of DNA by measuring the absorbance peaks at wavelengths of 280, 
260 and 230 nm. The measurements were taken according to the manufacturer’s 
instructions. If it was required to obtain the exact quantity of double stranded (dsDNA), 
the DNA was quantitated with Qubit dsDNA Broad Range Assay kit according to the 
manufacturer’s instructions for fluorometric quantification in a Qubit 2.0 Fluorometer 
(Invitrogen; Life Technologies). 
2.4.3.2. Agarose gel electrophoresis 
To determine if the genes were successfully amplified by PCR the DNA was separated 
on agarose gels by electrophoresis. Agarose gels (1 % (w/v)) were prepared with TAE 
buffer (40 mM Tris-base, 20 mM acetic acid, 1 mM EDTA, pH 8.4) and ethidium 
bromide (10 ng.ml
-1
) was added before pouring the gel into a mould. Electrophoresis 
was performed within TAE buffer at a constant voltage of 80 V. The AlphaImager HP 
System was used to visualise agarose gels by UV illumination at 304 nm. The 
wavelength was set to 365 nm if the DNA was cut and purified for further processing. 
2.4.4. Cloning and sequencing 
2.4.4.1. Preparation of PCR products 
The NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) or the Illustra GFX PCR 
DNA and Gel Band Purification kit (GE Healthcare) was used to purify selected DNA 
fragments from agarose according to the specific manufacturer’s instructions. 
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2.4.4.2. Preparation of electrocompetent cells 
Electrocompetent cells of E. coli GeneHogs (Invitrogen) were prepared according to 
Dower et al. (1988). The following modifications were made: the culture was incubated 
until an optical density at 600 nm (OD600) of 0.5 to 0.7 was reached and the washing 
step of the culture was performed with 10 % glycerol and not with HEPES. 
2.4.4.3. Transformation by electroporation 
The plasmids that were used included pJET1.2 (Thermo Scientific), pET21a and 
pET28a (Novagen). The pJET1.2 plasmid was the vector for the prepared PCR product. 
The pET21a and pET28a (Novagen) plasmids were used as controls for the 
transformation (without inserted PCR product).  
The ligation mixture was treated with chloroform as prescribed (CloneJET PCR 
Cloning Kit; Thermo Scientific) and drop-dialysis was performed before transformation 
to ensure that the DNA is in a low ionic strength solution. Drop-dialysis was performed 
by floating a 0.025 µm DNA filter paper (Millipore, VSWP01300 MF-Millipore) on 
UV treated MiliQ water. An aliquot of 5 to 10 µl DNA was pipetted onto the filter and 
incubated for 20 minutes. 
Cells, incubated on ice for 15 minutes with 1 µl of the DNA, were transferred to a 
cooled electroporation cuvette (BioRad) with a 1 mm gap. Electroporation was 
performed with a BioRad MicroPulser under the following conditions: 1.8 kV, 25 µF 
and 200 Ω. After electroporation, LB was added to the cuvette to a total volume of 1 ml. 
The transformed cells were transferred to a clean tube and incubated for 60 minutes in a 
water bath with a temperature of 37 °C. The culture (100 µl), diluted appropriately in 
LB, was spread onto LB plates. The appropriate antibiotics, depending on the plasmid 
that was used, were added during the preparation of the LB plates. For the culturing of 
transformants with pJET1.2 and pET21a, 50 µg.ml
-1
 of ampicillin was added. For 
pET28a, 100 µg.ml
-1
 of kanamycin was added. The plates were then incubated 
overnight at 37 °C. The transformation efficiency was calculated as CFU per ng of 
plasmid DNA added. 
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2.4.4.4. Plasmid extraction 
For the extraction of the plasmids from the transformants, colonies were picked and 
inoculated into 5 ml of LB broth with the appropriate antibiotic. A modified alkaline 
extraction of the plasmids was performed as described by Birnboim and Doly  (1979). 
Briefly; after pelleting the culture, cells were resuspended in 100 µl of the first solution 
(50 mM glucose, 25 mM Tris-HCl, 10 mM EDTA, pH 8.0) and 200 ng/µl RNase A. 
The second (lysis) solution (0.2 N NaOH, 1 % (w/v) SDS) was freshly prepared and 
500 µl was added to the mixture, inverted and cooled before 150 µl of the third 
(neutralization) solution of 5 M potassium acetate (pH 4.8) was added. The mixture was 
centrifuged to remove the cell debris and chromosomal DNA. The supernatant was 
transferred to a clean tube and the DNA was precipitated with absolute ethanol. This 
was followed by washing the plasmid DNA with 70 % (v/v) ethanol and evaporating the 
excess ethanol before the DNA was resuspended in TE buffer (10 mM Tris-HCl, 1 mM 
EDTA, pH 8.0). 
2.4.4.5. Confirmation of transformation by amplification 
Amplification of inserts with the pJET1.2 primer pair 
(pJET1.2F: CGACTCACTATAGGGAGAGCGGC, pJET1.2R: AAGAACATCGATTT
TCCATGGCAGT) was performed to check whether the extracted plasmids contained 
the inserts of the expected size. The PCR reaction mixtures were made to a total volume 
of 20 µl containing 2 µl of 10X DreamTaq buffer (already containing 2 mM MgCl2), 
200 µM of each dNTP, 0.025 U.µl
-1
 DreamTaq polymerase (Fermentas, Thermo 
Scientific) and 1 µM of the each primer. The final concentration of the MgCl2 was 
increased to 3 mM. The purified plasmid DNA was used as the template DNA. When 
the plasmid was not extracted from the clones, a colony PCR was performed according 
to the instructions of the CloneJET PCR Cloning Kit (Thermo Scientific).  
The PCR reaction was performed by denaturing the DNA at 95 °C for 5 minutes. This 
was followed by 35 cycles where the template DNA was denatured at 95 °C for 30 
seconds. The primers were annealed 65 °C for 30 seconds and then extended for 
30 seconds at 72 °C. A final extension step was performed at 72 °C for 10 minutes. 
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After the PCR, the reaction mixture was analysed by agarose gel electrophoresis for the 
presence of PCR product (Section 2.4.3.2.). 
2.4.4.6. Sequencing and identification of PCR products 
After confirmation of transformation, the plasmids (containing the correct insert size) 
were extracted from the clones with the QIAprep miniprep spin column kit (Qiagen) 
according to the manufacturer’s instructions.  
Sanger sequencing was done by the Central Analytical Facility at the University of 
Stellenbosch with the forward and reverse primers for PCR products from isolates 
PE14-3, 11, 12, 13, 17, 25, 40, 58, 61, 92, 104, 126, 144, 145, 146. Only the forward 
primer was used for the sequencing of PCR products from isolates PE14-22, 55, 60, 63, 
74.  
Isolates PE14-7, 10, 20, 27, 28, 30, 33, 64, 97, 108 were selected and used by 
colleagues. The 16S rRNA genes were partially amplified and sequenced with only the 
forward primer at Macrogen (Macrogenlab Inc., Rockville, USA). The sequences were 
processed by removal of low quality sequences and base calling. The software, 
ChromasPro version 1.5 (Technelysium Pty. Ltd.), was used to assemble the processed 
sequences when the amplicons were sequenced with the forward and the reverse 
primers. 
The sequences were compared to those available on the 16S ribosomal RNA sequences 
(Bacteria and Archaea) databases of Genbank with the BLAST algorithm (Altschul et 
al., 1997) through the National Center for Biotechnology Information website (NCBI; 
http://www.ncbi.nlm.nih.gov). The closest related species of the isolates were then 
identified.  
3. Results and discussion 
3.1. Cultivation of sponge symbionts and bioactivity screening 
The sponge, PE14 (Figure 19), was identified to be H. esperioides of the class 
Demospongiae (Parker-Nance, 2013). It has a tough leathery exterior layer (pinacocyte) 
that is highly pigmented. The sponge body (mesohyl) was rather thin and partially 
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encrusted with rock and coral material. This is an indigenous species to South Africa 
which has been described in 1886 by Ridley and Dendy (Ridley & Dendy, 1886). As 
stated earlier, no other research has been done on this sponge species (to the knowledge 
of the author) other than the description of the type species. For further information of 
the taxonomy and collection site of this sponge, refer to Appendix A Table 6. 
 
Figure 19 Sponge PE14 was identified as H. esperioides. It has a thin body, with little 
sponge material, which is encrusted with rock/coral debris (white arrow) and it has a 
thick leathery exterior layer (pinacocyte; black arrow). Photos are courtesy of Dr. 
Shirley Parker-Nance. 
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A wide variety of media was used to grow symbiotic bacteria from H. esperioides. 
Consequently, 150 isolates were obtained (Figure 20) and grown as pure cultures. Most 
of the isolates were cultured on the media favourable to aquatic bacteria (ZBA, ZBV, 
SWA, PMM and R2A) and firmicute selective media (TSA and SNA). 
 
Figure 20 Number of isolates obtained from the different selective media. The media 
was grouped according to the selectivity as general (green), pH (pink), firmicute (dark 
blue), actinobacteria (orange), cyanobacteria (purple), other (light blue). 
These isolates were screened for antimicrobial activity by an overlay assay with 
indicator strains. If antimicrobial activity is observed against one of these strains, it is an 
indication that the isolate that was overlaid with this organism is producing an 
antimicrobial secondary metabolite. The strains selected included Gram positive as well 
as Gram negative strains which are closely related to human pathogens (E. coli 1699, 
B. cereus ATCC10702, S. epidermidis ATCC14990, M. smegmatis LR222 and 
P. putida ATCC27853). The strain E. coli 1699 have been engineered by Cubist 
Pharmaceuticals to be resistant to 52 antibiotics. Its resistance covers a wide range of 
antibiotic classes with different mechanisms of action (Gross, 2011). This strain was 
selected as activity against it would indicate that a probable novel compound is 
produced by the isolate being tested. 
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For the antimicrobial screen, the isolates were grown on three different media before 
being overlaid as the production of secondary metabolites can be activated by changing 
the growth conditions of a culture (Sørensen & Sondergaard, 2014; Yoon & Nodwell, 
2014; Pietra, 1990). Activity was observed by 27 of the isolates and 19 of these 
displayed activities against more than one strain (Table 6). Isolate PE14-74 was the only 
one to display antimicrobial activity against four of the indicator strains.  
Table 6 Activity displayed against the indicator strains. The column total, summaries 
the number of indicator strains that were inhibited by the specific isolate. 
PE14 ID E. coli 1699 M. smegmatis S. epidermidis B. cereus P. putida Total 
3 x x x   3 
7  x  x  2 
11  x  x  2 
12  x  x  2 
13  x x x  3 
16   x   1 
17  x x x  3 
22  x x x  3 
25  x x x  3 
28  x x   2 
40 x   x  2 
48   x x  2 
55  x x x  3 
60  x x x  3 
61  x x x  3 
63  x x   2 
65   x   1 
73   x   1 
74 x x x x  4 
82    x  1 
116  x x   2 
127  x    1 
128  x    1 
129  x x x  3 
144   x   1 
145  x    1 
146  x x   2 
Green – isolates showing activity against three of the indicator strains. 
Red – an isolate showing activity against four of the indicator strains. 
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Most of the antimicrobial activities observed were against S. epidermidis and B. cereus 
and when organisms were grown on GYM and ZBA (Figure 21). None of the bacterial 
isolates showed activity against P. putida, on any of the media.  
 
Figure 21 Number of isolates showing antimicrobial activity against the five indicator 
strains (E. coli 1699, M. smegmatis, S. epidermidis, B. cereus and P. putida) on 
different media (GYM, ZBA and TSA).  
One of the interesting observations, when culturing the isolates for the antimicrobial 
screen, was that the colony morphology was irregular for some of the isolates when 
grown on GYM medium (Figure 22). This change in growth could be due to the change 
in the composition of the medium, as glucose and a high concentration of malt extract is 
included in the GYM medium. When isolates were grown on GYM, it was also noted 
that the CaCO3 in the medium was utilised by 15 of the isolates. This was noted as a 
“zone of clearance” formed at the bottom of the plate where the CaCO3 settled after the 
preparation of the agar (Figure 22).  
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Figure 22 Comparison of the growth of the same isolates on GYM (left) and ZBA 
(right) medium. Irregular colony morphologies and CaCO3 utilization (clear zones) was 
observed on GYM. 
The production of the antimicrobial products may be more prevalent when the isolates 
were cultured on GYM, as it is rich in carbohydrates and proteins. This has been 
observed in several studies where it was found that small changes in growth conditions, 
such as different carbon and nitrogen sources, can influence the expression of secondary 
metabolites (Sørensen & Sondergaard, 2014; Yoon & Nodwell, 2014; Pietra, 1990). In a 
study where the concentration of glucose, peptone and minerals were varied it was 
found that glucose and peptone improved the production of antibiotics by the bacterium 
Xenorhabdus nematophila (Yoon & Nodwell, 2014). This approach of altering nutrient 
composition is also known as the one-strain-many-compounds (OSMAC) principle, and 
it is typically employed for  drug discovery/screening (Bode et al., 2002) as discussed in 
the literature review.  
3.2. Screening liquid culture extracts by collaborators 
This work was done by fellow colleagues in the laboratory and PharmaSea consortium 
partners. It is included to show the potential of the isolates for natural product 
screening and development for a range of biomedical applications. 
Eleven of the 20 isolates screened by PharmaSea partners showed activity in the anti-
fungal, anti-inflammatory and cell toxicity screens. Anti-fungal activity was detected by 
eight of the isolates and four isolates showed anti-inflammatory activity (Table 7) which 
may be of pharmaceutical importance. Extracts can be further purified to identify the 
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compound(s) with the desired bioactivity. These compounds can then be re-analysed to 
confirm whether they are cytotoxic. 
Table 7 Activity displayed for the extracts from H. esperioides isolates that were 
screened by the PharmaSea partners.  
PE14 ID A. fumigatus ATCC 46645 C. albicans MY155 Anti-inflammatory 
7 T, Z T, Z  
12 Z Z  
20 G, Z   
25 A   
34   Z 
40 T  G, Z 
48 A, Z   
55   Z 
60   Z 
104 Z T, Z  
117 Z   
A = ACM, G = GYM, T = TSA, Z = ZBA. 
3.3. Identification and dereplication of isolates 
Some of the isolates (30) have been identified to their closest related species by 
amplifying and sequencing the 16S rRNA genes. A BLAST search of the sequences 
indicated to which species the isolates are closely related to. These isolates were found 
to be mostly from the genera Vibrio and Pseudovibrio (Table 8). A probable novel 
isolate, PE14-40, has an identity of 96% to the Marinomonas dokdonensis strain 
DSW10-10. This isolate is active against two of the indicator strains: E. coli 1699 and 
B. cereus (Table 6). 
The diversity of bacteria found in sponges, include species from the phyla 
Acidobacteria, Actinobacteria, Bacteroidetes, Chloroflexi, Cyanobacteria, Deinococcus-
Thermus, Firmicutes, Gemmatimonadetes, Nitrospira, Planctomycetes, Proteobacteria 
(Alpha-, Beta-, Delta-, and Gammaproteobacteria), Spirochaetes, and Verrucomicrobia 
(Taylor et al., 2007). Marine species from the genera Pseudovibrio and Vibrio are 
regularly found to be sponge symbionts with culture-dependent and culture-independent 
methods and they are the dominant species in certain sponges  (Flemer et al., 2012; 
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Taylor et al., 2007). These species have also shown antimicrobial activity against a 
broad range of strains (Flemer et al., 2012; O’ Halloran et al., 2011; Kennedy et al., 
2008; Muscholl-Silberhorn et al., 2008). 
Table 8 Number of isolates identified according partial 16S rRNA sequences to genus 
level. 
Phylum Genus 
Number of 
isolates 
Alphaproteobacteria Pseudovibrio 6 
Gammaproteobacteria Vibrio 15 
Gammaproteobacteria Aliivibrio 1 
Gammaproteobacteria Enterovibrio 1 
Firmicutes Bacillus 1 
Gammaproteobacteria Marinomonas 1 
Gammaproteobacteria Shewanella 3 
 
Dereplication, of the number of organisms and bioactive compounds that are screened 
for drug discovery, is a routine procedure in the pharmaceutical industry to reduce the 
chance of repetitive work and to make drug discovery a high throughput process. Many 
studies dereplicate based on the 16S rRNA sequence. This is at a specified cut-off 
similarity percentage, typically 97 %, where organisms can be differentiated at species 
level (Stackebrandt & Goebel, 1994). However, in addition to PCR and sequencing 
errors which get introduced, it is well-known that taxonomic dereplication is not 
necessarily analogous to the metabolic capacity of organisms, particularly when it 
concerns secondary metabolite capabilities (Ridley et al., 2005). Thus, the bioactivities 
of the isolates are compared together with identity of the 16S rRNA gene. For example, 
if more than one isolate is closely related to the same strain and they display the same 
bioactivities it is likely to be the same organism that was isolated as multiple isolates 
from the sponge.  
In our study there were five isolates (PE14-3, 11, 12, 13, 20) closely related to 
Pseudovibrio ascidiaceicola strain F423 of which only PE14-11 and -12 displayed 
antimicrobial activity against the same indicator strains (Table 9, blue text). Similarly 
there were four isolates (PE14-17, 55, 60, 63) closely related to Vibrio tasmaniensis 
strain Carson D39 of which PE14-17, 55 and 60 displayed the same antimicrobial 
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activities (Table 9, orange text). If the bioactivities displayed in the screens from the 
PharmaSea partners are also considered (Table 7), only PE14-55 and -60 displayed the 
same bioactivities throughout this research (thus far) and could be considered to be the 
same strain. Even though isolates related to the same strain, such as PE14-11 and 12, 
showed similar antimicrobial activities it is difficult to dereplicate the isolates only on a 
few characteristics.  
This was similarly observed by O'Halloran et al. (O’ Halloran et al., 2011). The 72 
strains of Pseudovibrio spp., isolated from three sponge species, were identified to 
belong to 33 types with molecular methods. For most of the types with multiple isolates 
the individual isolates had identical antimicrobial activity profiles. This suggests that 
the same isolates may have been selected during the initial isolation process. Opposing 
this, they also observed that an individual isolate had a different bioactivity profile than 
the rest of the isolates of the same type. This stress the importance of applying 
dereplication with great caution as isolates can be closely related but still have the 
ability to produce novel compounds and vice versa. 
 
4. Summary 
This study shows that the sponge H. esperioides has many bacterial symbionts which 
produce bioactive secondary metabolites, including those with antimicrobial and anti-
inflammatory activities. This indicates that the respective compounds might be of 
importance for further application in the pharmaceutical industry. 
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Table 9 Identification of the PE14 isolates according to partial sequences of their 16S 
rRNA genes. The column total bp is the total base pairs included in the BLAST search. 
Total bp PE14 ID Closest Related Species % ID Bioactivity 
1329 3 P. ascidiaceicola strain F423 100 EMS 
1330 11 P. ascidiaceicola strain F423 100 MB 
1330 12 P. ascidiaceicola strain F423 100 MB 
1329 13 P. ascidiaceicola strain F423 100 MSB 
1359 17 V. tasmaniensis strain Carson D39 99 MSB 
674 55 V. tasmaniensis strain Carson D39 99 MSB 
712 60 V. tasmaniensis strain Carson D39 99 MSB 
662 63 V.tasmaniensis strain Carson D39 99 MS 
970 92 Vibrio kanaloae strain LMG 20539 100 E 
744 74 V. kanaloae strain LMG 20539 99 EMSB 
1217 61 Vibrio lentus strain CIP 107166 99 MSB 
977 104 Vibrio pomeroyi strain CAIM 578 100 EM 
1209 144 Vibrio gigantis strain LGP 13 100 S 
614 22 Vibrio splendidus LGP32 strain LGP32 99 MSB 
1383 58 Shewanella sairae strain SM2-1 99 S 
1297 145 S. sairae strain SM2-1 100 M 
956 146 
Shewanella pneumatophori strain SCRC-
2738 
100 
MS 
1366 25 
Enterovibrio norvegicus strain LMG 
19839 
98 
MSB 
1373 40 M. dokdonensis strain DSW10-10 96 EB 
1393 126 Staphylococcus warneri strain SG1 100 - 
799 7 P. ascidiaceicola strain NBRC 100514 99 MB 
743 20 P. ascidiaceicola strain F423 100 E 
435 10 Vibrio gallaecicus strain CECT 7244 98 E 
360 97 V. gallaecicus strain CECT 7244 99 M 
501 27 V. atlanticus strain VB 11.11 98 E 
546 64 V. atlanticus strain VB 11.11 99 E 
422 28 V. splendidus strain LGP32 98 EMS 
320 30 Aliivibrio wodanis strain ATCC BAA-104 99 EM 
670 33 Photobacterium aplysiae strain GMD509 98 E 
934 108 Bacillus anthracis strain Ames 99 E 
E = E. coli 1699, M = M. smegmatis, S = S. epidermidis, B = B. cereus, P = P. putida. 
Green: isolates used and identified by colleagues. 
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1. Introduction 
The class of natural product peptides that are synthesized by ribosomes and post-
translationally modified into an active product are labelled as ribosomal peptides 
(RiPPs). The biosynthetic genes, arranged within an operon or cluster, play a role in the 
structure, modification, export and regulation of the RiPP biosynthesis. The structural 
gene, which becomes the precursor peptide, consists of a leader and core peptide. For 
many RiPPs the function of the leader peptide is not clear, but they seem to assist the 
post-translational process (Patton et al., 2008; Yang & van der Donk, 2013). It is the 
core peptide that will be modified by the post-translational enzymes into the active 
natural product. 
The interest in researching RiPPs as pharmaceutical drugs has increased over the last 15 
years. One of the driving factors for this is the fact that RiPPs are structurally diverse, 
with more than 17 classes (Arnison et al., 2013). Some of the diversity is brought about 
by post-translational modifications that are so different to traditional ribosomal peptide 
synthesis that the active product is sometimes not recognised as a product of ribosomal 
synthesis (Kersten et al., 2011). This is illustrated when the synthesis of 
polytheonamides was researched, as they were thought to be products of non-ribosomal 
synthesis. Recently the Piel laboratory discovered the ribosomal biosynthetic cluster of 
these peptides (Freeman et al., 2012) within the metagenomic DNA library of the 
sponge, Theonella swinhoei. It was hypothesised that the peptides are of bacterial origin 
and further research by the team led to the discovery of the uncultivable (hitherto) 
producing organism, a species of the candidate genus, ‘Entotheonella’ (Wilson et al., 
2014). 
Since many uncultivable bacteria are potential sources of other bioactive secondary 
metabolites, cultivation-independent screening methods, such as metagenomics, have 
been developed. Metagenomics is ideally suited for the screening (also referred to as 
mining) of RiPPs, for a number of reasons. These include, but are not limited to, the 
conserved nature of the leader peptide (Schmidt, 2010) and the clustering of the 
biosynthetic genes.  Traditionally, cultivation-independent screening methods require 
the construction of mDNA libraries that are screened either functionally or via sequence 
analysis. Examples of screening methods based on sequence analysis include 
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homology-based techniques, such as PCR, and those based on sequencing and 
bioinformatic analysis. The initial methods based on the sequencing of libraries proved 
to be unrefined, expensive and not widely available to researchers. However, advances 
in sequencing methods made the technology a financially viable option for more 
researchers. The improved sequence-based methods now enable one to screen mDNA 
without the construction of libraries, referred to as next-generation sequencing (NGS; 
Suenaga, 2012; Heidelberg et al., 2010).  
Homology-based screening methods such as PCR require the design of primers to 
conserved regions. The primers can be designed through two approaches. The first 
approach (Figure 23, A) is dependent on knowledge of the structure and biochemical 
characteristics of the compound. This knowledge can be used to deduce the sequence of 
the structural genes, which in the case of RiPPs, are the precursor genes. This approach 
is also referred to as retrobiosynthetic analysis (Piel, 2011; Huo et al., 2012). This 
approach can be easily implemented for preliminary screens to determine if the RiPP of 
interest is present within a sample. The screening can then be enriched with 
complimentary approaches to reveal the entire biosynthetic pathway. This can be 
achieved by screening the metagenomic library or NGS of the mDNA. 
 The second approach relies on a characterised biosynthetic pathway of the compound 
(Figure 23, B). Primers can be designed either to bind to the precursor gene, or to key 
maturation enzymes within the biosynthetic pathway. Note that the second approach 
differs from the first approach, by not being dependent on prior knowledge of the 
compound. 
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Figure 23 Sequence-based screening can be dependent on a characterised compound (A) 
or biosynthetic cluster (B). The construction of a DNA library for screening is optional. 
Both approaches have been successfully used for the screening of RiPPs. Notable 
examples include polytheonamides and lasso peptides. The Piel laboratory used the first 
approach where structural and biochemical knowledge of the compound 
(polytheonamide) was used to infer the genomic sequence of the precursor gene 
(Freeman et al., 2012). The mDNA library of T. swinhoei was screened with primers 
and the precursor gene was successfully amplified. Further research led to the 
characterisation of the entire biosynthetic pathway. The Link laboratory used a 
combination of both approaches where the structure of various lasso peptides, together 
with the conserved features within the known biosynthetic clusters, were used with 
bioinformatics to screen for novel peptides (Maksimov et al., 2012; Maksimov & Link, 
2014). 
This chapter describes the development of a cultivation-independent screen for RiPPs. 
This entails the design and validation of primers, the extraction of mDNA and the 
screening of the extracted DNA with the primers.  
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2. Materials and methods 
2.1. Sponge material 
In this study, sponge material from PE14 was used to extract mDNA (Appendix B; 
Table 6). The mDNA extracted from the other sponges (Table 10) was kindly provided 
by colleagues at IMBM. 
Table 10 Sponges and their associated mDNA sample names. 
Sponge Species 
mDNA 
extracted 
Sample name 
(mDNA) 
PE03 Guancha sp. 001RSASPN L. Black PE03 
PE05  Waltherarndtia caliculatum L. Black PE05-A 
PE05 W. caliculatum L. van Zyl PE05-B 
PE08 
Spongia (Spongia) 
sp.001RSASPN 
R. Matobole PE08 
PE14 H.  esperioides This study PE14-A 
PE14 H. esperioides 
J. Navarro-
Fernández 
PE14-B 
 
2.2. Bioinformatics and primer design 
2.2.1. Analysis of the polytheonamide biosynthetic cluster 
The BLAST Link (BLink) tool of NCBI, which displays the results of precomputed 
BLASTp searches of all the proteins against the non-redundant (nr) protein database, 
was used to analyse the homologues of the biosynthetic proteins of the polytheonamide 
gene cluster (accession: JX456532.1). The data was filtered as follows. Only hits from 
the RefSeq database, with a BLAST score of more than a 100, and only from the 
taxonomic groups: bacteria and archaea were included. Also, for proteins with identical 
sequences a representative protein was included. 
2.2.2. Design of primers 
Degenerate primers were designed to the conserved residues of two genes (poyB and 
poyC) of the polytheonamide biosynthetic cluster and other homologous genes. 
The PoyB and PoyC protein sequences (accession: AFS60637.1 and AFS60638.1) were 
obtained from the NCBI protein database. Sequences of the specific proteins to the 
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family model ribosomal peptide maturation radical SAM protein 1 (short name: 
rSAM_ocin_1; accession: TIGR03975) was accessed from the conserved domain 
database (CDD) of NCBI. These sequences together with PoyB and PoyC were aligned 
with the BioEdit Sequence Alignment Editor (Hall, 1999) and the Clustal W multiple 
alignment algorithm (Thompson et al., 1994). A maximum parsimonious (MP) tree was 
constructed from this alignment with the MEGA5 software (Tamura et al., 2011) to 
identify the proteins that are more closely related to PoyB and PoyC. All parameters 
were set to the default value. Bootstrap analysis (1000 replicates) was performed 
(Dunbar & Mitchell, 2013) to evaluate the support of the clades. Branches 
corresponding to partitions reproduced in less than 50 % bootstrap replicates were 
collapsed. The MP tree was obtained using the Subtree-Pruning-Regrafting (SPR) 
algorithm (pg. 126 in reference: Knerr & van der Donk, 2012) with search level 1 in 
which the initial trees were obtained by the random addition of sequences (10 
replicates). All positions containing gaps and missing data were eliminated. 
Conserved residues were obtained by alignment of the selected proteins (Hall, 1999; 
Thompson et al., 1994) and by setting the similarity threshold to 80 %. Degenerate 
primers were designed to these conserved residues by using the IUPAC code for 
incompletely specified bases in nucleic acid sequences (Cornish-Bowden, 1985). To 
reduce ambiguity the nucleotide sequences of the poy genes were compared to the 
reverse-translated sequences of the proteins. Primers were further analysed with 
OligoAnalyzer 3.1 (Owczarzy et al., 2008) for any hairpin formation or homo- or 
hetero-dimer formation.  
PoyA (precursor peptide) was aligned with the selective proteins of the family, 
TOMM_pelo (accession: TIGR03793), similar to the above-mentioned method. 
2.2.3. In silico PCR 
The amplification of designed primers was also tested by performing an in silico PCR 
with an online tool (http://insilico.ehu.es; Bikandi et al., 2004). The parameters of the in 
silico PCR were varied to allow one or two mismatches, but not in the last nucleotides 
of the 3’ end of the primers (Table 11). When available, plasmids were included as 
templates.  
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Table 11 Parameters used when the in silico PCR simulation was performed. A) The 
number of mismatches allowed. B) The number of nucleotides, at the 3’ ends of the 
primers, where mismatches were not allowed. 
A B  A B 
1 2  2 2 
1 3  2 3 
1 5  2 5 
1 10  2 10 
 
2.3. Nucleic acid extraction 
2.3.1. Genomic DNA extraction  
2.3.1.1. PE14 isolates 
Plate cultures (stored at 4 °C) of the isolates were used as inoculants for the liquid 
cultures from which gDNA was extracted as described in (Section 2.4.1; Chapter 2). 
The gDNA of isolates in Table 12 was extracted. 
Table 12 Isolates (PE14) cultured for gDNA extraction. 
 Isolates 
Group 1 48, 64, 65, 144 
Group 2 22, 28, 60, 92, 104 
Group 3 30, 61, 63, 91, 107 
Group 4 16, 17, 55, 74, 108W 
No group 7, 11, 12, 13, 25, 27, 70, 97, 106 
 
2.3.1.2. Sinorhizobium meliloti 
A plate culture of S. meliloti 1021 was prepared from a glycerol stock stored at -80 °C. 
The plates were prepared with TY medium (5 g.L
-1
 tryptone, 3 g.L
-1
 yeast extract, 10 ml 
of sterile 1 M CaCl2). The CaCl2 stock solution was autoclaved separately and the 
appropriate amount was added before plates were poured or inoculation of liquid culture 
(Beringer, 1974). Cultures were incubated at 28 °C for 2 days. A single colony was 
picked from the culture, inoculated into 50 ml TY broth and incubated until the 
stationary phase of growth was reached. The cultures were used to extract the genomic 
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DNA of the organism with a large-scale preparation of the method of Wilson (2001). 
The DNA obtained was stored at 4 °C and used directly as template DNA in the PCR. 
2.3.1.3. Extraction of plasmid DNA (poyB gene) 
A construct with the poyB gene was kindly provided by the Piel laboratory (ETH 
Zurich, Department of Biology, Institute of Microbiology, Switzerland). The construct, 
Nhis-PoyB-pCDFDuet-1, was transformed into electrocompetent E. coli GeneHogs 
cells (Section 2.4.4.2; Chapter 2) and the QIAprep Miniprep kit (Qiagen) was used 
according to the manufactrer’s instructions to extract the plasmid DNA. The DNA from 
the miniprep was diluted and stored at 4 °C. When needed the DNA (now referred to as 
poyB-plasmid DNA) was used directly as the template in the PCRs. 
2.3.2. Metagenomic DNA extraction and analysis 
Due to difficulty in generating high quality mDNA suitable for downstream 
applications, seven different extraction methods were used.  
2.3.2.1. Modified CTAB lysis 
Extraction was carried out at 4 °C by keeping samples on ice or setting the temperature 
on centrifuges, unless specified otherwise. 
Frozen sponge material was grounded to a fine powder with a sterile pestle and mortar 
under liquid nitrogen. Two grams of the material was suspended in 8 ml lysis buffer (15 
mM Tris, 15 mM EDTA, 1.4 M NaCl, 1 % CTAB, with 2 % SDS, pH 8.0) with 
lysozyme to a concentration of 200 µg.ml
-1
. The mixture was blended, but to prevent 
shearing of the DNA the tube was only inverted once before and once during incubation 
at 37 °C for 2 hours. Proteinase K (100 µg.ml
-1
) was added before inverting the tube 
once and incubating it at 65 °C for 2 hours. The sample was then centrifuged for 15 
minutes at 4 500 xg. The supernatant was transferred to a clean tube and centrifuged as 
before until most of the sponge debris and polysaccharides were removed. The 
supernatant was then treated twice with an equal volume of a 
phenol:chloroform:isoamyl alcohol solution (PCI: 24:24:1 (v/v)) and centrifuge at 6 
000 xg for 15 minutes. The DNA was precipitated with 0.7 times the volume of 
isopropanol and left at room temperature for 30 minutes. The DNA was pelleted by 
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centrifugation at 6 000 xg for 30 minutes. The supernatant was discarded and the pellet 
was washed three times with 70 % ethanol. After the pellet was air-dried at room 
temperature, it was dissolved in TE buffer (the volume depended on the size of DNA 
pellet) and stored at 4 °C. 
To remove impurities from the extracted mDNA it was treated a second time with PCI 
and precipitated, washed, dried and resuspended in TE buffer. 
The method was modified to enrich for the extraction of bacterial DNA. The sponge 
material was defrosted overnight at 4 °C and 60 g (wet weight) was homogenised in a 
blender with 250 ml TE buffer. The pellet obtained after enrichment (Section 2.3.2.1.1.) 
was transferred to a 15 ml Falcon tube and lysis was performed as described above, but 
without SDS in the lysis buffer. After lysis, SDS was added to a concentration of 2 % 
(v/v) together with the proteinase K. All of the centrifugation steps following lysis was 
performed at an increased speed of 10 000 xg. The supernatant was treated with PCI as 
described above until the aqueous layer was non-cloudy. 
2.3.2.1.1. Enrichment for bacterial DNA 
A modified enrichment step for the enrichment of bacterial cells (Ouyang et al., 2010) 
was included where the pellet was resuspended in 25 ml TE buffer and filtered with a 
70 µm cell strainer (BD Biosciences) by centrifugation at 10 000 xg for 20 minutes.  
2.3.2.2. Agarose embedded cell lysis method 
A method where cells are suspended in agarose gel plugs (Liles et al., 2008) before 
extraction of mDNA was modified as follows. Ten grams of sponge tissue was 
homogenised in a sterile blender in 250 ml TE buffer. The homogenate was centrifuged 
twice at 300 xg for 2 minutes and the supernatant was transferred to a clean tube. The 
cells were then pelleted by centrifugation at 10 000 xg for 20 minutes. The cells were 
enriched for bacterial cells (Section 2.3.2.1.1.) and after filtration the pellet was 
resuspended in 1 ml TE buffer. The cell-suspension was heated to 45 °C in a water bath. 
Standard melting point (SMP) agarose (DNA typing grade; SeaKem LE Agarose, 
Lonza), prepared with TE buffer, was preheated to 65 °C. Equal volumes (0.5 ml) of the 
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agarose and the cells were mixed and set in a 1 ml syringe at 4 °C. The final 
concentration of the agarose was 1 % (w/v). 
The plugs were incubated overnight at 37 °C in a modified lysis buffer (50 mM Tris, 50 
mM EDTA, 1.4 M NaCl, 2 % CTAB, pH 8.0) with RNase A (3 µg.ml
-1
) and lysozyme 
(5 mg.ml
-1
). The buffer was replaced with and proteinase K (0.2 mg.ml
-1
) was added 
before incubating the plugs for 24 hours at 55 °C. The plugs were washed three times 
for 10 minutes in TE buffer. The plugs were treated with the formamide and salt 
solution (Section 2.3.2.8.5.) to purify the DNA. Samples of the plugs were subjected to 
pulse field gel electrophoresis (Section 2.3.2.9.1.) to elute the DNA from the plugs. 
2.3.2.3. Modified urea lysis 
This method is described by Gurgui and Piel (Gurgui & Piel, 2010). Modifications to 
this method included the enrichment of bacterial cells (Section 2.3.2.1.1.). Also, TE 
buffer, used for homogenisation of the sponge material, was replaced with a Tris-NaCl 
buffer (10 mM Tris-HCl, 0.5 M NaCl, pH 8.0) before the extraction was done. Tris-
NaCl buffer was added to the ratio of 10 to 20 ml per gram of sponge material. The cell 
pellet obtained was treated with the sponge lysis buffer (8 M urea, 2 % sarkosyl 
(Sigma–Aldrich Co.), 1 M NaCl, 50 mM EDTA, 50 mM Tris–HCl, pH 7.5) as 
instructed. The CTAB purification step was not performed.  
Other extractions attempts with this method (Gurgui & Piel, 2010) included a modified 
bead-beating method of Hardoim et al. (Hardoim et al., 2009). Shortly: the amount of 
sponge material used was increased to 10 g (wet weight). The sponge material was 
ground for 1,5 minutes with a mortar and pestle in 10 ml Tris-NaCl buffer. The material 
was transferred to an Erlenmeyer flask with 35 ml Tris-NaCl buffer and 5 ml sterile 
glass beads. The flask was then incubated for 20 minutes at RT on a rotator (170 rpm). 
The material was enriched for bacterial cells (Section 2.3.2.1.1.) and a washing step 
(Ouyang et al., 2010) of the cell pellet with Tris-NaCl buffer was also included. The 
extraction procedure was then performed with the resulting cell pellet. 
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2.3.2.4. MoBio UltraClean Soil DNA Isolation kit 
Sponge material was thawed at 4 °C. Samples were prepared for extraction with the 
MoBio UltraClean Soil DNA Isolation kit as follows. For the first sample was 0.25 g 
(wet weight) sponge material was used, since the manufacturer recommended that 0.25 
to 1 g of soil should be used. For the other samples, 3 g sponge material (wet weight) 
was incubated for 5 minutes with 2 ml Tris-NaCl buffer. After incubation, the liquid 
was pressed out with a sterile hockey stick. The liquid was captured in a clean tube and 
centrifuged at 300 xg to obtain a pellet (sample two). The supernatant was transferred to 
a clean tube and centrifuged again at 5 000 xg (sample three). The supernatant was 
transferred as before and centrifuged at 10 000 xg (sample four). DNA was extracted 
from samples 1 to 4 as instructed by the manufacturer. 
2.3.2.5. A combination of previous extraction methods 
The initial objective was to extract HMW mDNA from the sponge PE14 to construct a 
library. Previously extracted mDNA was inadequate for further analysis or construction 
of a DNA library and the objective changed to extract DNA of sufficient quality for 
further analysis. A combination of some of the previous extraction methods was used to 
improve the quality and quantity of the mDNA.  
Extraction was carried out at 4 °C, by keeping samples on ice or setting the temperature 
on centrifuges, unless stated otherwise. 
Two different approaches were used to separate the bacterial cells from the sponge 
material. At first, sponge material (1.5 g; wet weight) was weighed and ground to a fine 
powder under liquid nitrogen. With the second approach, 1.5 g (wet weight) of sponge 
material was weighed in a 15 ml tube. A sterile hockey stick was used to press out the 
liquid from the sponge. The liquid was captured in a clean tube. The remaining sponge 
material (after the liquid was pressed out) was also used for extraction.  
TE buffer (5 ml) and a few sterile glass beads (about 4 mm) were added to the ground 
sponge material and the material from which the liquid was pressed out. The samples 
were then placed within a MoBio Vortex Adapter and shaken for 30 minutes at room 
temperature (RT). 
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All samples were centrifuged at 300 xg for 5 minutes. The supernatants were then 
filtered to enrich for bacterial cells as described in Section 2.3.2.1.1. The volumes of the 
samples were adjusted with TE buffer to a total of 5 ml and not 25 ml as described in 
Section 2.3.2.1.1. 
The cell pellet from the sponge material that was ground under liquid nitrogen was 
combined with the pellet from the cells of the liquid that was pressed out of the sponge 
material, because of the small size of the pellet of the liquid (now referred to as sample 
1). The pellet that was obtained from the sponge material after the liquid was pressed 
out is now referred to as sample 2. 
Plugs were made (Section 2.3.2.1.) with the samples and divided to be lysed with the 
urea lysis buffer (Section 2.3.2.3.) and the CTAB lysis buffer (Section 2.3.2.1.; Table 
13).  
Table 13 Lysis treatment of the plug samples. 
Tube Sample Lysis buffer 
A 1  Urea 
B 2 Urea 
C 1  CTAB  
D 2 CTAB  
 
After lysis the plugs were washed twice with TE buffer for an hour at RT. Plugs from 
tube A and B was treated with the formamide solution (Section 2.3.2.8.5.) for 8 hours at 
RT. The plugs were then washed three times for 15 minutes and overnight in TAE 
buffer before electrophoresis was performed to extract the DNA (Section 2.3.2.10.). 
Plugs from tube C and D was treated a second time with the formamide solution 
overnight. The plugs were then dialysed overnight with TE buffer. 
2.3.2.6. Crude mechanical and enzymatic extraction 
One gram of sponge material (wet weight) was cut into smaller pieces and 5 ml TE 
buffer was added with sterile glass beads to 15 ml tubes. The tubes were homogenised 
by incubation at RT for an hour on the MoBio vortex adaptor. Enrichment for bacterial 
cells was performed as described in Section 2.3.2.1.1.  
The cell pellet was resuspended in 5 ml TE buffer and sonicated for a second with a 
SONOPULS ultrasonic homogenizer (Bandelin). Lysozyme was added (200 µg.ml
-1
) to 
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the buffer and the sample was incubated for 30 minutes at 37 °C. After cell lysis, 
proteinase K was added (100 µg.ml
-1
) and the sample was incubated overnight at 55 °C. 
The sample was treated with PCI until the aqueous phase was clear and the DNA was 
precipitated with isopropanol (Section 2.3.2.1.). After evaporation of the isopropanol, 
the DNA was resuspended in 100 µl TE buffer. The dissolved DNA was pooled and 
reduced (by evaporation at 60 to 70 °C) to a volume of 100 µl. 
2.3.2.7. Modified yeast DNA extraction protocol 
Extraction was performed at 4 °C, by keeping samples on ice or setting the temperature 
on centrifuges, unless stated otherwise. 
Sponge material was thawed at 4 °C. Three samples of 1 g (wet weight) sponge material 
were cut into smaller pieces before transferring it to clean 15 ml tubes. Sterile beads 
were added together with 10 ml of TE buffer. The samples were homogenised on a 
MoBio vortex adaptor for a total of 30 minutes. The sample was vortexed for 5 minutes 
intervals and in between vortexing the sample was cooled on ice for 5 minutes. The 
samples were centrifuged for 5 minutes at 300 xg. The supernatants of the three samples 
were pooled for enrichment of bacterial cells (Section 2.3.2.1.1.). The pellet was 
resuspended in 5 ml TE buffer and stored as 1 ml aliquots at -20 °C. 
A tube of the prepared cells (stored at -20 °C) was thawed on ice and pelleted by 
centrifugation at 13 000 rpm for 5 minutes. The method for isolation of gDNA for 
southern blot analysis of Hoffman and Winston (Hoffman & Winston, 1987) was used. 
The following adjustments were made: TE buffer was not added before 100 % ethanol 
was added. After ethanol was added, the sample was incubated on ice for 10 minutes. 
The sample was also not treated with RNase. 
2.3.2.8. Purification of mDNA 
2.3.2.8.1. RNase treatment 
RNase (0.1 mg.ml
-1
) was added to the mDNA and incubated for one hour at 37 °C. The 
sample was treated with PCI (Section 2.3.2.1.) and precipitated by adding twice the 
volume of ice cold 100 % ethanol and one tenth the volume of 3 M sodium acetate (pH 
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7.0). The DNA was incubated for 2 hours at -20 °C and pelleted, washed, dried and 
resuspended as described before. 
2.3.2.8.2. CTAB precipitation of polysaccharides 
This purification method was described by Gurgui and Piel (2010). CTAB was added to 
a final concentration of 1 % (w/v). 
2.3.2.8.3. PVPP columns 
If amplification of the 16S rRNA genes was unsuccessful the mDNA was further 
purified with polyvinylpolypyrrolidone (PVPP) spin columns (Berthelet et al., 1996). In 
brief, columns were prepared by stacking a cut, filtered-tip with PVPP (Sigma; P-6755). 
The columns were equilibrated with TE buffer and dried by centrifugation. The DNA 
was applied and eluted by centrifugation.  
2.3.2.8.4. 2. Drop dialysis 
In a sterile Petri dish, a 0.025 μm membrane (Millipore, VSWP01300 MF-Millipore) 
was floated on sterile water. The mDNA was placed (in aliquots of 10 μl) on the filter 
and incubated for at least 10 minutes. The dish was gently swirled a few times during 
incubation. After incubation, the mDNA was transferred to clean tube(s). 
2.3.2.8.5. Formamide treatment 
DNA was purified by following the method described by Newman et al. (2010). Plugs 
were slowly rotated while being incubated at room temperature.  
2.3.2.9. Recovery of mDNA from plugs 
2.3.2.9.1. Pulse field gel electrophoresis (PFGE) 
Initially a 1 % (w/v) SMP agarose gel was prepared with 0.5 times TBE buffer. 
Electrophoresis was performed with the CHEF-DR II Pulsed Field Electrophoresis 
System (BioRad, South Africa) in 0.5 times TBE buffer with the following programme: 
the field strength was 6 V.cm
-1
 (200 V) with the switch times set to be initially 1 second 
and then 6 seconds. After electrophoresis (approximately 22 hours), the gel was stained 
with ethidium bromide before visualisation. If electrophoresis of DNA into the gel was 
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observed, the experiment was repeated with a gel that was prepared with a low melting 
point agarose gel (LMP; 0.8 % (w/v)) section (Figure 24). 
 
Figure 24 Electrophoresis setup for size selection of extracted DNA. The dashed lines 
indicate where the gel was cut after electrophoresis. A standard melting point (SMP) 
agarose gel was prepared and a part of it was replaced with low melting point agarose 
gel (LMP). 
2.3.2.9.2. Size selection and recovery of mDNA from LMP 
The method was followed as described by Gurgui and Piel (2010) with the following 
alterations. A SMP agarose gel was partially replaced with a LMP section (Figure 24). 
Overnight electrophoresis was performed at 10 V. The mDNA was recovered from the 
LMP gel with agarase (Thermo Scientific) according to the instructions of the 
manufacturer. 
2.3.2.9.3. GeneJET Gel Extraction Kit 
The GeneJET Gel Extraction Kit (ThermoScientific) was used to extract the mDNA 
from normal agarose plugs C and D (Section 2.3.2.5). With the first attempt 200 mg and 
with the second attempt 500 mg of the plugs were used according to the manufacturer’s 
instructions. 
2.3.2.10. Qualitative and quantitative analysis of mDNA 
The quality and quantity of the extracted mDNA was determined with 
spectrophotometric or fluorometric analysis (Section 2.4.3.1.; Chapter 2), as well as 
agarose gel electrophoresis (Section 2.4.3.2.; Chapter 2). DNA was electrophoresed in a 
0.8 to 1 % (w/v) agarose gel at 20 V. Ethidium bromide was not added during the 
preparation of the gels when the mDNA was required for further analysis. 
 
SMP agarose 
Well for extracted DNA 
Well for DNA Ladder 
LMP agarose 
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2.4. PCR analysis  
2.4.1. Validating purity of the mDNA 
The amplification of the 16S rRNA genes within the mDNA was analysed with the 
universal eubacterial primers E9F and U1510R (Section 2.4.2; Chapter 2) to validate if 
the DNA was suitable for down-stream screening purposes. PCR reaction mixtures 
(20 µl) were prepared with DreamTaq polymerase (Fermentas, Thermo Scientific) 
according to the manufacturer’s instructions.  
The PCR reaction was performed by denaturing the DNA initially at 94 °C for 5 
minutes. This was followed by 35 cycles where the template DNA was denatured at 
94 °C for 30 seconds; the primers were annealed at 50 °C for 30 seconds and then 
extended for 1 minute 25 seconds at 72 °C. A final extension step of 10 minutes was 
performed at 72 °C. 
The gDNA of Dietzia maris, obtained from a colleague (W. Mavengere), was a positive 
control to this PCR and a reaction with no template DNA was the negative control. 
To determine if inhibitors were present in the mDNA sample, an internal control can be 
used (Dunbar & Mitchell, 2013). The internal control for this study, the gDNA of D. 
maris, was added in equal volumes to the mDNA and the resultant DNA, referred to as 
spiked-mDNA, was used as a template at various concentrations in the PCR. 
2.4.2. PCR screening for ‘Entotheonella’ spp. and RiPP genes 
2.4.2.1. Ocin1 and ‘Entotheonella’-specific 16S rRNA primers and 
PCR setups 
All primers (Table 14) were synthesized by Inqaba Biotech (Pretoria, South Africa) and 
purified on a reverse-phase cartridge. 
These primers were used in the PCR setup (Table 15) for screening purposes. 
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Table 14 Primers used for screening of DNA.  
Name Sequence Tm (°C)
 
Source 
Ta 
(°C) 
Ocin1F ATKGGYGGHGCRAACTGYGARR 
55.3/ 
69.2 
This study 
58 to 
49 
Ocin1R GTTSAGSCCRCARAARGTRCA 
53.5/ 
62.8 
This study 
58 to 
49 
Ento271F GGGAAASGTTCGCBGGTCTG 
58.4/ 
61.2 
(Wilson et 
al., 2014) 
60 
Ento735F GYATTAAGCCKYGGAAACKGT 
50.4/ 
61.0 
(Wilson et 
al., 2014)  
60 
Ento1290R GCCCRGCWYVACCCGGTA 
57.4/ 
66.2 
(Wilson et 
al., 2014) 
60 
The letters in red are defined by the IUPAC ambiguity codes for nucleotides (Cornish-Bowden, 
1985). 
Tm: the melting temperature of the primer (min/ max) as calculated with OligoAnalyzer 
(Owczarzy et al., 2008). 
Ta: the annealing temperature used during PCR amplification.  
2.4.2.2. ‘Entotheonella’-specific 16S rRNA PCR screen 
The following primer pairs were used (Table 14) to screen for ‘Entotheonella’ spp. 
Initially the 16S rRNA gene was partially amplified with the primers Ento271F and 
Ento1290R. A nested PCR was performed with products from the first PCR using the 
primers Ento735F and Ento1290R. DNA from an ‘Entotheonella’ species was not 
available as a positive control for this screen and the gDNA of D. maris was used as a 
negative control along with a reaction without template DNA. 
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Table 15 PCR setup for the screening of rSAM_ocin_1 related proteins (primers: Ocin1F and Ocin1R) and ‘Entotheonella’ species 
(primers: Ento271F, Ento735F, Ento1290R).  
1
 MgCl2: 2 mM 
2
 MgCl2: 1.5 mM  
m: minutes 
s: seconds   
Primers 
DNA 
polymerase 
PCR reaction mixtures (20 µl) PCR programme description 
PCR programme 
Reaction 
Temperature 
(°C) 
Duratio
n 
Cycle
s 
Ocin1F  
Ocin1R 
DreamTaq 
(Fermentas, 
Thermo 
Scientific) 
1X DreamTaq buffer
1
, 200 µM 
dNTP, 0.025 U.µl
-1
 polymerase, 
1 µM of each primer, 50 to 100 ng 
template DNA.   
MgCl2 was increased to 3 mM 
when specified. 
Gradient:  
Annealing temperatures ranged from 
55 to 65 °C across the 12 rows of the 
sample block. 
Denature 95 5 m 1 
Denature 95 30 s 
35 Anneal 55 to 65 30 s 
Extend 72 30 s 
Extend 72 10 m 1 
Touchdown: 
The annealing temperatures were 
changed by -1 °C per cycle for 10 
cycles.  
The annealing temperature of the next 
25 cycles was kept constant at the 
lowest temperature reached after the 
first 10 cycles (49 or 51 or 53 °C). 
Denature 95 5 m 1 
Denature 95 30 s 
10 Anneal 58 or 60 or 62 30 s 
Extend 72 30 s 
Denature 95 30 s 
25 Anneal 49 or 51 or 53 30 s 
Extend 72 30 s 
Extend 72 10 m 1 
Phusion High-
Fidelity 
polymerase 
(Fermentas, 
Thermo 
Scientific) 
1XPhusion HF buffer
2
, 200 µM 
dNTP, 0.02 U.µl
-1
 polymerase, 
1 µM of each primer, 50 to 100 ng 
template DNA.   
Touchdown: 
See the description above. 
Denature 98 1 m 1 
Denature 98 10 s 
10 Anneal 58 or 60 or 62 15 s 
Extend 72 15 s 
Denature 98 10 s 
25 Anneal 49 or 51 or 53 15 s 
Extend 72 15 s 
Extend 72 10 m 1 
Ento271F 
Ento735F 
Ento1290R 
Phusion High-
Fidelity 
polymerase 
See the reaction mixture above. 
DMSO: 3 % (v/v). 
 Denature 95 5 m 1 
 Denature 95 15 s 
40  Anneal 60 30 s 
 Extend 72 15 s 
 Extend 72 1 m 1 
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2.4.2.3. Cloning and sequencing 
Cloning and sequencing of selected PCR products was performed according to methods 
in Section 2.4.4.; Chapter 2. The nucleotide collection (nr/nt) and the non-redundant 
protein sequences (nr) databases were selected respectively for the BLASTn and 
BLASTx analysis of the sequences obtained from the Ocin1 screens.   
3. Results and discussion 
3.1. Analysis of the polytheonamide biosynthesis pathway and 
identification of putative pathways in sequenced genomes 
Currently polytheonamides are the only known members of the RiPP family proteusins. 
They were first extracted from the sponge T. swinhoei in 1994 and became of interest 
when their anti-tumour properties were elucidated (Hamada et al., 1994; Hamada et al., 
2005). It was thought that the peptides belonged to the class of non-ribsomal peptides 
and that the producing organism was a symbiotic bacterium of the sponge since other 
non-ribsomal peptides were shown to be produced by the symbionts of lithistid sponges 
(Hamada et al., 2005). The biosynthetic cluster of polytheonamide was only discovered 
in 2012 within the metagenome of the T. swinhoei (Freeman et al., 2012). Subsequently 
two closely related strains were isolated, ‘E. factor TSY1’ and ‘E. factor TSY2’, from 
the T. swinhoei (chemotype Y) sponge using fluorescence-assisted cell sorting and 
whole-genome amplification (Wilson et al., 2014). The genomes were sequenced and 
revealed that the biosynthetic cluster of polytheonamide was located on the plasmid of 
TSY1 along with three additional putative proteusin gene clusters and another putative 
cluster from the genome of TSY2  (Figure 25; Wilson et al., 2014).  
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Figure 25 Polytheonamides biosynthetic cluster and putative proteusin pathways of ‘Entotheonella factor TSY1 and TSY2’. This figure is adapted from  
the Extended Data Figure 4 of Wilson et al. (2014). 
 
Figure 26 A map of the polytheonamide biosynthetic gene cluster (A) along with the hypothetical proteusin pathways on the genomes of other 
organisms (B-I). A) ‘E. factor TSY1’ (KI932682.1), B) Bradyrhizobium japonicum USDA 6 (NC_017249.1), C) Anabaena variabilis ATCC 29413 
(CP000117.1), D) Desulfarculus baarsii DSM 2075 (NC_014365.1), E) Microcoleus sp. PCC 7113 (NC_019738.1), F) Nostoc sp. PCC 7120 
(NC_003272.1), G) Rhizobium leguminosarum bv. trifolii WSM2304 (NC_011368.1), H) S. meliloti SM11 (CP001830.1), I) Stigmatella aurantiaca 
DW43-1 (NC_014623.1). The open reading frames (arrows) are coded according to the predicted function of the product.  
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At the start of this study (2013), the polytheonamide biosynthetic cluster (Figure 26, A) 
was the only proteusin pathway available to design primers for the screening of 
metagenomic material for novel proteusin encoding pathways. However, it was 
reasoned that the polytheonamide genes might have homologues in other bacterial 
genomes, which if identified, could be used to design degenerate screening primers. 
Consequently, the Poy protein sequences were used to query for homologues in 
GenBank. Homologous proteins to at least four of the proteins within the biosynthetic 
cluster of polytheonamide were identified in ten organisms including A. variabilis 
ATCC 29413, D. baarsii DSM 2075, Nostoc sp. PCC 7120, S. aurantiaca DW4/3-1 and 
Microcoleus sp. PCC 7113 (Table 16; a more exhaustive summary of organisms with 
homologues is included in Appendix C; Table 8). During the analysis of the homologous 
proteins, it was observed that rSAM_ocin_1 related genes (accession: TIGR03975), that 
include poyB and poyC, are positioned in close proximity to genes that encode 
TOMM_pelo superfamily proteins (Figure 26). The precursor of polytheonamide, PoyA, 
that is related to nitrile hydratase-related leader peptides (NHLPs), is described by the 
conserved domain model TOMM_pelo (Haft et al., 2010). This could indicate that the 
organisms with homologues to the polytheonamide biosynthetic proteins harbour 
putative proteusin biosynthetic operons (Figure 26). 
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Table 16 A summary of the BLink analysis of proteins involved with polytheonamide biosynthesis (PoyB to I).   
 
PoyB PoyC PoyA PoyD PoyE PoyF PoyI 
 QC ID QC ID QC ID QC ID QC ID QC ID QC ID 
A. variabilis ATCC 29413 96 41 95 43 65 34 93 34   90 28   
D. baarsii DSM 2075 97 35 99 36 59 30 95 30       
Microcoleus sp. PCC 7113 96 43 96 43       89 29 74 31 
Nostoc sp. PCC 7120 98 38 95 41 64 38   45 33 92 29   
S. meliloti SM11 99 40 95 38   94 31 64 33 89 28   
S. aurantiaca DW4/3-1 95 42 95 41       97 31 81 30 
R. legumin bv, trifolii WSM2304 95 40 95 37   91 28   92 29   
B. japonicum USDA 6 97 39 99 37   30 29       
PoyC 99 47             
QC: query cover (%) 
ID: identity (%)  
Purple: Proteins not within the flanking regions of the other homologous proteins (Figure 26). 
Orange: Proteins not identified with the BLink analysis, but observed in nearby regions (Figure 26). 
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3.2. Degenerate primer design 
At the time this research was conducted, and to our knowledge, there were no 
degenerate primers available to screen for the biosynthetic genes of polytheonamides or 
related proteins. 
The design of degenerate primers to the precursor of polytheonamide, PoyA, was 
considered. PoyA was aligned with the TOMM_pelo proteins. The alignment (with a 
threshold setting of 80 %, Figure 28) did not identify appropriate conserved regions 
within the leader to enable primer design. 
Although PoyB and PoyC only have 47 % amino acid identity to each other (Table 16), 
both are C-methyltransferases (Freeman et al., 2012), and the homologous bottromycin 
proteins (BmbB, BmbJ, BmbF and BstC, BstF, BstJ) perform a similar function. These 
proteins catalyse C-β-methylation (Figure 27) at un-activated carbons of 
polytheonamides, bottromycins and other RiPPs (Freeman et al., 2012; Dunbar & 
Mitchell, 2013). These proteins belong to the rSAM_ocin_1 family (Figure 29) which in 
turn align with the Radical_SAM superfamily.  
 
Figure 27 Class B radical SAM methyltransferases catalyse the C-β-methylation 
(highlighted in red) at un-activated carbons of RiPPs (Dunbar & Mitchell, 2013). These 
rSAM proteins include PoyB and PoyC with a cobalamin-binding domain (CBD). 
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Figure 28 An alignment of PoyA with the representative proteins of the protein family, TOMM_pelo (accession: TIGR03793), that include 
proteins from A. variabilis, Nostoc spp., Pelotomaculum thermopropionicum and other species. The alignment was performed with the 
BioEdit Sequence Alignment Editor (Hall, 1999) and the Clustal W algorithm (Thompson et al., 1994) and the similarity threshold was set 
to 80 % (highlighted residues). 
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Figure 29 Conserved domain hits (from NCBI) of PoyB (top) and PoyC (bottom). The 
arrows in red indicate the regions to which the Ocin1 primers were designed. The 
jagged edges for some of the conserved domains indicate only a partial hit to the query. 
The protein sequences of representative proteins of the rSAM_ocin_1 model were 
obtained (CDD; NCBI) and aligned (accession numbers are available in Appendix C; 
Table 9). A maximum parsimonious tree from the alignment showed seven proteins in 
the same clade as PoyB and PoyC (Figure 30, Clade B). These included proteins from 
A. variabillis, Microcoleus sp. PCC 7113, Nostoc sp. PCC 7120, S. aurantiaca, 
Chondromyces apiculatis and Myxococcus sp.  
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Figure 30 Clade A of the maximum parsimonious (MP) tree of the representative 
proteins of the rSAM_ocin_1 family (full tree is available in Appendix C; Figure 1). 
The presented clade is that of PoyB and PoyC (Clade C) and the seven closest related 
proteins (Clade B). Analyses were conducted in MEGA5 (Tamura et al., 2011). The 
reference sequences (RefSeq; NCBI), denoted with the prefix 'WP_' in their accession 
numbers, were used as the representatives of identical sequences.  
The proteins within Clade B and the homologous rSAM proteins associated with 
bottromycins were aligned to determine the conserved residues (Figure 31). Primers 
(Ocin1F and R) were designed to the conserved residues within the conserved domains. 
The designed primers (Table 17) were analysed (Section 2.2.2) and no hairpins or 
significant homo- or hetero-dimers formed. Taking the melting temperatures of the 
primers into account, the mean annealing temperature was 56.9 °C (OcinF1) and 
53.2 °C (OcinR1).  
 
 gi|499397310|ref|WP_011084777.1| radical SAM protein [Bradyrhizobium]
 gi|504310739|ref|WP_014497841.1| radical SAM protein [Bradyrhizobium japonicum]
 gi|499973432|ref|WP_011654150.1| radical SAM protein [Rhizobium leguminosarum]
 gi|504342089|ref|WP_014529191.1| radical SAM protein [Sinorhizobium meliloti]
 gi|406822303|gb|AFS60638.1| C-methyltransferase [bacterium symbiont of Theonella swinhoei pTSMAC1]
 gi|406822302|gb|AFS60637.1| C-methyltransferase [bacterium symbiont of Theonella swinhoei pTSMAC1]
C
 gi|499637246|ref|WP_011317980.1| radical SAM protein [Anabaena variabilis]
 gi|504995450|ref|WP_015182552.1| bacteriocin maturation radical SAM protein 1 [Microcoleus sp. PCC 7113]
 gi|499305409|ref|WP_010996184.1| radical SAM protein [Nostoc sp. PCC 7120]
 gi|503141422|ref|WP_013376083.1| radical SAM protein [Stigmatella aurantiaca]
 gi|488695032|ref|WP_002619126.1| radical SAM protein [Stigmatella aurantiaca]
 gi|488710451|ref|WP_002634339.1| radical SAM protein [Chondromyces apiculatus]
 gi|397092464|gb|EJJ23222.1| hypothetical protein A176_7046 [Myxococcus sp. (contaminant ex DSM 436)]
B
100
100
99
72
100
100
100
100
81
62
A 
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Figure 31 An alignment of the rSAM_ocin_1 proteins (accession: TIGR03975) that are closely related to PoyB and PoyC, together with the 
bottromycins’ rSAM_ocin_1 proteins. The alignment was performed with the BioEdit Sequence Alignment Editor (Hall, 1999) and the 
Clustal W algorithm (Thompson et al., 1994) and the similarity threshold was set to 80 % (highlighted residues). The conserved region in 
the black blocks corresponds to the region selected for the design of the primers (Ocin1F and R). The conserved domains for PoyB (grey 
bars) together with the B12-binding sites or FeS/SAM binding sites (black arrows) are indicated.  
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Table 17 Degenerate primers designed from conserved residues of rSAM_ocin_1 
proteins. 
Name Sequence (5' - 3') 
Size 
(bp) 
Mean Tm 
(°C)
 a 
Mean 
CG % 
Degeneracy
 b
 
OcinF1 ATKGGYGGHGCRAACTGYGARR 22 61.9 56.1 192 
OcinR1 GTTSAGSCCRCARAARGTRCA 21 58.2 52.4 64 
a
 Calculated with OligoAnalyzer 3.1 (Owczarzy et al., 2008) 
b
 Degeneracy was calculated as the product of the number of possible nucleotides at each 
ambiguous position (red). 
The rSAM_ocin_1 protein sequences were also aligned to other rSAM protein families, 
since the conserved domains, cobalamin (vitamin B12)-binding and rSAM, are present 
in other proteins. For example, when B12_rSAM_oligo proteins (Figure 32) were 
aligned with rSAM_ocin_1 protein less conserved residues were observed than between 
rSAM_ocin_1 proteins. 
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Figure 32 An alignment of the rSAM_ocin_1 proteins (accession: TIGR03975) that are closely related to PoyB and PoyC, bottromycins’ 
rSAM_ocin_1 proteins and representative proteins of the B12_rSAM_oligo family. Alignment was performed with the BioEdit Sequence 
Alignment Editor (Hall, 1999) and the Clustal W algorithm (Thompson et al., 1994) and the similarity threshold was set to 80 % 
(highlighted residues). The conserved region in the black blocks corresponds to the region selected for the design of the primers (Ocin1F 
and R), as in Figure 8.  
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3.3. In silico PCR screening with Ocin1 primers 
An online tool was used for the simulation of a PCR to analyse the binding of the Ocin1 
primers to poyB and poyC, as well as to the genomes available with putative PoyB and 
PoyC homologues. The species included were S. meliloti, A. variabilis, Nostoc sp. PCC 
7120 and S. aurantiaca. In silico tools, such as this online PCR tool, is used to give 
some confidence of the designed primers.  
The in silico amplification of the Ocin1 primers, using poyB as the template, resulted in 
the amplification of a 390 bp fragment of the gene (Table 18). Similarly, a 398 bp 
fragment was amplified from poyC. A 387 bp fragment of a homologous gene was 
amplified from the genome of Nostoc sp. PCC 7120. A BLAST analysis of the latter 
amplicon confirmed that the gene is a hypothetical protein and part of the rSAM_ocin_1 
family of proteins. Similarly, a radical SAM domain-containing protein was amplified 
(327 bp) from S. aurantiaca DW4/3-1. The sequences of these fragments are reported in 
Appendix C; Figure 2. 
Table 18 In silico PCR simulations with the Ocin1 primers.  
Template sequence Strain Accession number 
1
 bp 
2
  Parameters 
3
 
poyB (2026 bp)  JX456532.1:8815-10806 390  (1, 2) (1, 3) (1, 5) 
poyC (2047 bp)  JX456532.1:10848-12860 398  (2, 10) 
S. meliloti 1021 
4
 PRJNA57603 NB  
S. meliloti  SM11 PRJNA159685 NB  
A. variabilis  ATCC 29413 PRJNA58043 NB  
Nostoc sp.  PCC 7120 PRJNA57803 387  (2, 10) 
S. aurantiaca  DW4/3-1 PRJNA158509 327  (2, 10) 
1
 Nucleotide sequences were obtained from NCBI. 
2
 The number of base pairs amplified.  
3
 The parameters given in brackets are those used when amplification was observed. The 
number of mismatches that were allowed and number of nucleotides in the 3’ end where 
mismatches were not allowed.   
4
 The strain used for in vitro PCR screening. 
NB: The simulated amplification resulted in no bands. 
Grey: strains identified with BLAST searches to have putative PoyB and/or PoyC homologues. 
Although the BLink analysis showed that A. variabilis have putative proteins 
homologous to PoyB and PoyC, the in silico PCR did not produce any amplicons with 
the Ocin1 primers. Likewise, the Sinorhizobium strains did not produce amplicons 
(Table 18) even though strain SM11 was identified to have a homologous protein. Even 
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though the in silico PCR and BLAST algorithms did not produce the same set of results, 
S. meliloti 1021 was included in the in vitro experiments since the parameters of an in 
vitro PCR can be manipulated to change the stringency of the amplifications to obtain 
the desired amplicon.  
3.4. In vitro PCR screening with Ocin1 primers 
3.4.1. Verification of the amplification of the positive control genes 
A requirement for screening with the Ocin1 primers was to confirm that the correct 
genes were amplified from the control DNA.  
During the study of the biosynthetic gene cluster of polytheonamide by the Piel 
laboratory (Freeman et al., 2012) the Nhis-poyB-pCDFDuet-1 plasmid, containing 
poyB, was constructed for expression experiments. The total size of Nhis-poyB-
pCDFDuet-1 (now referred to as the poyB-plasmid) is 5550 bp. The poyB gene 
(1990 bp) in this plasmid was used as a positive control for the Ocin1 PCR screen. It 
was estimated that an amplicon of 360-390 bp would be obtained (Table 18). In order to 
compensate for variance in gene sizes, it was decided to focus on amplicons (obtained 
with the Ocin1 screens) within the size range of 350 to 400 bp.  
S. meliloti 1021 was selected as another control because it is closely related to other 
rhizobacteria (S. meliloti SM11, Bradyrhizobium spp. and R. leguminosarum) with 
homologous genes to poyB and poyC (Figure 30, Clade A).  
Amplicons generated from the gDNA of S. meliloti and the poyB-plasmid, that were 
within the expected size range of 350 to 400 bp, were sequenced (Appendix C; Figure 
3). Analysis showed that the fragment amplified from S. meliloti was 99 % similar to 
the radical SAM domain protein of S. meliloti SM11 (total gene length: 1827 bp). This 
protein is part of a cluster that is conserved in rhizobacteria (PCLA 629334; protein 
cluster database, NCBI). The fragment amplified from the poyB-plasmid was 99 % 
similar to poyB. 
Analysis of the polytheonamide biosynthetic cluster showed that S. meliloti SM11 has 
homologous proteins to (PoyB, C, D and F; Table 16, Figure 26 H). However, the in 
silico PCR with the Ocin1 primers detected no homologous genes within any of the 
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screened S. meliloti strains (1021 and SM11). In silico analysis is an indication of what 
could be found with in vitro experiments. The result of the in silico PCR is not as 
definitive as in vitro experiments. This was clearly demonstrated when a homologous 
gene (initially identified with BLAST searches) was amplified. This could be because 
the stringency of the in silico PCR is not as flexible as with in vitro experiments and 
thus the in silico PCR is not always an accurate representation.  
3.4.2. Optimising the Ocin1 PCR parameters 
Various parameters of the PCR reaction were altered to reduce the level of non-specific 
amplification obtained, as well as to establish the limits of the Ocin1 primers since the 
primers are degenerate and since metagenomic DNA (a complex mixture of DNA) was 
the target for screening. Different annealing temperatures, DNA polymerases and 
concentrations of MgCl2 were used. 
The melting temperature range for the Ocin1 primers was calculated to be between 
53.5 °C (lowest for the reverse) and 69.2 °C (highest for the forward). A gradient PCR, 
with annealing temperatures ranging from 55 to 65 °C, was performed with the poyB-
plasmid DNA. A DNA fragment, within the expected size range, was observed (Figure 
33) across the entire gradient. Annealing temperatures above 61 °C reduced the binding 
capacity of some of the primers and resulted in a lower yield of the PCR product. 
Taking into account the amplification of the poyB gene at different annealing 
temperatures, together with the calculated melting temperatures, the optimal annealing 
temperature for the Ocin1 primers to the poyB gene was 58 °C and lower.  
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Figure 33 Gradient PCR of Ocin1 primers with poyB-plasmid DNA as the template. The 
annealing temperature for each lane was as follows: 1) 55.0 °C, 2) 55.6 °C, 3) 56.1 °C, 
4) 57.4 °C, 5) 58.9 °C, 6) 60.3 °C, 7) 61.0 °C, 8) 62.3 °C, 9) 63.4 °C, 10) 64.4 °C, 11) 
64.7 °C, 12) 65.0 °C. The negative control (lane 13), where no template DNA was 
added, had an annealing temperature of 60.3 °C. M1) λ phage DNA digested with the 
endonuclease PstI was used as the DNA ladder. 
When screening with degenerate primers, where it is uncertain which conditions are the 
best suited for the binding of the primers to the template, it is recommended to use 
stringent annealing temperatures (Korbie & Mattick, 2008) for the first few cycles of the 
PCR. This reduces miss-priming and non-specific products (Don et al., 1991). This is 
why a touchdown PCR was used for the Ocin1 screens to compensate for the variance 
in annealing temperatures of the degenerate primers. A touchdown PCR was performed 
with DreamTaq polymerase using three different annealing temperature ranges (Table 
15). The temperature ranges were chosen around the optimal annealing temperature.  
When the touchdown PCR at the lower annealing temperature range (58 to 49 °C) was 
used with the S. meliloti DNA there was non-specific amplification (Figure 34, lane 1), 
which was reduced as the annealing temperatures increased (60 to 51 °C and 
62 to 53 °C). At higher annealing temperatures the control fragment from the more 
complex DNA (S. meliloti) was weakly amplified compared to the fragment from the 
poyB-plasmid. Therefore, it was decided not to use the higher temperature ranges for the 
screening of mDNA, as the target gene is not likely to be over-represented in the 
mDNA, as was the case with the poyB-plasmid, and as a consequence the amplification 
of the gene might be too weak to be detected. 
The effect of different PCR reagents (DNA polymerase and MgCl2) was also evaluated. 
There was less non-specific amplification from the S. meliloti DNA with the Phusion 
polymerase (Figure 34, lane 11) and although the desired fragment was better amplified 
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than with the DreamTaq polymerase, the opposite was true for the control fragment 
amplified from the poyB-plasmid. When an increased concentration of MgCl2 with the 
DreamTaq reaction mixture (Figure 35) was used, the non-specificity of S. meliloti did 
not improve and the amplification of the 400 bp fragment of both controls was not 
negatively influenced. Therefore, it was decided to use the increased concentration of 
MgCl2 for the Ocin1 screens, since the source of the DNA or the extraction methods 
used may result in increased chelators within the DNA sample which will sequester the 
MgCl2 available in the PCR reaction mixture for the DNA polymerase (Schrader et al., 
2012). 
The optimisation of the touchdown PCR with S. meliloti DNA gives an indication of 
what conditions could be used to screen other DNA for rSAM_ocin_1 homologous 
genes, but it should be remembered that the optimisation of the PCR is also template 
dependent. The conclusion of the optimisation procedure was to use DreamTaq 
polymerase with the annealing temperature range of 58 to 49 °C and an increased 
concentration of MgCl2. 
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Figure 34 Touchdown PCRs with DreamTaq (Lanes 1-9) and Phusion (Lanes 10-12) polymerase and 2 mM MgCl2 at annealing temperatures (Ta): 58 to 
49 °C (Lanes 1-3), 60 to 51 °C (Lanes 4-6 and 10-12) and 62 to 53 °C (Lanes 7-9). The template DNA used for Lanes 1, 4, 7 and 11) S. meliloti; Lanes 
2, 5, 8 and 12) poyB-plasmid and Lanes 3, 6, 9 and 10) no DNA. M1) 1 kb; M2) λ PstI and M3) 100 bp DNA markers. 
 Ta: 58 to 49 °C    Ta: 60 to 51 °C  Ta: 62 to 53 °C  
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Figure 35 Touchdown PCRs with DreamTaq polymerase and 3 mM MgCL2 at annealing temperature (Ta): 58 to 49 °C (Lanes 1-3), 60 to 51 °C (Lanes 
4-8) and 62 to 53 °C (Lanes 9-13). Template DNA added: S. meliloti (Lanes 1, 4, 6, 10 and 12) and poyB-plasmid (Lanes 2, 5, 7, 9 and 11). The DNA 
ladders are as follows: M1) 1 kb; M2) λ PstI and 100 bp.   
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3.4.3. Extraction of mDNA from PE14 
Initially the objective for this part of the research was to extract high molecular weight 
(HMW) metagenomic DNA to construct a library. The construction of a metagenomic 
library has many advantages for the screening of secondary products, such as RiPPs. 
The DNA library could be screened functionally or with sequence-based methods. 
Through functional screening, the genes are expressed heterologously. With the 
advances of next generation sequencing, sequence-based screening of DNA libraries has 
become more attractive. One of the attractive characteristics for bioprospecting 
secondary products through sequencing is that the biosynthetic genes are usually 
clustered together (Hoffmeister & Keller, 2007; Lee et al., 2008). Thus, an entire 
pathway could be encoded in a single clone, depending on the size of the inserts. 
Another sequence-based method of screening is dependent on homology techniques 
such as PCR. 
Although the conventional approach of metagenomics is to construct DNA libraries, 
various limitations experienced with library construction and difficulties with 
heterologous expression has driven homology-based screening of metagenomes 
(Charlop-Powers et al., 2014) without the construction of DNA libraries (Więckowicz 
et al., 2011; Woodhouse et al., 2013; Ridley et al., 2005). 
In this study, seven different extraction methods were employed to extract HMW DNA 
(Table 19).  
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Table 19 Methods employed to extract HMW mDNA and the characteristics of the 
respective methods. 
 Method Characteristic of method 
1 Modified CTAB lysis 
CTAB is known to improve purification of DNA for further 
manipulation. 
2 Agarose embedded cells 
Embedding cells within agarose prevents shearing of DNA 
and help to obtain DNA that is more pure for downstream 
processes. 
3 Modified urea lysis 
Successfully used for HMW DNA libraries from sponges. 
The use of CTAB during extraction, which could influence 
the yield of DNA negatively, is optional. 
4 MoBio Soil extraction kit 
mDNA from soil is usually contaminated with humic acid 
and other compounds that inhibit molecular manipulation of 
DNA. This kit was used to see whether more DNA of better 
quality could be obtained.  
5 
Agarose plugs with CTAB  
or urea lysis 
This was a combinatorial method of Newman et al (Newman 
et al., 2010) with the lysis buffers of Method 1 and 3. 
6 Crude extraction  
7 Yeast extraction method  
 
It is well known that it is a challenge to extract sufficient HMW mDNA from sponges 
that is pure enough for the construction of metagenomic libraries; for medium-insert 
(45 kb) or large-insert libraries (100 to 350 kb; Ouyang et al., 2010; Salgado et al., 
2007; Gurgui & Piel, 2010; Charlop-Powers et al., 2014). There were many difficulties 
experienced during the extraction of HMW mDNA, which included low concentration 
of DNA, shearing of DNA, co-extraction of inhibitors and loss of DNA after 
purification. Consequently, the objective changed rather to extract sufficient DNA that 
is of good enough quality to be screened without the construction of a library. 
Some of the practical precautions applied to prevent shearing of DNA included 
trimming of pipette tips before sterilisation, to become wide bore tips, and gentle or 
minimal mixing of solutions during cell lysis or DNA precipitation. 
Another practical method was to embed the cells within agarose plugs to prevent 
shearing (Liles et al., 2008; Handelsman et al., 2002; Table 20, Method 2). The plugs 
were subjected to PFGE to recover the DNA. Faint smears of DNA were observed after 
electrophoresis and the concentration of the DNA was too low for recovery after gel 
electrophoresis. Another problem encountered with the PFGE experiment was to 
maintain a low temperature during electrophoresis. The apparatus was used at room 
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temperature (and could not be moved to a cold room). This is acceptable and the buffer 
was circulated through tubes coiled through an ice water bath as recommended 
(BioRad), but low temperatures could not be maintained (below 30 °C; BioRad) and 
this could have influenced the resolution of DNA bands. Alternatively, the field strength 
could have been lowered to prevent overheating of the buffer. Another difficulty 
experienced with this method was the recovery of DNA from the plugs. The plugs were 
made with SMP agarose. This should not influence the recovery of the DNA after the 
plugs were subjected to PFGE in a LMP gel. However, if the plugs were made with 
LMP agarose the DNA could be recovered by enzymatic digestion of the agarose or by 
electroelution (Osoegawa et al., 1998; Liles et al., 2008). 
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Table 20 Metagenomic DNA extraction methods used and the result thereof. The amplification of 16S rRNA genes was evaluated. If there 
was no amplification from the mDNA it was further purified with various techniques. 
 
Extraction 
method 
Section 
Sponge 
(g) 
DNA 
obtained 
Initial 
concentration 
(ng/ul) 
Purification 
Concentration 
after 
purification 
(ng/ul) 
16S 
rRNA 
Conclusion 
1 
Modified CTAB 
lysis 
2.3.2.1. 
2 Yes 335.6 PCI 48.8 No Too low concentration. 
50 Yes 754.1 RNase 7.6 No Loss of DNA during purification. 
2 
Agarose 
embedded cells 
2.3.2.2. 10 No - - - - 
DNA not recovered from agarose with 
PFGE. 
3 
Modified urea 
lysis 
2.3.2.3. 
1 Yes 379.1 CTAB 5.2 No Loss of DNA during purification. 
10 Yes 90.2 
size selection  
PVPP and desalt 
39.2 
46.4 
No No amplification after purification. 
10 Yes 141.8 
RNase; size 
selection;  
PVPP 
48.8 (RNase); 
127.5 (PVPP) 
No DNA not recovered after size selection. 
10 Yes 198.5 PVPP 180.2 
Yes, after 
PVPP 
Amplification when highly diluted, but 
concentration too low for screening. 
4 
MoBio Soil 
extraction kit 
2.3.2.4. 3 Yes - - - - Too low concentration. 
5 
Agarose plugs 
with CTAB 
lysis 
2.3.2.5. 1.5 
1
 No - Formamide - - DNA could not be recovered. 
6 
Agarose plugs 
and urea lysis 
2.3.2.5. 1.5 
1
 No - Formamide - - DNA could not be recovered. 
7 Crude extraction 2.3.2.6. 1 Yes 113.0 PVPP 56.5 No DNA too fragmented (< 500 bp). 
8 
Yeast extraction 
method 
2.3.2.7. 1 ml 
2 
Yes 68.6 PVPP - No DNA not pure enough. 
1
 See the methods section for a description of how the samples were prepared. 
2
 The cells were separated from 3 g of sponge material and enriched for microbial cells. The cell-suspension (5 ml) was stored as 1 ml aliquotes.  
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Metagenomic DNA was obtained with various attempts of the modified urea lysis 
extraction method (Table 20, Method 3). This method seemed to yield better quality 
DNA than the modified CTAB method (Table 20, Method 1). Electrophoresis showed 
that most of the fragments obtained were about 23 to 48 kb and darker smears were 
observed below 2000 bp (Figure 36, lanes 1 to 4).  
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Figure 36 Different attempts of extracting mDNA with the modified urea lysis method. 
Lanes 1-4) the extracted mDNA. Lanes 5-6) the mDNA, from lanes 3 and 4, after 
purification with PVPP. The DNA markers are M1) λ DNA, about 48.5 kb; M2) λ Hind 
III and M3) λ PstI. 
Sponges are known to contain phenolic compounds and high concentrations of 
polysaccharides (Gurgui & Piel, 2010; Salgado et al., 2007) that are co-extracted with 
DNA. These are common PCR inhibitors that are also co-extracted from plant samples 
(Schrader et al., 2012). Purification methods for DNA extracted from environmental 
material, with high concentrations of inhibitors for molecular methodologies, have been 
widely studied. The purification methods include the use of column chromatography, 
polyvinylpyrrolidone (PVP; Schrader et al., 2012) and PVPP or precipitation of 
polysaccharides with a cationic detergent such as CTAB (Gurgui & Piel, 2010). 
Newman  et al. (2010) found that the loss of DNA could be limited by embedding the 
DNA in agarose before purification. They incubated the agarose-plugs in a formamide 
and salt solution and effectively removed PCR inhibitors from samples, which were 
previously contaminated with PCR inhibitors. 
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Different purification methods (Section 2.3.2.8.) were used to remove contaminants and 
improve the quality of the mDNA. Less DNA was recovered after purification (Figure 
36, lanes 5 and 6) and for some of the purification methods (CTAB and size selection) 
the concentration of the DNA was too low for further analysis. 
The extraction of high quality mDNA (low or high molecular weight) mDNA from the 
sponge H. esperioides was proven difficult in our experience, even though numerous 
attempts were made. The yield of mDNA is dependent on the species, time and method 
of storage as well as the extraction method (Simister et al., 2011). One of the factors 
that have been found to significantly influence the yield of DNA is the storage method 
of a sample. This have been analysed by various researchers (Simister et al., 2011; 
Salgado et al., 2007; Dunlap et al., 2007). Generally, the preservation methods include 
freezing or the use of fixatives or buffered solutions, which are not always accessible in 
remote locations. For future studies we recommended to use fresh samples (Dunlap et 
al., 2007) or samples that have only been stored for a short period of time. 
It is not only the method of storage or method of extraction that influences the yield of 
DNA. As reported within previous chapters, the symbionts of sponges are important 
producers of natural products and thus metagenomic studies that screen for natural 
products focus on obtaining the DNA of the symbionts. Many of these organisms are 
endosymbionts and consequently it is difficult to obtain high quantities and quality 
DNA as the techniques employed for the separation of the cells from the host affects the 
yield and molecular weight of the DNA (Dunlap et al., 2007). 
3.4.4. DNA screens 
3.4.4.1. Validating the amplification of mDNA 
Before screening with the Ocin1 primers, the DNA was used in a validation PCR with 
universal 16S rRNA primers to determine whether the DNA is amplifiable with 
DreamTaq polymerase (Section 2.4.1.). The hypothesis was that if conserved genes, 
such as the 16S rRNA genes, are not amplified the concentration of the mDNA could be 
too low or PCR inhibitors were co-extracted with the mDNA.  
To determine if inhibitors are present in the DNA sample, an internal control (Burkardt, 
2000) was used  by adding gDNA of D. maris to the mDNA (spiked-mDNA; Section 
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2.4.1.) The gDNA of D. maris has been successfully used in previous PCRs with the 
16S rRNA primers. Therefore, amplification of a DNA fragment with the internal 
control should always be observed, but if amplification was not observed, there is a 
possibility of PCR inhibitors within the extracted mDNA sample. Inhibitors could be in 
solution or bound to the DNA. DNA could be purified from inhibitors that are in 
solution, but it is more difficult when the inhibitors are bound to the DNA. It should 
also be remembered that all of the DNA will not be fully recovered after purification 
(Burkardt, 2000) and the method of purification  should be carefully selected. 
In general, the extracted mDNA could not be manipulated in downstream steps. For all 
of the extraction attempts the 16S rRNA genes could not be amplified during the 
validation PCR. When the mDNA was spiked with gDNA of D. maris it could also not 
be amplified, suggesting the presence of inhibitors. For one of the validation PCRs 
(Figure 37) the mDNA and spiked-mDNA only amplified when it was highly diluted, 
but the DNA could not be used for screening purposes, as the DNA concentration would 
be too low for efficient PCR screening (Wintzingerode et al., 1997).   
1 2 3 4 M1 5 6 7 8 9 10  M1 M1 (bp) 
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Figure 37 The validation PCR of the extracted mDNA with the universal 16S rRNA 
primers. Lanes 1, 3, 5 and 7) mDNA at concentrations: undiluted, 10 times diluted, 50 
times diluted and 100 times diluted. Lanes 2, 4, 6 and 8) spiked-mDNA (mDNA with 
gDNA of D. maris). The spiked-mDNA was diluted the same as the mDNA. Lane 9) 
control reaction with gDNA of D. maris as template and lane 10) no template DNA. 
DNA marker λ PstI (M1). 
Some of the extracted mDNA was purified by treatment with RNase, CTAB, PVPP, 
drop dialysis and formamide (Figure 38), but even after purification the DNA did not 
pass the validation PCR. 
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Figure 38 Size selection of the DNA purified with formamaide. The fragments greater 
than 23 kb in size was cleaned (A) as well as fragments between approximately 9 to 
23 kb (B). 
Metagenomic DNA, extracted by members of IMBM from the sponges PE03, PE05, 
PE08 and PE14 (Table 10) was also validated before screening it with the Ocin1 
primers. The mDNA samples that passed the validation PCR with the DreamTaq DNA 
polymerase were PE03, PE05-B and PE14-B (Table 21). The validation of the latter two 
samples was confirmed by personal communication with the colleagues who extracted 
the DNA. 
The mDNA screened for the presence of ‘Entotheonella’ spp. was first validated with 
the universal 16S rRNA primers (E9F and U1510R) and the same PCR reaction mixture 
that was used for screening with the ‘Entotheonella’-specific primers (i.e. Phusion 
polymerase with 3 % DMSO; Table 15). Failure of amplification with the Phusion 
validation PCR led to the purification of the samples PE05-A, PE05-B, PE08, PE14-A 
and PE14-B with the PVPP method (Section 2.3.2.8.3.). Only sample PE05-A was 
amplifiable in the Phusion validation PCR after purification (1500 bp; Figure 39, 
Lane 1). 
A A 
B B 
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Table 21 Validation of the extracted mDNA with different DNA polymerases.  
Species Sample name 
(mDNA) 
Validation 
 DreamTaq Phusion 
Guancha sp. 001RSASPN PE03 Y ND 
W. caliculatum PE05-A N Y 
W. caliculatum PE05-B Y * N 
Spongia sp.001RSASPN PE08 N N 
H. esperioides PE14-A N N 
H. esperioides PE14-B Y * N 
* Amplification was determined by the person that extracted the mDNA. 
Y: yes, amplified. 
N: no, did not amplify. 
ND: not determined. 
The discrepancy between the validation results when different polymerases were used, 
illustrates that the mDNA, validated with DreamTaq DNA polymerase, was still 
contaminated with inhibitors that inhibited the activity of the Phusion DNA polymerase 
(Table 21). Even though the manufacturer of the Phusion DNA polymerase states that it 
will tolerate numerous PCR inhibitors, our validation experiments showed that the 
Phusion DNA polymerase was sensitive to the unknown inhibitors still present in the 
mDNA samples. Although some PCR inhibitors have been identified for various 
samples, and methods to overcome the effects are available, many inhibitors and their 
mechanism of action remain unknown (Abu Al-Soud & Râdström, 1998; Wilson, 
1997). It should also be noted that an increase in the fidelity of a polymerase usually 
affects some of the other characteristics such as resistance to inhibitors and efficiency. 
This is why manufacturers optimise DNA polymerases and their reaction mixtures to 
achieve the best amplification, but this is not a guarantee as each reaction is unique. 
3.4.4.2. Screening for the presence of ‘Entotheonella’ spp. 
Concurrent to this study, the Piel laboratory determined that the organisms producing 
the proteusin, polytheonamide, belong to the candidate genus ‘Entotheonella’ (Wilson 
et al., 2014). In their study, they screened 37 sponge species (47 sponges in total), from 
various taxonomical groups and locations, with the ‘Entotheonella’-specific 16S rRNA 
gene primers they developed. These filamentous species were present in 40 of the 
sponges they have screened (Table 22). 
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Table 22 The number of sponges screened, from various locations, with the 
‘Entotheonella’-specific 16S rRNA gene primers.1 
Origin of sponges Sponges screened Sponges with ‘Entotheonella’ spp. 
Japan 29 24 
Caribbean Sea 8 7 
Croatia 3 3 
Madagascar 1 0 
Papua New Guinea 1 1 
Saudi Arabia 3 3 
USA 1 1 
Vanuatu 1 1 
1
 Data was adapted from Table S9 of (Wilson et al., 2014). 
It may seem that the presence of ‘Entothenella’ is biased towards Japanese sponges; 
however, this might be due to a lack of bioprospecting efforts in other biodiversity 
hotspot regions. Leal et al. (2012) showed that the geographical trends of 
bioprospecting efforts for marine natural products from invertebrates (1990-2009) are 
primarily in Asian countries. The relatively increased focus on bioprospecting sponge 
and invertebrate natural products from the Pacific Ocean (Leal et al., 2012) illustrates 
the great need for metagenomic studies of sponges from other geographical regions.  
It was decided to do preliminary screens with the mDNA of South African sponges with 
the ‘Entotheonella’-specific 16S rRNA primers. The purpose of this screen was to 
determine whether the DNA of any ‘Entotheonella’ spp. were present. The 
‘Entotheonella’ spp. are a rich source of different classes of bioactive secondary 
metabolites  (Wilson et al., 2014) and if they are detected in the South African sponges, 
it will be worthwhile to research which bioactive products they produce.  
The mDNA used for this screen was extracted as described in Section 3.4.3. Only 
sample PE05-A was amplifiable with the Phusion validation PCR (Section 3.4.4.1.) and 
was screened with the ‘Entotheonella’-specific primers (Ento271F-Ento1290R; Table 
14). DNA fragments of approximately 600, 1200 and 1500 bp were amplified (Figure 
39, Lane 3). A nested PCR (with Ento735F-Ento1290R) was performed with the 
resultant PCR reaction mixture, but DNA fragments of incorrect sizes were obtained 
(Figure 39, Lane 2).  
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Figure 39 Phusion PCR with 16S rRNA primers: E9F with U1510R (lanes 1 and 4), 
Ento271F with Ento1290R (lanes 3 and 6) and Ento735F with Ento1290R (lanes 2, 5 
and 7). Sample PE05-A was added as template to the reactions in lanes 1, 3 and 7. 
Lane 2) A nested PCR was performed with the products of a PCR reaction mixture that 
was the same as lane 3. Lanes 4-6) Control reactions with D. maris gDNA as template. 
DNA marker λ PstI (M1). The control PCR without template DNA was electrophoresed 
on another gel, and no amplicons were produced.  
Screening with the ‘Entotheonella’-specific primers was not pursued any further, 
primarily because this was not a core objective of this study, moreover, an appropriate 
control for the screen was not available and the results obtained were inconclusive. 
Screening for polytheonamides or proteusin related proteins was pursued by screening 
the extracted mDNA with the designed Ocin1 primers. 
3.4.4.3. Screening mDNA with Ocin1 primers 
After numerous extraction and purification attempts, the metagenomic DNA that passed 
the validation PCR was screened with the Ocin1 primer pair. No DNA fragments were 
produced from the Ocin1 screens with samples PE03, PE05-B and PE14-B. This could 
be because non-optimal PCR conditions were used or contaminants were still within the 
sample. Due to the complexity of the mDNA, consisting of a consortium of genomes, it 
is difficult to find the correct set of PCR parameters for this type of template, as there is 
a multitude of possibilities for the parameters.  
Another reason could be that the target gene is not within the sample, which represents 
a high probability. Analysing the BLink report (2014) of PoyB and PoyC (with the 
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parameters set as described within the methods section) only 489 and 386 species, 
respectively, have homologous proteins and generally one gene per species.  
No microbial diversity studies have been done yet for the sponges used in this study and 
therefore it is not known whether the samples were from high or low microbial biomass 
sponges. Thus it was not known if the extracted DNA was biased towards the most 
dominant species within the sponge as this is often encountered with metagenomic 
DNA extraction (Suenaga, 2012).  
It should also be remembered that because the DNA was screened directly it was diluted 
to a suitable concentration for the PCR, and thus may have resulted in the diluting out of 
genes represented in low abundance.  
3.4.4.4. Screening sponge isolates with Ocin1 primers 
It was decided rather to screen the gDNA of bioactive isolates from the H. esperioides 
(PE14; Appendix B; Table 6) sponge to determine if any of them have rSAM 
homologues and as a way to test the specificity of the primers. 
Twenty-eight of the isolates from the sponge, which displayed antimicrobial activity, 
were selected for the Ocin1 PCR screen. DNA from these isolates was extracted as 
described in Section 2.4.1.; Chapter 2. 
At first the DNA of some of the isolates was extracted and screened in groups (Table 
12) with DreamTaq and an increased concentration of MgCl2 with the annealing 
temperature range of 58 to 49 °C (Figure 40, lanes 1-4). When the same DNA was 
screened with the same annealing temperature range and Phusion polymerase, no 
amplicons were obtained (Figure 40, lanes 8-11). As we wanted to evaluate the 
specificity of the primers, it was decided to screen the gDNA of the isolates with the 
screening conditions chosen after optimisation with the gDNA of S. meiloti (DreamTaq 
polymerase and increased MgCl2 at annealing temperatures of 58 to 49 °C; refer to 
Figure 35).  
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Figure 40 Touchdown PCRs with DreamTaq and 3 mM MgCL2 and Phusion 
polymerase. Annealing temperature range used 58 to 49 °C. Template DNA added: 
Group 1 to 4 (lanes 1-4), S. meliloti (lane 5) and poyB-plasmid (Lane 6) and no DNA 
(lane 7). The 1 kb DNA ladder (M1) was used. Refer to Table 12 for the individual 
isolates included in the different groups.  
Experiment A, D, B and E (Figure 41) showed the difference in amplified fragments 
with more stringent annealing temperatures, compared to fragments obtained with 
annealing temperatures of 58 to 49 °C. Fewer non-specific amplicons were obtained 
from the sponge isolates when more stringent annealing temperatures were used.  
Each isolate was screened at least twice and PCR reactions were relatively reproducible 
as different reactions with the same template DNA produced similar profiles of 
amplified DNA fragments (Figure 41). For all of the screens the control DNA fragment 
(400 bp) was amplified from the poyB-plasmid and gDNA from S. meliloti. Some of the 
prominent DNA fragment sizes amplified were about 150 bp and 500 to 600 bp. 
Fragments between 300 to 500 bp were extracted and sequenced (as described in 
Section 2.4.4.1.; Chapter 2). 
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Figure 41 DreamTaq touchdown PCR with annealing temperature ranges 58 to 49 °C (A-D) and 
62 to 53°C (E and F). The number above each lane is the PE14-isolate number. The control 
reactions (green) with poyB-plasmid (PoyB) and gDNA from S. meliloti (Sm) where the 400 bp 
fragment represents the partially amplified rSAM_ocin_1 homologous gene. No template DNA 
added (Neg). DNA markers included M1) λ PstI; M2) 100 bp and M3) 1 kb. The negative 
control in B is the control for experiment A and B. Similarly, the negative control in E was for 
experiment E and F. The region between 250 to 600 bp (C and D) was cleaned and used in a 
second PCR with Ocin1 primers and selected fragments (white blocks) were sequenced and 
analysed. Unfortunately the loading dye used for some of the samples in A and B masked some 
of the DNA bands (bright lines at 1 500 and 250 bp region). 
The sequences of the selected DNA fragments were analysed with BLASTn and 
BLASTx. The closest hit, according to the expectation value (E-value) to the query 
sequence, was recorded (Table 23). None of the amplified genes were related to the 
target genes. Interestingly homologous genes were amplified from different isolates: 
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formate dehydrogenase subunit alpha from PE14-13 and PE14-22 and C4-dicarboxylate 
ABC transporter from PE14-61 and PE14-91.  
Alignment of the 16S rRNA sequences of PE14-13 (P. ascidiaceicola strain F423) and 
PE14-22 (V. splendidus strain LGP32) showed that these isolates are not the same 
organisms. The sequences had a similarity of only 82 % (BLAST; NCBI). Although, 
both organisms showed activity against the same indicator strains (M. smegmatis, S. 
epidermidis and B. cereus; Chapter 2), another anti-microbial screen that was performed 
by colleagues in the laboratory showed that PE14-13 also inhibited the growth of E. coli 
1699 (Appendix B; Table 7). From this we can conclude that these isolates are most 
probably not the same strain. 
The bioactivity profiles for isolates P14-61 and PE14-91 were not the same (Appendix 
B; Table 7).  They appear to be different strains, but since the 16S rRNA identity of 
both strains is not known, we cannot definitely conclude whether they are the same 
strain. 
The conserved domains of poyB and C, the cobalamin-binding and rSAM domain, were 
not present in any of the amplified genes. Further research of the function and 
conserved domains of the top hit (Table 24) indicated that two of the proteins have iron-
sulphur binding sites: formate dehydrogenase (FDH, WP_017111042.1) subunit alpha 
in V. tasmaniensis and ribonucleotide-diphosphate reductase (RDR, WP_011261821.1) 
in A. fischeri. The reverse primer was designed to the N-terminus region of the 
Radical_SAM domain (Figure 31), that contains binding sites for the co-factor SAM 
and an iron-sulphur cluster. The amplification of non-specific genes with protein 
domains featuring an iron-sulphur binding site indicates that the reverse primer target 
the correct sequence, but it is not specific enough for the purpose of screening for 
rSAM_ocin_1 related genes. This was supported when the iron-sulphur binding sites 
(protein and gene sequences) of these proteins were aligned with the reverse primer 
(Figure 42). The alignment showed that the Ocin1R primer could bind to the iron-
sulphur binding sequence of other unrelated proteins, for example FDH (Figure 42, 
A and B). That said, even though there is an iron-sulphur binding sequence in RDR, a 
low binding consensus was obtained from the alignment of this protein with the Ocin1R 
primer (Figure 42, D).   
 
 
 
 
125 
 
Table 23 Top BLASTx hit with the nr database, according to the E-value, of the selected sequenced DNA fragments. The column Apx, indicates the 
approximate size (after gel electrophoresis) of the DNA fragment that was sequenced. The conserved domains found on the queried sequence was also 
noted. Different amplicons from the same isolate (column PE14) are denoted as “a” or “b”. Proteins of the same colour are homologous to each other. 
PE14 
Apx 
(bp) 
Description  Organism Conserved domains (query) 
Query 
cover 
(%) 
E value 
ID 
(%) 
Accession 
13 500 formate dehydrogenase subunit alpha V. tasmaniensis 
MCP_like superfamily;  
Fer4_7;  
Fer4_10;  
99 5.00E-75 98 WP_017111042.1 
22 500 formate dehydrogenase subunit alpha  V. tasmaniensis 
MCP_like superfamily;  
Fer4_7;  
Fer4_10 
99 5.00E-75 98 WP_017111042.1 
30a 350 ammonium transporter  
Vibrio sp. JCM 
19236 
Ammonium_transp 
superfamily 
89 1.00E-49 90 GAM67232.1 
30b 350 ribonucleotide-diphosphate reductase Al. fischeri 
RNR_PFL superfamily;  
PRK09103 
91 6.00E-45 95 WP_011261821.1 
55a 350 phosphoenolpyruvate synthase  V. tasmaniensis 
PRK06464;  
Pyruvate_Kinase super family  
92 4.00E-54 99 WP_017110707.1 
55b 350 4-hydroxyphenylpyruvate dioxygenase  Vibrio sp. J2-17 
AP_endonuc_2;  
TIM_phosphate_binding 
superfamily 
92 4.00E-55 93 CDU12663.1 
55c 300 
putative transcriptional regulator, LysR 
family protein  
Vibrio sp. MED222 
No putative conserved 
domains detected 
72 1.00E-22 87 EAQ52045.1 
61a 500 C4-dicarboxylate ABC transporter  
MULTISPECIES: 
Vibrio 
DcuA_DcuB superfamily;  
RE_SinI 
68 5.00E-55 94 WP_009844713.1 
61b 420 C4-dicarboxylate ABC transporter  Vibrio cyclitrophicus DcuA_DcuB superfamily 98 5.00E-46 93 WP_010435396.1 
64 400 flagella basal-body protein  V. tasmaniensis PHA02989 91 3.00E-61 93 WP_017106340.1 
91a 500 
Conserved hypothetical protein; 
putative hemolysin-type calcium-
binding region 
Vibrio sp. J2-15 T1SS_rpt_143 98 5.00E-66 93 CDT76620.1 
91b 480 C4-dicarboxylate ABC transporter  
MULTISPECIES: 
Vibrio 
DcuA_DcuB superfamily 95 1.00E-62 96 WP_009844713.1 
108
W 
500 
RND family efflux transporter MFP 
subunit  
P. putida 
8a0102;  
HlyD3 
93 2.00E-68 93 WP_009395914.1 
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Table 24 Properties of the protein that was the top hit to the sequenced DNA fragments. The first two columns are a repeat of Table 13 for referencing 
purposes. Superfamilies of conserved domains were determined with the conserved domain database. The protein cluster, the taxonomical groups in 
which the protein cluster is conserved (NCBI databases) and the function of the protein according to the clusters of orthologous groups (COGs) were 
recorded. Proteins of the same colour are homologous to each other. 
PE14 Top hit accession # Superfamily of conserved domains Protein cluster PCLA # Conserved in COG functional categories 
13 WP_017111042.1 
fer2 superfamily; HCP_like superfamily; 
Molybdop_Fe4S4 superfamily; Molybdopterin-
Binding superfamily; MopB_CT superfamily; 
NADB_Rossmann superfamily 
formate dehydrogenase 906042 
Gammaproteo-
bacteria 
Amino acid transport and 
metabolism; Energy production and 
conversion; General function 
prediction only 
22 WP_017111042.1 
fer2 superfamily; HCP_like superfamily; 
Molybdop_Fe4S4 superfamily; Molybdopterin-
Binding superfamily; MopB_CT superfamily; 
NADB_Rossmann superfamily 
formate dehydrogenase 906042 
Gammaproteo-
bacteria 
Amino acid transport and 
metabolism; Energy production and 
conversion; General function 
prediction only 
30a GAM67232.1 Ammonium_transp superfamily - - - - 
30b WP_011261821.1 
ATP-cone superfamily; Ribonuc_red_lgN 
superfamily; RNR_PFL superfamily 
ribonucleotide-diphosphate 
reductase subunit alpha 
419463 Bacteria Function unknown 
55a WP_017110707.1 Pyruvate_Kinase superfamily 
phosphoenolpyruvate 
synthase 
747200 Vibrionales - 
55b CDU12663.1 
Glo_EDI_BRP_like superfamily; 
TIM_phosphate_binding superfamily 
- - - - 
55c EAQ52045.1 
HTH superfamily; 
Periplasmic_Binding_Protein_Type_2 superfamily 
- - - - 
61a WP_009844713.1 DcuA_DcuB superfamily 
 C4-dicarboxylate ABC 
transporter 
2553644 Bacteria General function prediction only 
61b WP_010435396.1 DcuA_DcuB superfamily 
 C4-dicarboxylate ABC 
transporter 
2553644 Bacteria General function prediction only 
64 WP_017106340.1  flagellar basal-body protein 874712 Vibrionales - 
91a CDT76620.1 T1SS_rpt_143 superfamily - - - - 
91b WP_009844713.1 DcuA_DcuB superfamily 
 C4-dicarboxylate ABC 
transporter 
2553644 Bacteria General function prediction only 
108W WP_009395914.1 
Biotinyl_lipoyl_domains superfamily; MT 
superfamily; OEP superfamily; PHA00671 
superfamily 
cytochrome C peroxidase 908411 Bacteria - 
Information that was not available is indicated by a dash. 
PCLA #: Protein cluster accession number.  
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Figure 42 The iron-sulphur binding regions of poyB, poyC, (A and B) formate dehydrogenase subunit alpha (FDH; WP_017111042.1) and 
(C and D) ribonucleotide-diphosphate reductase (RDR; WP_011261821.1). The proteins and gene was aligned with the reverse-
compliment sequence of primer Ocin1R. Alignment was performed with the BioEdit Sequence Alignment Editor (Hall, 1999) and the 
Clustal W algorithm (Thompson et al., 1994) and the similarity threshold was set to 80 % (highlighted residues). Below the alignment of 
the nucleotides, the binding consensus is illustrated with a colon for an exact match and a period for a match with an ambiguous sequence. 
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To determine the binding efficiency of the primers (Table 25) the amplicon sequences were 
aligned with the ClustalW algorithm (Figure 43) to the original gene sequence of the closest 
BLAST hit (as listed in Table 24). The primers were then manually aligned to the appropriate 
regions. This analysis showed that amplification occurred even though there were 
mismatches scattered across the length of the primer and within the 3’ region of the primer. 
There are indications that the binding of primer Ocin1R was better than the binding of primer 
Ocin1F. For amplicon 55c, amplification was initiated since the binding of the 3’ region of 
one of the primers was strong, even though the overall binding of the primers was poor 
(Table 25).  
Table 25 Comparison of the binding efficiency of the primers to the Ocin1 amplicons.  
Ocin1 
amplicon 
BLAST hit 
accession number 
(see Table 23) 
Primer1 
3’ match 
(last 5 bp) 
Primer2 
3’ match 
(last 5 bp) 
13 and 22 WP_017111042.1 NA 
1
 NA 
1
 NA 
1
 NA 
1
 
30a GAM67232.1 R poor 2 R (RC) strong 5 
30b WP_011261821.1 F good 5 R (RC) strong 4 
55a WP_017110707.1 R good 4 F (RC) poor 1 
55b CDU12663.1 R good 5 F (RC) strong 5 
55c EAQ52045.1 R poor 1 F (RC) poor 4 
61a and 91b WP_009844713.1 F poor 1 R (RC) strong 5 
61b WP_010435396.1 NA 
2 
NA 
2 
NA 
2
 NA 
2 
64 WP_017106340.1 R strong 4 F (RC) good 4 
91a CDT76620.1 R good 4 F (RC) good 4 
108W WP_009395914.1 R good 4 F (RC) good 2 
Binding was defined as poor, good or strong according to the number of matches across all three sequences 
(gene, amplicon and primer). Poor <50%, good =50 to 70%, strong >70%. 
1
 The amplicons obtained were sequenced directly and not cloned before sequencing. 
2
 Primer binding site could not be identified, even though the amplicon could be aligned to the hit gene, due to 
poor sequence quality. 
RC: The reverse compliment of the sequence was used. 
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Figure 43 Alignment of the sequenced amplicons with the DNA sequence of the top hit 
(accession numbers are as in Table 23). The binding sites of the primers are also indicated. 
Alignment was performed with the BioEdit Sequence Alignment Editor (Hall, 1999) and the 
Clustal W algorithm (Thompson et al., 1994). Matches in the gene, amplicon and primers are 
highlighted in yellow. RC indicates that the reverse compliment of a sequence was used. 
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The amplification of non-specific products with the Ocin1 primers might be related to a few 
factors. One such factor is the regions selected for the design of primers. These regions are 
located within conserved domains, specifically the binding site of cobalamin (Ocin1F) and 
the iron-sulphur cluster (Ocin1R). That being said, during the design of the primers, proteins 
from the rSAM_ocin_1 family were aligned with proteins from the B12_rSAM_oligo family 
that are also part of the Radical_SAM superfamily. In this case, the regions selected for the 
primers were not conserved between the two families (Figure 32). This topic requires more 
research and analysis can focus on comparing the conserved domains of rSAM_ocin_1 
proteins to more protein families with similar domain architectures (a cobalamin binding 
domain followed by an rSAM domain). From the analysis, regions that are more specific to 
the rSAM_ocin_1 family can be identified.  
4. Summary 
In this chapter degenerate primers were designed to screen for a novel RiPP by targeting the 
biosynthetic genes of the known proteusin, polytheonamide. The first control was to amplify 
the target gene of the primers, poyB, from a construct. Bioinformatic analysis of homologous 
proteins to the polytheonamide biosynthetic proteins, PoyB and PoyC, showed that S. meliloti 
contains a homologous gene. This was confirmed through in vitro amplification with the 
Ocin1 primers. Subsequently, the mDNA of South African marine sponges was screened with 
the primers for putative biosynthetic genes of polytheonamide or proteusin related peptides. 
No amplification was observed from any of the samples, mainly because the mDNA used 
was not of good enough quality and quantity for PCR screening purposes. There is also a 
high probability that the gene of interest is not present in the samples. The biosynthetic genes 
of secondary metabolites constitute less than 2 % of sequenced genomes and therefore it can 
be concluded that the biosynthetic genes of a natural product is rarely found within mDNA 
(Charlop-Powers et al., 2014). Our study found that, in the sequenced genomes of 
prokaryotes available on the NCBI database, 489 and 386 species have homologous proteins 
to PoyB and PoyC respectively. This further substantiates the claim that the target genes 
might not be present in the mDNA that was screened. 
Consequently, it was decided to focus rather on determining the specificity of the primers. 
This is why the gDNA of the isolates from the sponge PE-14, H. esperioides, was extracted 
(to represent a fraction of the metagenome of the sponge) and screened with the designed 
primers. Numerous non-specific genes were amplified, although some of the genes have 
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similar conserved domains as the target genes. To reduce the non-specificity of the primers, 
the PCR parameters of the screen with the designed primers can be altered for future screens. 
Alternatively, the specificity of the primer sequence can be improved or different primers can 
be designed to regions that do not contain conserved binding sites within the sequences. 
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1. Natural product discovery 
Natural products have been developed into suitable drugs for the treatment of a wide 
array of diseases (Newman & Cragg, 2012). Many of the pharmaceuticals available on 
the market are natural products produced by terrestrial organisms. Marine natural 
products have gained popularity as highly effective compounds with unprecedented 
chemical structures (Cuevas & Francesch, 2009; Nakao et al., 1995; Hamada et al., 
2005). Marine invertebrates, such as sponges are rich sources of natural products and it 
has been established that the microbial symbionts are the true producers of some of the 
known natural products. Examples of these include patellamides, polytheonamides, 
bryostatins and discodermins, as discussed in Chapter 1. The discovery and 
development of marine natural products is vital as there is a need for pharmaceuticals 
such as antimicrobials, anti-tumour, anti-inflammatory, neuro-active, antiviral and 
antimalarial drugs. 
The methods used for the discovery of microbial natural products are classified as 
cultivation-dependent and -independent. Cultivation-dependent methods were favoured 
before the turn of the century, whereas cultivation-independent methods have been 
employed since advances were made with techniques such as sequencing and 
metagenomics. There are advantages and limitations experienced with 
cultivation-dependent and -independent methods and this is why a few studies have 
incorporated both approaches to screen the symbiotic bacteria of invertebrates (Kennedy 
et al., 2008; Engelhardt et al., 2010; O’Halloran et al., 2011; Öztürk et al., 2013; 
Bondarev et al., 2013). By employing both approaches some of the limitations are 
circumvented. With cultivation-dependent methods the organisms producing bioactive 
compounds are identified, whereas natural product biosynthetic pathways can be 
elucidated with cultivation-independent methods. The combination of the methods 
could contribute to the ultimate goal of associating the genotype, chemotype and 
phenotype of a natural product and exploiting the knowledge gained for the 
development and production of therapeutic drugs.  
In this study the bacterial symbionts of the South African marine sponge, H. 
esperioides, have been researched for the first time. Cultivation-dependent 
and -independent methods were employed to screen for natural products.  
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2. Biodiversity and bioactivity of microbial communities in South 
African marine sponges  
2.1. The phylogenetic diversity of the symbiotic communities in sponges 
Note that this discussion focusses on the prokaryotic (bacterial and archaeal) symbiotic 
species of sponges as the eukaryotic symbionts have not been widely researched 
(Rodríguez-Marconi et al., 2015). The composition of the symbiotic communities of 
marine invertebrates is dependent on biotic factors such as host-species, and abiotic 
factors such as the climate and location. The composition of the microbial communities 
associated with sponges has been widely investigated around the world. Although not 
absolutely true for all sponge species, the communities within the same sponge species 
seem to be temporally stable (Taylor et al., 2007; Blanquer et al., 2013). Generally there 
is no core community of symbionts amongst different sponge species, even within the 
same location (Taylor et al., 2007; Schmitt et al., 2012; Blanquer et al., 2013). 
However, the sponge symbionts are more closely related to each other when compared 
to species found in other marine environments (Schmitt et al., 2012; Blanquer et al., 
2013). This is supported by the monophyletic clustering of sponge-specific bacterial 
species (Schmitt et al., 2012).  
South Africa offers a unique environment as it has the cold, mineral rich Benguela 
current on its Western coast and the warm Agulhas current on the eastern coast. These 
currents influence the diversity of organisms greatly. Although the biodiversity of South 
African marine fauna and flora is well known, limited literature is available about the 
microbial biodiversity (Cowan et al., 2013). Recently the microbial diversity of the 
South African sponge Tsitsikamma favus was published using culture-independent 
analyses. The bioactive tsitsikammamines extracted from T. favus is believed to be 
produced by the symbiotic microorganisms (Walmsley et al., 2012). Tsitsikammamine 
B has anti-fungal, antimicrobial and cytotoxic activities (Walmsley et al., 2012). The 
prevalent species in T. favus were within the phylum Proteobacteria, specifically a 
unique Betaproteobacterium. This is different from what was found in other sponges as 
this is the first time that a Betaproteobacterium has been reported as the dominant taxon.  
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T. favus was collected in the Algoa Bay area, as was the H. esperioides material used in 
this study. The scope of this thesis was not to determine the diversity of the symbionts 
of H. esperioides, however, phylogenetic analysis was performed for some of the 
isolates. These isolates were primarily Proteobacteria of the genera Pseudovibrio and 
Vibrio (Alphaproteobacteria and Gammaproteobacteria respectively, Chapter 2). Studies 
that have used similar culture-dependent and culture-independent methods have found 
that Pseudovibrio and Vibrio are regularly found within sponges and that they produce 
antimicrobial compounds (Flemer et al., 2012; Taylor et al., 2007; O’Halloran et al., 
2011; Kennedy et al., 2008; Muscholl-Silberhorn et al., 2008). Species from other 
genera: Aliivibrio, Enterovibrio, Marinomonas, Shewanella and Bacillus were isolated 
from H. esperioides, which are also known to be ubiquitous  in other sponges (Taylor et 
al., 2007). Most of the species identified showed 99% similarity to known type cultures. 
However, a probable novel isolate, PE14-40, was only 96% similar to the M. 
dokdonensis strain DSW10-10 (Gammaproteobacteria) at the 16S rRNA level 
(discussed further later in this chapter). 
In future, a phylogenetic diversity study of the symbionts of H. esperioides can be 
performed to expand our current understanding of the biodiversity and novelty of South 
African marine microorganisms. 
2.2. The effect of climate change on sponges and their symbiotic 
communities 
The effect of climate change has been observed worldwide in all biomes. The fauna and 
flora of the ocean is also greatly affected. According to the World Wide Fund for Nature 
(WWF) some of the major effects of climate change are (coral) reef bleaching and 
acidification of the ocean. Coral reefs are unique ecosystems inhabited by many other 
macroorganisms such as sponges. The effect of coral bleaching is important as all of the 
inhabitants of that environment (macro and micro) are influenced.  
The effect of climate change on sponges and their symbionts have not been studied 
extensively, however, Fan et al. (2013) recently monitored the response of a Great 
Barrier Reef sponge and its associated microorganisms when the sponge was subjected 
to controlled thermal stress. Elevated temperatures induced sponge necrosis. Changes in 
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the expression of stress-related genes were observed and the symbiotic relationship 
between the sponge and its associated microorganisms also changed (Fan et al., 2013). 
The diversity of the microorganisms changed and species with lower host specificity 
and high growth rates were prevalent. These microorganisms were proven to be 
nutrient-scavenging bacteria that preyed on the decaying sponge material (Fan et al., 
2013). This example of the change in sponge-microbe symbiosis due to thermal stress 
indicates that environmental changes, such as climate change, greatly affect the survival 
of marine species.  
Bleaching was observed at the high-latitude marginal reefs on the East coast of South 
Africa. This is a result of, among other things, elevated sea surface temperatures. The 
health of an encrusting sponge was also deteriorating as a result of bleaching (Celliers 
& Schleyer, 2002). Although bleaching is observed, the effect of climate change on the 
symbiotic microorganisms of marine sponges in South Africa has not been significantly 
researched. This is of great concern, because if we are losing marine species (macro and 
micro), we are losing a large source of natural products and this could have dire 
consequences on ecosystem function and on marine industries.  Although this thesis was 
focused more on a drug discovery angle, what has been presented in this piece of work 
and that of T. favus represents important insights of the microbial biodiversity of this 
unique environment. Since symbiotic microorganisms are considered bio-indicators of 
changes in environmental conditions (Papapetropoulou & Rodopoulou, 1994; Kefalas et 
al., 2003), these studies could form the baseline for future monitoring studies to help us 
understand the effect of climate change on these communities and how they respond to 
it.  Microbial communities or key indicator species (Gordon & Leggat, 2010; Motti, 
2012) could be monitored, with metagenomics and metabolomics. Further analysis of 
the symbiotic relationship of marine organisms and the natural products that they 
produce could provide us with an understanding of the ecological role of the microbial 
symbionts.   
2.3. Potential bioactive compounds 
This study generated a large collection of symbionts of H. esperioides that produce 
bioactive secondary metabolites. The bioassays performed showed that these secondary 
metabolites have antimicrobial and anti-inflammatory properties and the activities were 
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primarily against M. smegmatis and S. epidermidis. Almost a third of the isolates 
showed antimicrobial activity with the overlay assays that were performed. More than 
half of the active isolates showed activity against more than one of the tested strains. 
These activities demonstrate that this collection could harbour a range of important 
natural products suitable for future screening and development. 
The bioactive compounds of this study have not been elucidated and therefore future 
investigations will include the purification, identification and characterisation of these 
natural products. The compounds could be purified by sequential bioactivity-guided 
fractionation of the extracts with chromatographic techniques (Van Middlesworth & 
Cannell, 2005). Once a pure compound is obtained the structure can be determined with 
spectroscopic methods and the compound can finally be identified. Dereplication of the 
bioactive compounds early on in the study is important to prevent replicate work. 
However, this should be implemented carefully. For instance, if a compound is related 
to, or identified as a previously extracted compound, the compound can be subjected to 
different screens to determine what other bioactivities it may exhibit. Also, if the related 
compound can be supplied more efficiently and exhibit less side effects it might be a 
better candidate for drug development (Sipkema et al., 2005). 
Crude extractions of liquid cultures from 20 isolates were screened by some of the 
PharmaSea consortium partners. From this, eleven of the extracts showed either anti-
fungal or anti-inflammatory activity. The extracts that showed bioactivity can be 
purified to identify the compound and further analysis can be performed to determine its 
drug-like properties. Further investigations of the bioactivity capabilities of the isolates 
could include other pathogenic screens or even non-pharmaceutical related screens.  
An isolate that is of interest for future research is the above-mentioned novel isolate 
PE14-40. Cultivation-dependent screens showed that it produces either a wide range of 
bioactive compounds or a singular compound with antimicrobial activity, anti-fungal 
activity as well as anti-inflammatory activity. Sequencing the genome (personal 
communication; unpublished data) of this organism further revealed its potential to 
produce novel secondary metabolites. Three NRPSs, a butyrolactone and a bacteriocin 
biosynthetic pathway was identified. Based on average nucleotide identity analysis of 
the sequenced genome; PE14-40 represents a novel species, and possibly a novel genus.  
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The discoveries made from the symbionts of H. esperioides demonstrate that traditional 
cultivation-dependent screening methods are important as novel species that produce 
potential natural products can be isolated. The research of T. favus (Walmsley et al., 
2012) and sponges within our laboratory is the foundation for future cultivation-
dependent and -independent studies on South African sponges. With this type of 
research more novel organisms and bioactive compounds from South African marine 
sponges can be discovered. 
3. Discovering RiPPs and understanding their evolutionary 
mechanisms 
3.1. Precursor genes and maturation enzymes 
It was originally thought that there is little similarity between the proteins of different 
RiPP classes (Arnison et al., 2013) and that each class has its own defined precursor and 
biosynthetic genes. However, recent research shows that the evolution of RiPPs is based 
on the promiscuity of the maturation enzymes. Various precursors from distantly related 
genes can be modified with distantly related enzymes. The following paragraphs will 
discuss recent findings concerning the evolution of RiPPs, with a focus on the 
proteusins.  
The only characterised proteusin is polytheonamide B. The polytheonamide precursor, 
PoyA, is clustered with RiPP maturation enzymes such as the LanM-like PoyF and the 
rSAM-related proteins PoyB, PoyC, PoyD and PoyE (Freeman et al., 2012).  PoyA, is 
part of the TOMM_pelo protein family (Haft et al., 2010). The precursor peptides of 
different RiPP classes including lanthipeptides and TOMMs also have a conserved 
TOMM_pelo domain (CDD; NCBI). The leader peptides of TOMM_pelo proteins are 
classified as nitrile hydratase-related leader peptides (NHLP) since they are related to 
the alpha subunit of nitrile hydratases (NHases). As a result Haft et al. (2010) concluded 
that NHLP proteins and NHases share a common ancestor  (Haft et al., 2010; Yang & 
van der Donk, 2013). NHases convert nitriles into their corresponding amides, but the 
TOMM_pelo proteins do not function as NHases since they lack the catalytic metal-
binding site (Haft et al., 2010).   
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Another protein family, Nif11 nitrogen-fixing proteins (N11P), could serve as RiPP 
precursors (Haft et al., 2010; Zhang et al., 2014). These proteins are found in some 
cyanobacteria and nitrogen-fixing bacteria and even though they play a role in nitrogen 
metabolism, their exact function is unknown (Jacobson et al., 1989). The NHLP and 
N11P proteins were found to cluster with known RiPP maturation enzymes and 
transporter proteins (Haft et al., 2010). The insights Haft et al. (2010) obtained from 
their research led to their conclusion that Nif11 proteins and NHases have been adapted 
for secondary metabolism by assisting allosteric regulation (Yang & van der Donk, 
2013). Since NHLP- and N11P-containing proteins might be precursors to natural 
products, Haft et al. (2010) also cautioned that the classification of small proteins 
should be considered carefully, even if it is a homologue of a functionalised protein (as 
for instance NHases). This is supported by the fact that classic gene-identification 
algorithms do not always recognise the biosynthetic genes of natural products (Haft, 
2009; de Jong et al., 2010).   
During the maturation of polytheonamide the enzyme PoyF, homologous to LanM-like 
proteins, catalyse a dehydration reaction (Freeman et al., 2012). LanM-like proteins 
have been found within the biosynthesis pathways of various RiPPs, even though LanM 
enzymes were first identified to be involved in the synthesis of lanthipeptides. Hence 
the mnemonic locus code, Lan, from lanthipeptides. LanM enzymes have two 
functional domains for dehydration and cyclisation (Zhang et al., 2012), which is key 
for the formation of the thioether bridges and the resultant rings of lanthipeptides.  
 Zhang et al. (2014) showed that putative precursor peptides of cyanobacterial 
lanthipeptides (collectively termed LanA) with N11P and NHLP leader peptides are 
clustered with proteins related to the maturation enzymes of lanthipeptides, LanM-like 
proteins. Examples include the LanM-like proteins, ProcM and NpnM, of 
Prochlorococcus MIT9313 and N. punctiforme PCC 73102. The putative precursor 
peptide genes associated with these LanM-like synthetases appear to have different 
evolutionary origins to LanA peptides, since their leader peptides are related to the 
abovementioned NHases and Niff11 proteins. Some of the cyanobacteria with these 
precursors do not have other NHase- and Niff11-related genes, and thus it seems that 
they were obtained by horizontal gene transfer. While analysing the putative LanA 
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precursors that are clustered with the LanM-like proteins, they also found that some 
lacked cysteine residues. Analysis of the modification of these precursors by these 
LanM-like proteins (ProcM and NpnM) resulted in the core peptide to be only 
dehydrated and not cyclised as for lanthipeptides with cysteine-containing precursors 
(Zhang et al., 2014). Since the precursor peptides do not require cyclisation Zhang et al. 
(2014) suggested that the lanthipeptide synthetases (ProcM and NpnM) co-evolved with 
their associated precursors as only the dehydration domain remained functional. This 
shows that the putative RiPP precursor peptides lacking cysteine residues that are 
associated with lanthipeptide synthetases are not lanthipeptides, however, their function 
is not known (Zhang et al., 2014).  
Similar to these putative RiPPs, the precursor peptide of polytheonamide, PoyA, has a 
NHLP leader peptide and also does not have a cysteine residue in the core peptide. 
Consequently the core peptide is dehydrated by the LanM-like protein, PoyF (Freeman 
et al., 2012). It seems that LanA precursors with NHLP- and N11P-leader peptides that 
lack cysteine residues might be more closely related to other RiPP precursors, such as 
TOMM_pelo precursors, but further phylogenetic analysis is needed to determine the 
relationship of these precursors. 
The different subfamilies of radical SAM proteins perform various enzymatic reactions 
including the post-translational modification of peptides into natural products (Haft, 
2011). The in silico analyses presented in this thesis showed that rSAM_ocin_1 related 
genes, such as poyB and poyC, are positioned in close proximity to TOMM_pelo family 
proteins in various bacteria (Chapter 3, Figure 26). Similar to the recent findings of 
Morinaka et al. (2014) our analysis also showed that homologues of the rSAM protein 
PoyD are also found in several bacteria including some cyanobacteria and nitrogen 
fixing bacteria, such as A. variabilis ATCC 29413, D. baarsii DSM 2075 and S. meliloti 
SM11 (Chapter 3, Figure 26). The PoyD homologues clustered with NHLP genes and 
other putative related biosynthetic genes. Morinaka et al. (2014) showed that one of the 
cyanobacteria strains, Pleurocapsa sp. PCC 7319, has N11P-type precursors that could 
be modified by PlpD, a homologue of PoyD. From their analysis Morinaka et al. (2014) 
concluded that the putative cyanobacterial proteusin genes could produce peptides with 
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diverse structures. This is due to the difference in the sequence of the precursor peptides 
as well as the combination of genes involved in biosynthesis.  
As seen in the above-mentioned studies we are beginning to understand the 
evolutionary mechanisms of RiPPs. This indicates the need for detailed analysis of RiPP 
biosynthetic genes. By conducting studies similar to the ones discussed above we can 
determine whether the biosynthetic genes of RiPPs from different classes share 
ancestral origins. This might identify the commonalities and evolutionary mechanisms 
of RiPPs. 
3.2. Focussing on nitrogen metabolising bacteria 
It is well known that cyanobacteria produce a plethora of natural products of various 
chemical classes, including RiPPs (Wang et al., 2011). From this study (Chapter3) and 
the discussion above, we speculate that many nitrogen metabolising bacteria 
(diazotrophs), such as some cyanobacteria and rhizobacteria, may contain putative 
proteusin biosynthetic gene clusters that were probably adapted from their nitrogen 
metabolising genes, namely Nif11 proteins and NHases. There seems to be an 
evolutionary relationship between the biosynthetic genes of polytheonamides and other 
proteusins discovered in ‘Entotheonella’ spp. and nitrogen-metabolising genes. It is thus 
intriguing to consider whether ‘Entotheonella’ spp. are nitrogen metabolisers. There is 
no direct evidence that ‘Entotheonella’ spp. are nitrogen metabolising bacteria as they 
have only been sequenced recently and they have not, despite several efforts, been 
cultured. Dos Santos et al. (Dos Santos et al., 2012) proposed that the presence of a 
minimum set of six genes (nifHDK and nifENB) is indicative of a diazotroph. A 
preliminary scan of the ‘Entotheonella’ genome indicated that proteins related to 
nitrogen metabolism (Appendix C; Table 11) are present; however a nitrogen fixation 
operon was not identified. The origin of the nitrogen fixation genes may thus be due to 
horizontal gene transfer as was proposed by Zhang et al. (2014) for cyanobacteria with 
NHLP- and N11P RiPP precursors that do not have other NHase or Nif11 related genes.  
Since some of the biosynthetic genes of proteusins and other RiPPs are related to 
nitrogen metabolising genes it will be interesting to determine how or why these 
primary metabolising genes have evolved into secondary metabolism products. 
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Final Conclusions 
As we have seen, the search for novel natural products, driven by the need for new and 
effective antimicrobials, is achieved by combining cultivation-dependent and –
independent methods. These methods were used in this study to screen the bacterial 
symbionts of H. esperiordes. We showed that various pharmaceutical-relevant natural 
products are produced by these symbionts and future studies will show us their true 
potential. 
There is also great potential in the screening of RiPPs, especially proteusins, as only 
polytheonamides have been isolated so far and other (non-‘Entotheonella’) species have 
been identified that contain putative proteusin pathways. It will be exciting to see what 
future studies might reveal, as we have suggested that nitrogen-metabolising bacteria 
can be targeted for the screening of RiPPs and proteusins. 
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Appendices 
Appendix A 
Artificial sea salts (Table 1) were added to the media, unless specified, to have a similar 
salinity to sea water. If a medium was used in a solid state 15 g.L
-1
 of bacteriological agar 
was added before sterilisation, except for PMM that was made with 12 g.L
-1
. 
Table 1 Solid media used to cultivate the symbiotic bacteria isolated from the sponge PE14.  
Medium pH Composition  Per 1 L Source 
Artificial 
sea salts 
NA 
NaCl 
MgCl2 
KCl 
CaCl2 
18.0 g 
2.0 g 
0.525 g 
0.075 g 
 
TSA 7.5 Tryptic soya broth 3.0 g Merck 
TS4 4.5 Tryptic soya broth 3.0 g  
SNA 7.5 
Peptone 
Beef Extract 
5.0 g 
3.0 g 
 
ZBA 7.5 
Yeast Extract 
Peptone 
1.25 g 
3.75 g 
 
ZBV 7.5 
ZBA (see above) 
0.1% Crystal Violet Solution 
1
 
 
1.0 ml 
 
SWA 6.5 
Sea Water 
Wolf's Mineral Solution 
2
 
Wolf's Vitamin Solution 
2
 
250.0 ml 
5.0 ml 
10.0 ml 
 
CCA 7.5 
Cellulose 
Xylan 
Chitin 
NH4Cl 
0.5 g 
0.5 g 
0.5 g 
0.5 g 
 
SEM
 
NA Sponge Extract
 3
 10.0 g  
GYM 
5, 6
 7.2 
D-Glucose 
Yeast Extract 
Malt Extract 
CaCO3 
4
 
NaCl 
MgCl2 • 6H2O 
KCl 
CaCl2 
4.0 g 
4.0 g 
10.0 g 
2.0 g 
24.0 g 
5.3 g 
0.7 g 
0.1 g 
 
172 
6
 7.5 
Glucose 
Yeast Extract 
Starch 
Tryptone 
10.0 g 
5.0 g 
10.0 g 
5.0 g 
 
 
 
 
 
144 
 
MgSO4 • 7H2O 
CaSO4 • 7H2O 
2.0 g 
2.0 g 
OMA 
6
 NA Jungle Oats Oatso Easy (No sugar) 40.0 g 
Tiger Brands, 
South Africa 
AIM 8.1 Actinomycete Isolation Agar 22.0 g Sigma-Aldrich 
R2A 
5
 NA Reasoner´s 2A agar 15.2 g Sigma-Aldrich 
ACM 7.0 
HEPES 
Sodium pyruvate 
Yeast Extract 
Soybean peptone 
NaNO3 
KHPO4 
MgSO4 • 7H2O 
Activated charcoal 
4
 
2.38 g 
3.00 g 
0.10 g 
3.00 g 
0.34 g 
0.10 g 
0.15 g 
3.00 g 
 
MAA 
5,6 10.0-
10.5 
Glucose 
Peptone 
Yeast Extract 
KH2PO4 
MgSO4 • 7H2O 
NaCl 
Na2CO3 
10.0 g 
5.0 g 
5.0 g 
1.0 g 
0.1 g 
20.0 g 
10.0 g 
 
PCS NA 
KNO3 
(NH4)2HPO4 
MgSO4 • 7H2O 
CaCl2 • 2H2O 
FeCl2 
0.20 g 
0.02 g 
0.01 g 
5.00 mg 
0.50 mg 
 
PMM
 
NA 
Glucose 
(NH4)2SO4 
Peptone 
Yeast Extract 
1.00 g 
0.25 g 
0.15 g 
0.15 g 
 
NA: pH was not adjusted. 
1
 Crystal violet solution: 2.3% (w/v) crystal violet; 0.1% (w/v) ammonium oxalate; 20% (v/v) ethanol. 
2
 Wolfe's solution: refer to Table 2. 
3
 Sponge extract was prepared by homogenising 1 part Redbait with 3 parts marine sponge. The solid 
material was removed by centrifugation and supernatant was freeze dried before addition to the 
medium. 
4
 This was omitted in liquid medium. 
5
 Artificial sea water salts were not included. 
6
 Cycloheximide and nalidixic acid were added at 100 µg.ml
-1
and 50 µg.ml
-1
, respectively. 
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Table 2 Wolfe's supplementary solutions for sea water agar. The solutions were filter 
sterilised through a 0.22 μm filter and stored at 4°C. The mineral solution was prepared by 
dissolving the nitrilotriacetic acid in water and adjusting the pH to 6.5 with KOH before 
adding the other reagents. 
Wolfe's mineral 
solution 
g.L
-1
 Wolfe's vitamin solution mg.L
-1
 
Nitrilotriacetic acid 1.5 Biotin 2.0 
MgSO4 • 7H2O 3.0 Folic Acid 2.0 
MnSO4 • H2O 0.5 Pyridoxine hydrochloride 10.0 
NaCl 1.0 Thiamine-HCl 5.0 
FeSO4 • 7H2O 0.1 Riboflavin 5.0 
CaCl2 0.1 Nicotinic acid 5.0 
CoCl2 • 6H2O 0.1 Calcium D-(+)-pantothenate 5.0 
ZnSO4 • 7H2O 0.1 Vitamin B12 0.1 
CuSO4 • 5H2O 0.01 p-Aminobenzoic acid 5.0 
AlK(SO)4 • 12H2O 0.01 Thioctic acid 5.0 
H3BO3 (Boric Acid) 0.01   
Na2MoO4 • 2H2O 0.01   
 
Table 3 BG11 liquid medium (Rippka et al., 1979) for the isolation of cyanobacteria. 
Stock Solution Reagent g.L
-1
 BG11 (ml.L
-1
) 
1 NaNO3 15.00 100 
2 K2HPO4 2.00 10 
3 MgSO4 • 7H2O 3.75 10 
4 CaCl2 • 2H2O 1.80 10 
5 Citric Acid 0.30 10 
6 Ammonium ferric citrate 0.30 10 
7 Na2 EDTA 0.05 10 
8 Na2CO3 1.00 10 
Wolf's mineral solution
 
a
  
 1 
a 
The composition of the solution is presented in Table 2. 
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Table 4 General media used in this study. 
Medium Composition (per litre or specified otherwise) Ref. 
Lysogeny broth 
(LB) 
10 g Tryptone, 5 g Yeast Extract, 5 g NaCl (Bertani, 
2004) 
TY
 
5 g Tryptone, 3 g Yeast Extract 
10ml of sterile 1 M CaCl2 
(CaCl2 stock made and autoclaved separately and added 
before pouring of plates or inoculation of liquid culture.) 
(Beringer, 
1974) 
 
Table 5 Buffers and antibiotics used within this study. The composition and concentration is 
also listed.  
Buffer Abbr. Composition pH 
Tris-EDTA buffer TE 10 mM Tris-HCl, 1 mM EDTA  8.0 
Tris-acetate-EDTA 
buffer 
TAE 
40 mM Tris-base, 20 mM acetic acid, 1 mM 
EDTA 
8.4 
Tris-NaCl buffer  - 10 mM Tris-HCl, 0.5 M NaCl 8.0 
Tris-borate-EDTA buffer TBE 
89 mM Tris-base, 89 mM Boric acid, 2 mM 
EDTA 
8.0 
Antibiotic Abbr. 
Working concentration 
(ug.ml
-1
) 
Media 
Kanamycin Kan 100 LB 
Ampicillin Amp 50 LB 
Spectinomycin Spc 50 LB 
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Appendix B 
Table 6 Details of the sponge material used. All collections and identifications were done by Dr. Shirley Parker-Nance (2013). 
 Collection details Taxonomy and description notes Photo 
PE03 Date collected: 23 January 2013  
Site collected: Algoa Bay, White Sands 
Reef  
Depth: 23-25m depth  
Longitude: 34°00.366S  
Latitude: 25°43.209E  
Habitat notes:  Low profile rocky reef  
Also:  
Phylum: Porifera  
Class: Calcarea  
Subclass: Calcinea  
Order: Clathrinida  
Family:  Clathrinidae  
Genus:  Guancha, Miklucho-Maclay, 1868  
Species:  Guancha sp. 001RSASPN  
  
 Date collected:  23 January 2013  
Site collected: Algoa Bay, Phillips Reef  
Depth:  10-13m depth  
Longitude:  33°58.452S  
Latitude:  25°40.807E  
Habitat notes:  Medium profile rocky reef 
Close affinities to Guancha pulcherrima (Dendy, 1891) and G. stiptata (Dendy, 1891) both from 
Australia and both species very small with differences in spicules shape, size, growth form and 
colour of the organism. Not Clathrina blanca or C. blanca forma pulcherrima as previously 
identifies in literature. 
PE05 Date collected: 23 January 2013  
Site collected: Algoa Bay, White Sands 
Reef  
Depth: 23-25m depth  
Longitude: 34°00.366S  
Latitude: 25°43.209E  
Habitat notes: Low profile rocky reef 
Phylum:  Porifera  
Class: Demospongiae 
Order: Poecilosclerida 
Suborder: Microcionina  
Family:  Raspailiidae 
Subfamily: Cyamoninae 
Genus: Waltherarndtia 
Species: Waltherarndtia caliculatum, 
Kirkpatrick, 1903 
Common and characteristic sponge. 
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PE08 Date collected: 23 January 2013  
Site collected: Algoa Bay, White Sands 
Reef  
Depth: 23-25m depth  
Longitude: 34°00.366S  
Latitude: 25°43.209E  
Habitat notes: Low profile rocky reef 
Phylum:  Porifera  
Class:  Demospongia  
Order:  Dictyoceratida  
Family:  Spongiidae  
Genus:  Spongia  
Subgenus: Spongia (Spongia), Linnaeus, 
1759  
Species: Spongia(Spongia) sp.001RSASPN 
  
PE14 Date collected: 4 April 2013  
Site collected: Algoa Bay, White Sands 
Reef  
Depth: 23-25m depth  
Longitude: 34°00.406S  
Latitude: 25°43.117E  
Habitat notes: Low profile rocky reef 
Phylum:  Porifera  
Class:  Demospongia  
Order:  Poecilosclerida  
Suborder:  Mycalina  
Family:  Hamacanthidae  
Genus:  Hamacantha  
Subgenus:  Hamacantha (Vomerula), 
Schmidt, 1880  
Species:  Hamacantha (Vomerula) 
esperioides,  
 Ridley and Dendy, 1886 
  
 
 
 
 
 
149 
 
Table 7 Isolates from the sponge PE14 which showed antimicrobial activity with the 
overlay assay. This is a more comprehensive table (compared to Table 6; Chapter 2) of 
the antimicrobial assays. The assays were performed by the author of this thesis as well 
as colleagues at IMBM. 
PE14 
ID 
E. coli 
1699 
M. smegmatis S. epidermidis B. cereus P. putida 
Number of organisms  
active against 
3 x x x 
  
3 
7 
 
x 
 
x 
 
2 
10 x 
    
1 
11 x x 
 
x 
 
3 
12 
 
x 
 
x 
 
2 
13 x x x x 
 
4 
16 
  
x 
  
1 
17 
 
x x x 
 
3 
20 x 
    
1 
22 
 
x x x 
 
3 
25 
 
x x x 
 
3 
27 x 
    
1 
28 x x x 
  
3 
30 x x 
   
2 
33 x 
    
1 
40 x 
  
x 
 
2 
48 
  
x x 
 
2 
55 
 
x x x 
 
3 
58 
  
x 
  
1 
60 
 
x x x 
 
3 
61 
 
x x x 
 
3 
62 x 
    
1 
63 
 
x x 
  
2 
64 x 
    
1 
65 
  
x 
  
1 
73 
  
x 
  
1 
74 x x x x 
 
4 
82 
   
x 
 
1 
91 
 
x x 
  
2 
92 x 
    
1 
96 x 
    
1 
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97 
 
x 
   
1 
104 x x 
   
2 
106 x 
    
1 
108 x 
    
1 
116 
 
x x 
  
2 
117 
  
x 
  
1 
127 
 
x 
   
1 
128 
 
x 
   
1 
129 
 
x x x 
 
3 
144 
  
x 
  
1 
145 
 
x 
   
1 
146 
 
x x 
  
2 
Total 18 24 22 15 0 43 
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Appendix C 
Table 8 The structural gene, poyA, is found along with at least two of the maturation enzymes involved in post-translational modiﬁcation of PoyA, within three 
known organisms (dark grey). Key maturation enzymes, as well as the organism which have homologous genes to poyB or poyC, are highlighted in light grey. 
 
PoyK PoyJ PoyB&C PoyA PoyD PoyE PoyF PoyG PoyH PoyI Number homologous proteins
a
 
Cystobacter violaceus Cb vi76 
  
B 
   
x 
  
x 3 
Desulfarculus baarsii DSM 2075 
  
x x x 
     
3 
Enhygromyxa salina 
  
x 
   
x 
  
x 3 
Fischerella sp. PCC 9605 
   
x 
  
x 
  
x 3 
Kamptonema 
   
x x 
    
x 3 
Microcoleus sp. PCC 7113 x 
 
x 
   
x 
  
x 4 
Micromonospora sp. ATCC 39149 
  
x 
    
x x 
 
3 
Microvirgula aerodenitrificans 
 
x 
   
x x 
   
3 
Nostoc sp. PCC 7120 
  
x x 
  
x 
   
3 
Pleurocapsa sp. PCC 7319 
   
x x 
 
x 
   
3 
Sandaracinus amylolyticus 
 
x C 
     
x 
 
3 
Scytonema hofmanni 
   
x x 
 
x 
  
x 4 
Streptomyces 
 
x x 
  
x x 
 
x 
 
5 
Streptomyces acidiscabies 
  
x 
  
x 
  
x 
 
3 
Streptomyces sp. NTK 937 
 
x x 
   
x 
   
3 
unclassified Verrucomicrobia 
(miscellaneous)   
x x x 
     
3 
a
 Homologous proteins to the biosynthetic genes of polytheonamide from the bacterium symbiont of Theonella swinhoei pTSMAC1  
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Table 9 Accession numbers of the rSAM_ocin_1 proteins used for the construction of the 
maximum parsimonious tree (Figure 1). 
AFS60638.1 WP_015925801.1 WP_019872099.1 
AFS60637.1 WP_015182552.1 WP_011541977.1 
CCM09442.1 WP_012826784.1 WP_018827354.1 
CCM09446.1 YP_003266069.1 WP_018724970.1 
CCM09450.1 ACY14176.1 WP_018818802.1 
AFU90397.1 WP_002634339.1 WP_018813532.1 
AFU90405.1 EJJ23222.1 WP_018219751.1 
AFU90401.1 WP_011654150.1 WP_018811133.1 
WP_010996184.1 WP_018739566.1 WP_011084777.1 
WP_011317980.1 WP_012013523.1 WP_014497841.1 
WP_011682652.1 WP_018832590.1 WP_018742506.1 
WP_015924487.1 WP_018736939.1 WP_014529191.1 
WP_013376083.1 WP_018215450.1 WP_018263008.1 
WP_002619126.1 WP_018731946.1 WP_012330098.1 
WP_011750427.1 WP_018821137.1 WP_011750427.1 
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Figure 1 The maximum parsimonious (MP) tree of the representative proteins of the 
rSAM_ocin_1 family. Clade A contains the proteins: PoyB and PoyC (Clade C) and the 
seven closest related proteins (Clade B). Branches corresponding to partitions reproduced in 
less than 50 % bootstrap replicates were collapsed. The percentage of replicate trees in which 
the associated taxa clustered together in the bootstrap test (1000 replicates) are shown above 
the branches (Dunbar & Mitchell, 2013). The MP tree was obtained using the SPR algorithm 
(pg. 126 in ref. (Knerr & van der Donk, 2012)) with search level 1 in which the initial trees 
were obtained by the random addition of sequences (10 replicates). The analysis involved 45 
amino acid sequences. All positions containing gaps and missing data were eliminated. There 
were 459 positions in the final dataset. Analyses were conducted in MEGA5 (Tamura et al., 
2011). The reference sequences (RefSeq; NCBI), denoted with the prefix 'WP_' in their 
accession numbers, were used as the representatives of identical sequences. 
 
 
 gi|517027312|ref|WP_018219751.1| radical SAM protein [Salinispora pacifica]
 gi|517640925|ref|WP_018811133.1| radical SAM protein [Salinispora pacifica]
 gi|517657146|ref|WP_018827354.1| radical SAM protein [Salinispora pacifica]
 gi|517650929|ref|WP_018821137.1| radical SAM protein [Salinispora pacifica]
 gi|517648594|ref|WP_018818802.1| radical SAM protein [Salinispora pacifica]
 gi|517019297|ref|WP_018215450.1| radical SAM protein [Salinispora pacifica]
 gi|517554762|ref|WP_018724970.1| radical SAM protein [Salinispora pacifica]
 gi|517643324|ref|WP_018813532.1| radical SAM protein [Salinispora pacifica]
 gi|517572298|ref|WP_018742506.1| radical SAM protein [Salinispora pacifica]
 gi|517569358|ref|WP_018739566.1| radical SAM protein [Salinispora pacifica]
 gi|517566731|ref|WP_018736939.1| radical SAM protein [Salinispora pacifica]
 gi|517561738|ref|WP_018731946.1| radical SAM protein [Salinispora pacifica]
 gi|518711002|ref|WP_019872099.1| radical SAM protein [Salinispora pacifica]
 gi|500898729|ref|WP_012013523.1| radical SAM protein [Salinispora tropica]
 gi|517662382|ref|WP_018832590.1| radical SAM protein [Salinispora tropica]
 gi|405110146|emb|CCM09446.1| bmbF [Streptomyces bottropensis]
 gi|408776747|gb|AFU90401.1| radical SAM-dependent protein [Streptomyces sp. WMMB 272]
 gi|405110142|emb|CCM09442.1| bmbB [Streptomyces bottropensis]
 gi|405110150|emb|CCM09450.1| bmbJ [Streptomyces bottropensis]
 gi|408776743|gb|AFU90397.1| radical SAM-dependent protein, partial [Streptomyces sp. WMMB 272]
 gi|408776751|gb|AFU90405.1| radical SAM-dependent protein [Streptomyces sp. WMMB 272]
 gi|499861243|ref|WP_011541977.1| radical SAM family protein [Sphingopyxis alaskensis]
 gi|500074414|ref|WP_011750427.1| radical SAM domain-containing protein [Paracoccus denitrificans]
 gi|499397310|ref|WP_011084777.1| radical SAM protein [Bradyrhizobium]
 gi|504310739|ref|WP_014497841.1| radical SAM protein [Bradyrhizobium japonicum]
 gi|499973432|ref|WP_011654150.1| radical SAM protein [Rhizobium leguminosarum]
 gi|504342089|ref|WP_014529191.1| radical SAM protein [Sinorhizobium meliloti]
 gi|406822303|gb|AFS60638.1| C-methyltransferase [bacterium symbiont of Theonella swinhoei pTSMAC1]
 gi|406822302|gb|AFS60637.1| C-methyltransferase [bacterium symbiont of Theonella swinhoei pTSMAC1]
C
 gi|499637246|ref|WP_011317980.1| radical SAM protein [Anabaena variabilis]
 gi|504995450|ref|WP_015182552.1| bacteriocin maturation radical SAM protein 1 [Microcoleus sp. PCC 7113]
 gi|499305409|ref|WP_010996184.1| radical SAM protein [Nostoc sp. PCC 7120]
 gi|503141422|ref|WP_013376083.1| radical SAM protein [Stigmatella aurantiaca]
 gi|488695032|ref|WP_002619126.1| radical SAM protein [Stigmatella aurantiaca]
 gi|488710451|ref|WP_002634339.1| radical SAM protein [Chondromyces apiculatus]
 gi|397092464|gb|EJJ23222.1| hypothetical protein A176_7046 [Myxococcus sp. (contaminant ex DSM 436)]
B
A
 gi|506404768|ref|WP_015924487.1| radical SAM protein [Clostridium cellulolyticum]
 gi|506406082|ref|WP_015925801.1| radical SAM protein [Clostridium cellulolyticum]
 gi|500001934|ref|WP_011682652.1| radical SAM domain-containing protein [Candidatus Solibacter usitatus]
 gi|502589109|ref|WP_012826784.1| radical SAM protein [Haliangium ochraceum]
 gi|262078207|gb|ACY14176.1| Radical SAM domain protein [Haliangium ochraceum DSM 14365]
 gi|262194860|ref|YP_003266069.1| radical SAM protein [Haliangium ochraceum DSM 14365]
 gi|494033646|ref|WP_006975779.1| hypothetical protein [Plesiocystis pacifica]
 gi|517074190|ref|WP_018263008.1| hypothetical protein [Methylobacterium sp. WSM2598]
 gi|501287080|ref|WP_012330098.1| radical SAM domain-containing protein [Methylobacterium sp. 4-46]
100
100
100
100
100
100
100
100
100
99
99
99
97
93
98
94
92
100
92
91
80
100
72
100
81
70
62
59
94
66
54
88
100
88
74
100
97
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Table 10 The degeneracy of different regions were compared when designing the primers. The IUPAC ambiguity code for incompletely 
specified bases in nucleic acid sequences was used (Cornish-Bowden, 1985). 
Primer1 1 2 3 4 5 6 7 8 9 10 11 12 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 
Consensus (MEGA5) M G G A N C E G P M G K 
IUPAC A T G G G N G G N G C N A A Y T G Y G A R G G N C C N A T G G G N A A R 
Conserved r-transl degenerate A T K G G Y G G H G C R A A C T G Y G A R R G C S M R A T G G G K S T G 
Degeneracy 
  
2 
  
2 
  
3 
  
2 
     
2 
  
2 2 
  
2 2 2 
     
2 2 
  
 96 
               
Conserved at 100% A T K G G Y G G H G C R A A C T G Y G A R R G C 
            
  192   
            
  
         
128 
         
  
         
128 
      
  
         
256 
   
              
PoyB_nt A T G G G C G G T G C G A A C T G T G A G G G G C C A A T G G G T A A G 
              
PoC_nt A T G G G T G G A G C A A A T T G C G A A A G C G A G A T G G G G C G G 
  M G G A N C E G P M G K 
PoyB Primer1 219-230 A T G G G C G G C G C G A A C T G C G A A G G C C C G A T G G G C A A A 
  M G G A N C E S E M G R 
PoyC Primer1 219-230 A T G G G C G G C G C G A A C T G C G A A A G C G A A A T G G G C C G T 
  M G G A N C E G A M G L 
Nostoc homolog Primer1 219—230 A T G G G C G G C G C G A A C T G C G A A G G C G C G A T G G G C C T G 
  I G G A N C E G S M G V 
Anabeana homolog Primer1 219—230 A T T G G C G G C G C G A A C T G C G A A G G C A G C A T G G G C G T G 
  M G G A N C E G E M G V 
Stigmatella homolog Primer1 219-230 A T G G G C G G C G C G A A C T G C G A A G G C G A A A T G G G C G T G 
  M G G A N C E G V M G L 
Microcoleus homolog Primer1 219-230 A T G G G C G G C G C G A A C T G C G A A G G C G T G A T G G G C C T G 
  M G G A N C E G D M G V 
Chondnomyces homolog Primer1 219-230 A T G G G C G G C G C G A A C T G C G A A G G C G A T A T G G G C G T G 
  M G G A N C E G D M G V 
Myxococcus homolog Primer1 219-230 A T G G G C G G C G C G A A C T G C G A A G G C G A T A T G G G C G T G 
  L G G S N C E G S M G R 
bmbBJ Primer1 219-230 C T G G G C G G C A G C A A C T G C G A A G G C A G C A T G G G C C G T 
  M G G S N C E G S M G R 
bstCF Primer1 219-230 A T G G G C G G C A G C A A C T G C G A A G G C A G C A T G G G C C G T 
  L G G A N C D R P M G Q 
bmbF bstJ Primer1 219-230 C T G G G C G G C G C G A A C T G C G A T C G T C C G A T G G G C C A G 
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Primer2 1 2 3 4 5 6 7 8 9 10 11 12 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
Consensus (MEGA5) K H H C T F C G L N G 
IUPAC A A R C A Y C A Y T G Y C A N T T Y T G Y G G N Y T N A A Y G G N 
Conserved r-transl degenerate A A A C A Y C A T T G C A C C T T T T G C G G C C T G A A C G G C 
Degeneracy 
     
2 
  
2 
                        
Consensus poyBC_nt_r-transl A A A C A Y S A G T G C A C C T T T T G C G G C C T G A A C G G C 
  
     
2 2 
                          
Consensus_r-transl_IUPAC_poyBC A A A C A B C H K T G C A C C T T T T G C G G C C T G A A C G G C 
 Degeneracy 
     
3 
 
3 2 
                        
Conserved at 100% 18 
         
Conserved at 90% 
      
6 
   
  
      
6 
  18 
            
  
         
0 
  
         
T G C A C C T T T T G C G G C C T G A A C 
   
  
         
0 
   
 more degenerate 
         
T G Y A C Y T T Y T G Y G G S C T S A A C    
          64    
             
PoyB_nt A A A G A C G T C T G T A C C T T C T G T G G G T T G A A T G G C 
             
PoC_nt A A A C A C C C G T G C A C T T T T T G C G G C C T C A A C G G T 
  K D V C T F C G L N G 
PoyB Primer2 344—354 A A A G A T G T G T G C A C C T T T T G C G G C C T G A A C G G C 
  K H P C T F C G L N G 
Poyc Primer2 344—354 A A A C A T C C G T G C A C C T T T T G C G G C C T G A A C G G C 
  K H H C T F C G L N G 
Nostoc homolog Primer2 344—354 A A A C A T C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K N H C T F C G L N G 
Anabeana homolog Primer2 344—354 A A A A A C C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K H H C T F C G L N G 
Stigmatella homolog Primer2 344-354 A A A C A T C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K Q H C T F C G L N G 
Microcoleus homolog Primer2 344-354 A A A C A G C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K H H C T F C G L N G 
Chondromyces homolog Primer2 344-354 A A A C A T C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K H H C T F C G L N G 
Myxococcus homolog Primer2 344-354 A A A C A T C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K T H C T F C G L N G 
bmbBJ Primer2 344-354 A A A A C C C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K T H C T F C G L N G 
bstCF Primer2 344—354 A A A A C C C A T T G C A C C T T T T G C G G C C T G A A C G G C 
  K L Q C T F C G E N G 
bmbF bstJ Primer2 344-354 A A A C T G C A G T G C A C C T T T T G C G G C G A A A A C G G C 
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A poyB (JX456532.1) 
GTTGAGGCCGCAAAAAGTGCACGGGTGTTTTTCCCCCCACCAGCAACCGCGCGCGGTCTCGACGAGAAGCCCAGGTGTCGCAA
AGTATTCGATTTTTGTCTCTGCCAATTCGCGGAAGTAATCGTCGTAGTCCGGCAGGGGTAATCCGTCCATGTCCTGAGTCGTG
GCGCGCTCGACCACCTGAAAATTAGCGAACGGTCGGGACGCGGGGGTGAATACGAAACGGCGCAGCGCCTCGTTAGACGCGAT
GCCCGCAATGTCGTTGTGAAGAATCCGCTCGCAGAGGTCGGGGAACACCTCGTCCCCATCACCCGAGACGACGTAATCTACCC
AGTCGAAGTTCGTATGGAGAGCCCGCCCCATCTCGCTTTCGCAATTTGCTCCACCCAT  
390 bp 
B poyC (JX456532.1) 
TTCAACCCACAGAAGGTACAGACGTCTTTCTCTCCCCACCAGCAGCCCCGCGAGGTCTCAAGCATGAGCCCCGGCAGAACCTG
CCGGGCGACCCCGGCTTCCTGAAGGTCGCGGAAGTAGTCGTCGTAATCGGGGGTTGGGAGAGAACTGAGATCCTTAGCCACAG
AGCGCTCGCTCGCTTCCGCCTGCAGCATGAGCCCTGTTGAGACCTGAAAGATCGACCCAGGCGCCCAGTCAGCGATGCGGCGC
ATGGCTTGCTCCCGGTCAGTTGCGTCCAGGATCAATGCACAGAACTCCGGAAAAAGGTCGTCCGCCTCGCCTGAGAACACGTG
ATCCACCCAGTCGAAACACTGCTTGAGCGCCTTACCCATTGGCCCCTCACAGTTCGCACCGCCCAT  
398 bp 
C Nostoc sp. PCC 7120 (NC_003272) 
GTTCAATCCACAAAAAGTGCAATGATGTTTTTGCCCCCACCAACATCCACGAGAGGTTTCAATCAAAAGTCCAGGTTGAATGT
AGGGCGAAAGTGTAGAAGCATGGAGGGTTTGAAAGTAATCATCGTAGTCAGGAATTGGTACTTGATCTAAGTTCTGTACGGAA
GCTCTTGGCGCGGCTATGCTGATTTTGGTAGAAGTCCGATGAGATGGACTAATTACACCATAAGGCAATATTGATGGATCAAC
CTCTCGACCACCATCCAAAAGCTGATAGCAAAACTCATTAAATAAATCGTCACCCTCTCCCGAAATGATAAAATCTACCCAAG
AAAAATGTGTGTGAGTAGCTAACCCCATAGCCCCTTCACAGTTAGCACCTCCCAT  
387 bp 
D  Stigmatella aurantiaca DW4/3-1 (NC_014623) 
CGTTGAGGCCACAGAAGGTGCAATGCGCCTTGGCACCCCACCAGCAACCGCGAGAGGACTCAGCGGTCAGGTTGGCGCGCTTG
GCCATCGGCATGTCCTTGATGGCCTGGAAGTAGTGATCGAAATCCGGCATCGGCAGCGAGTCCATGTTCTCGATCTGAGGCGC
CGCCACATAGCGCGGCTGCGGCCGGTTCGTCCCAGGGTTCAGCACCCCCTTGACGAGATCGAGGATGACCCCCTCCCCCTCTC
CGGAGACCACATGATCCAGGAAGGGGAAGTTGTCCGAGATCGCCTTGCCCATGTCCGCTTCGCAGTTGGCGCCCCCCA  
327 bp 
Figure 2 A - D) Amplicons obtained with the in silico PCR analysis. The accession number 
of the genome that was analysed is given in brackets. 
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A poyB 
CGCAGAAGGTGCACGGGTGTTTTTCCCCCCACCAGCAACCGCGCGCGGTCTCGACGAGAAGCCCAGGTGTCGCAAAGTATTCG
ATTTTTGTCTCTGCCAATTCGCGGAAGTAATCGTCGTAGTCCGGCAGGGGTAATCCGTCCATGTCCTGAGTCGTGGCGCGCTC
GACCACCTGAAAATTAGCGAACGGTCGGGACGCGGGGGTGAATACGAAACGGCGCAGCGCCTCGTTAGACGCGATGCCCGCAA
TGTCGTTGTGAAGAATCCGCTCGCAGAGGTCGGGGAACACCTCGTCCCCATCACCCGAGACGACGTAATCTACCCAGTCGAAG
TTCGTATGGAGAGCCCGCCCCATCTCGCTTTCACAGTTCGC 
373 bp 
B In vitro amplicon S. meliloti: 
TGTTCAGGCCGCAGAAGGTGCAGTGGCTGCGCTGCCCCCACCAGCAGCCGCGAGAGAACTCCATCGGCAGCCCGGGATAGACG
CGGTCGGCGTAGAGCGACTGATCGAGTTCGGCAAAATAGTCCGAGAAATCGGGCAGCGGCAGGTCATGCATATTCTCGACCAC
TGCGCGGGGCACCAAGTCGCCCGTTGTGGTCGCAGGATAGCCGGCCTTGCGATGTGCTGGACCAAAGACGCCGAATGGTAGGT
TGGCCGGCGGAATATCTTTACCGTGCTTTAAAATGTTGCGACAAAGCGGGCCGATCAGTGCGTCGGCCTCGCCCGACACGACG
TAGTCGACCCACGGGAAACTCGCGTGAGTGGTACGTCCCATCACCG 
378 bp 
C  
 
Figure 3 The in vitro PCR product of the control DNA: poyB (A) and the PCR product 
obtained from the gDNA of S. meliloti 1021 (B). C) BLAST analysis showed that the 
amplicon (from B; orange box) was a hit to the rSAM_ocin_1 protein (black box) in 
S. meliloti SM11. 
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Table 11 Examples of the nitrogen fixation related genes in Entotheonella spp. Nitrogen 
fixation genes (defined by their conserved domains) were used as the query for BLAST 
analysis. The analysis was restricted by selecting Candidatus Entotheonella (taxid: 93171) in 
the “Organism” field of the BLAST search set. All other settings were set as default. 
Conserved domain/ gene BLASTp (locus_tag) BLASTn 
nifD NA No significant similarity found 
nifH NA No significant similarity found 
nifK NA No significant similarity found 
nifE NA No significant similarity found 
nifN NA No significant similarity found 
nifB NA No significant similarity found 
NifA 
ETSY1_04610 
ETSY2_36840 
 
Nif11 
ETSY2_03690 
ETSY1_03980 
ETSY1_15720 
ETSY_26035 
 
NifM ETSY2_32570  
NA: not available 
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